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 Abstract 
 To overcome potential harmful threats from microbes, our immune system relies 
on complex mechanisms that involve interactions between diverse cells and proteins. 
Nowadays, growing evidence suggests that the ancient and highly conserved group of 
proteins belonging to the Scavenger Receptor Cysteine-Rich (SRCR) superfamily 
display a great functional variability, indispensable for the proper function of the 
immune system. This heterogeneous group is composed of membrane and soluble 
extracellular proteins that are expressed in various cell types, and some were found to 
mediate bacteria binding and possibly to contribute to the eradication of virulent 
agents. Human SSC5D is a soluble glycoprotein of the SRCR superfamily that consists 
of two structurally distinct parts: an N-terminal domain, which contains five SRCR 
domains, and a C-terminal mucin-like domain. In some members of this superfamily, 
the SRCR domains were shown to mediate protein-protein interactions and pathogenic 
recognition, suggesting that SSC5D can have a role as an innate sensor for 
pathogens. To better understand the function of SSC5D, we produced the two domains 
independently to screen for putative interactions with cell surface receptors and to 
explore the ability of SSC5D to bind bacteria through its SRCR domains. To further 
characterize the ability of N-SSC5D to interact with bacteria, we developed a novel and 
more sensitive approach using a surface plasmon resonance (SPR)-based method. 
Our results showed that despite no interactions with cell surfaces were observed at this 
stage, N-SSC5D could interact with bacteria, which makes this protein a potential 
receptor for bacterial sensing. Moreover, our studies of native SSC5D tissue 
distribution using a new antibody showed that SSC5D is highly expressed by epithelial 
cells at the interface of mucosal tissues and in placenta. The SSC5D privileged 
localization suggests an active role in the protection of mucosa from pathogens and at 
the maternal-foetal interface. These body locations are extremely vulnerable to 
infection and inflammation; therefore, to perceive the biological relevance of SSC5D 
we initiated a process of generation of a mouse deficient for the SSC5D gene. 
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Resumo 
 Para superar possíveis ameaças de agentes patogénicos, o nosso sistema 
imunitário depende de um conjunto de mecanismos complexos que envolvem 
interações entre diversas células e proteínas. Estudos recentes sugerem que os 
membros da antiga e altamente conservada família “Scavenger Receptor Cysteine 
Rich (SRCR)”, apresentam uma grande diversidade funcional, indispensável para um 
correto funcionamento do sistema imunitário. Estas proteínas, que podem ser 
membranares ou solúveis, são expressas em diversos tipos de células e formam no 
seu conjunto um grupo bastante heterogéneo, onde alguns membros se ligam a 
bactérias, possivelmente contribuindo para a sua erradicação. A glicoproteína SSC5D 
humana é um membro solúvel da superfamília SRCR, que consiste em duas partes 
estruturalmente distintas: um domínio N-terminal, que contém cinco domínios SRCR e 
um domínio C-terminal semelhante a uma mucina. Noutros membros desta 
superfamília, os domínios SRCR, mostraram-se capazes de mediar interações 
proteína-proteína e de detetar agentes patogénicos, sugerindo que o SSC5D pode 
também agir como um sensor inato para agentes patogénicos. Assim, para se 
compreender melhor a função do SSC5D, produzimos de forma independentes os dois 
domínios com o intuito de encontrar possíveis interações com recetores na superfície 
celular, e explorar a capacidade do SSC5D se ligar a bactérias através dos seus 
domínios SRCR. Adicionalmente, para se caracterizar com maior profundidade a 
capacidade do SSC5D se ligar a bactérias, desenvolvemos uma nova abordagem 
mais sensível que envolve a aplicação da técnica de ressonância de plasma de 
superfície (RPS). Os nossos resultados mostraram que, apesar de não termos 
observado nenhuma interação com a superfície das células nesta fase inicial, o 
domínio N-terminal da proteína SSC5D consegue interagir com bactérias, o que torna 
esta proteína é um potencial recetor para deteção de bactérias. Adicionalmente, 
utilizamos um anticorpo novo para analisar a distribuição da proteína nativa em 
diversos tecidos humanos. Nestes estudos observamos que o SSC5D é altamente 
expresso nas células epiteliais que se encontram na interface dos tecidos da mucosa 
e na placenta. Esta localização privilegiada sugere, que o SSC5D pode ter um papel 
ativo contra agentes patogénicos nas mucosas e também na interface materno-fetal. 
Como estes locais do organismo são extremamente vulneráveis à infeção e 
inflamação, iniciamos um processo para gerar um ratinho sem o gene SSC5D com o 
objetivo de se compreender melhor a relevância biológica do SSC5D.  
 ix 
 
Abbreviations 
AA  amino acid 
Ab   Antibody 
Ag   Antigen 
AIM  Apoptosis Inhibitory factor expressed by Macrophages  
ALCAM Activated leukocyte cell adhesion molecule 
APC   Antigen Presenting Cell 
BCR   B cell receptor 
bp  base pair 
BSA  Bovine Serum Albumin 
C-terminal  Carboxy-terminal  
CD   Cluster of Differentiation 
CLR   C-type lectin receptors 
CUB  Complement C1r/C1s, Uegf, Bmp1 
DAMP  Damage-associated molecular patterns 
DC  Dendritic cell 
DMBT1 Deleted in Malignant Brain Tumours 
EGF  Epidermal growth factor 
FACS   Fluorescently-activated Cell Sorting and Analysis  
FCS   Foetal Calf Serum 
HA   Hemagglutinin 
His  Histidine 
HIV  Human Immunodeficiency Virus 
HRP  Horseradish Peroxidase 
Ig   Immunoglobulin  
IFN  Interferon 
 x 
 
IHC  Immunohistochemistry 
IL  Interleukin 
IS  Immunological synapse 
ITAM  Immunoreceptor tyrosine based activation motif 
IP   Immunoprecipitation 
IS   Immunological Synapse 
ITIM   Immunoreceptor tyrosine based Inhibitory Motif 
Kd   Dissociation Constant 
kDa  Kilodaltons 
KO  Knockout 
LAT  Linker for activation of T cells 
LFA-1  Leukocyte function-associated antigen  
LPS  Lipopolysaccharide 
LTA  Lipoteichoic acid  
M160  Scavenger receptor cysteine-rich type 1 protein M160 
mAb  Monoclonal antibody 
MAPK  Mitogen-activated protein kinases 
MHC  Major Histocompatibility Complex 
MW  Molecular weight 
N-terminal Amino-terminal 
NF-κB  nuclear factor kappa B 
NK  Natural killer 
NLR  NOD-like receptors 
NOD   Nucleotide-binding oligomerization domains 
PAMP   Pathogen-associated molecular patterns 
PBL  Peripheral blood lymphocyte(s) 
 xi 
 
PBMC  Peripheral blood mononuclear cell(s) 
PE  Phycoerythrin 
PGN  Peptidoglycan 
Pro (P) Proline 
PRR  Pattern recognition receptor 
RLR  Retinoic acid-inducible gene (RIG)-I-like receptors 
Ser (S) Serine 
SID  SRCR Interspersed Domains 
SP  Surfactant proteins 
SPR  Surface plasmon resonance 
SR  Scavenger receptor 
SRCR  Scavenger receptor cysteine rich  
SSC4D Scavenger receptor cysteine rich family member with 4 domains 
SSC5D Soluble Scavenger with 5 SRCR Domains 
TCR  T cell receptor 
TCS  Tissue culture supernatant 
Th  T helper cell 
Thr (T) Threonine 
TLR  Toll-like receptors 
TNF  Tumor necrosis factor 
TWEAK TNF-like inducer of apoptosis 
Tyr  Tyrosine 
WB  Western blot 
WT  Wild-type 
ZP  Zona pellucida  
 
 
 xii 
 
 
  
  
 
 
 
General Introduction 
 

General Introduction 
3 
1. The immune system  
The second we are born and throughout our lifetime we continuously interact with 
trillions of microbial species (Bulek et al., 2010; Hancock et al., 2012). These include 
commensal bacteria that colonize the mucosal surfaces of our body and provide us 
with vital benefits such as products of the metabolism of nutrients in gut (Bulek et al., 
2010), but also pathogenic agents that can become lethal if not efficiently neutralized. 
The evolution of our immune system was therefore driven by the need to balance all 
these interactions so we can have an effective system that eliminates or neutralizes 
pathogens while preserving beneficial mutualistic relations (Hooper et al., 2012; Ayres, 
2016). Not surprisingly, the dysregulation of such a complex system often results in 
life-threatening infectious and inflammatory diseases (Takeuchi and Akira, 2010; 
Hancock et al., 2012; Hooper et al., 2012). At the same time, it is well established that 
even in the absence of an infectious organism, an altered or inappropriate activity of 
the immune system contributes to other pathologies such as cancer and autoimmune 
disorders (Crespo et al., 2013; Lu, 2013; Nishikawa and Sakaguchi, 2014; Singh et al., 
2014; Coffelt et al., 2015; Nelson et al., 2015). 
The immune system can be broadly divided into innate and adaptive arms that are 
nevertheless highly interdependent, and often effective responses encompass 
components of both systems (Flajnik and Du Pasquier, 2004; Hancock et al., 2012). 
Interestingly, as new immune mechanisms are being revealed such as ‘trained 
immunity’ properties in NK cells and macrophages, the distinction between the two 
arms is becoming less clear  (Flajnik and Du Pasquier, 2004; Litman et al., 2010; Netea 
et al., 2011). 
 
1.1. Microbial recognition by the immune system 
The main distinction between innate and adaptive immunity resides in the type of 
receptors used to recognize pathogens (Fig. 1) (Medzhitov, 2007). Innate cells sense 
microorganisms directly through pattern recognition receptors (PRR) that recognize 
‘immutable’ and defined microbial signature molecules, also known as pathogen-
associated molecular patterns (PAMP) that are foreign to the host (Janeway Jr and 
Medzhitov, 2002). These include bacterial and fungal cell wall components or viral 
nucleic acids (Littman 2010, Iwasaki 2015). PRR are germline-encoded and collectively 
enable the recognition of a wide universe of microbes (Litman et al., 2010). An even 
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larger universe of structures is recognized by B and T cells. These express unique 
types of functional receptors, generated by random genetic recombination, that 
recognize a particular antigen. Antigenic challenge leads to the activation and clonal 
expansion of monotype lymphocytes expressing a specific receptor, which results in 
the generation of both effector and ‘memory’ cells (Mahnke et al., 2013; Kugelberg, 
2015). 
 
 
Figure 1. Innate and adaptive immunity (Source: Kobayashi K., 2017; Retrieved from 
http://research4.dfci.harvard.edu/innate/innate.html). Innate immune cells include epithelial cells, 
phagocytic cells (macrophages and neutrophils), natural killer (NK) cells and dendritic cells (DC) that 
rapidly recognize conserved microbial structures through pattern recognition receptors (PRR). The 
specialized components of the immune system, the T and B lymphocytes, are activated trough their cell 
surface receptors (T- or B- cell receptor) that recognize specific antigenic structures. APC: Antigen-
presenting cell; MHC: Major histocompatibility complex; TCR: T- cell receptor. 
 
1.1.1. Innate immunity and PRR 
Microbial nonself recognition by PRR is an evolutionary conserved strategy used by a 
wide range of organisms to activate diverse cellular defence mechanisms. In response 
to virulent agents, innate cells produce pro-inflammatory cytokines, which alert other 
host cells to the occurrence of infection, promote recruitment of immune cells to the 
site of infection, stimulate cell differentiation and induce microbicidal mechanisms, like 
the production of reactive oxygen species (Janeway Jr and Medzhitov, 2002; Hancock 
et al., 2012). In addition, during infection microbe-invaded cells can emit danger or 
General Introduction 
5 
stress signals, which are sensed by PRR (Rivera 2016). As a consequence, PRR 
signalling triggers the expression of differential cytokine secretion to promote pathogen 
eradication (Fig. 2) (Rivera et al., 2016). 
Toll-like receptors (TLR) are the first and foremost studied class of PRR. Initially 
identified on the basis of sequence similarity with the Drosophila protein Toll, TLR are 
evolutionary conserved type 1 transmembrane proteins found in vertebrates, 
invertebrates and plants. Members of the TLR family have a common cytoplasmic 
domain designated Toll-1L-1R, or TIR domain, responsible for signal transduction, and 
an amino-terminal extracellular leucine-rich repeat (LRR) domain (Armant and Fenton, 
2002). Each member recognizes different microbial structures through differences in 
their extracellular domain (Akira et al., 2001; Armant and Fenton, 2002). TLR may be 
located on the cell surface or in the endosomal compartment and their expression is 
modulated in response to various stimuli (Akira et al., 2001). 
Evidence that TLR were PRR involved in mammalian innate immune defence stemmed 
from the discovery that a mouse strain hyporesponsive to lipopolysaccharide (LPS) 
carried a loss-of-function mutation in the TLR4 gene, thus establishing TLR4 as a 
putative receptor for LPS of Gram-negative bacteria (Poltorak et al., 1998; Armant and 
Fenton, 2002). This observation was confirmed by the generation of TLR4-/- knockout 
(KO) mice that could not trigger LPS-driven responses. However, overexpression of 
TLR4 in vitro was not sufficient to trigger an LPS-induced response, which suggested 
that other molecules were involved in LPS recognition. One such molecule was found 
to be the secreted MD2 protein that physically associates with the extracellular domain 
of TLR4 to recognize LPS in the presence of CD14, already described as binding LPS 
(Kim et al., 2005). Interestingly, the TLR4-MD2 complex is also responsible for the 
recognition of viral proteins and endogenous host proteins that result from stressed or 
damaged cells such as endogenous HSP60 and fragments of the extracellular matrix 
components like fibronectin (Ohashi et al., 2000; Okamura et al., 2001; Vabulas et al., 
2001; Mollen et al., 2006) 
Further studies using various KO mice challenged with diverse pathogens clarified the 
function of other TLR. Transmembrane TLR typically recognize microbial cell wall 
components or virulence factors. For instance, TLR2 in conjunction with TLR1 or TLR6 
recognize lipopeptides, Gram-positive bacteria and fungal cell wall components while 
TLR5 recognizes flagellin. Conversely, endosomal TLR sense microbial nucleic acids. 
TLR3 recognizes double-stranded RNA, TLR7 and TLR8 bind single-stranded RNA, 
and TLR9 recognizes unmethylated CpG dinucleotides (Hancock et al., 2012; Broz and 
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Monack, 2013). TLR signalling ultimately leads to the activation of nuclear factor-κB 
(NF-κB) and mitogen-activated protein kinase (MAPK) signalling, as well as IFN-
regulatory factors (IRFs) (Hatada et al., 2000). These pathways induce pro-
inflammatory cytokines, chemokines and type I interferons (IFN) resulting in the 
activation of cellular antimicrobial functions such as phagocytosis, oxidative burst and 
production of antimicrobial peptides (Hancock et al., 2012). 
Besides TLR, other families of PRR are also known to have relevant roles in pathogen 
recognition (Akira et al., 2001; Kawai and Akira, 2011). C-type lectin receptors (CLR) 
are a heterogeneous group of transmembrane (e.g., dectins, mannose receptor) or 
soluble proteins (e.g., collectins) with C-type lectin domains that recognize a wide 
range of carbohydrate ligands. These include b-glycans, mannose and fucose from 
fungi and bacteria, but they can also bind non-carbohydrate ligands (Cambi et al., 
2005). Transmembrane receptors are mainly expressed on immature dendritic cells 
and macrophages and can induce signalling pathways that directly activate NF-κB, to 
promote the production of pro-inflammatory cytokines and reactive oxygen species 
whereas other CLR affect signalling by Toll-like receptors (Geijtenbeek and Gringhuis, 
2009). On the other hand, soluble CLR such as collectins including the mannose-
binding lectin (MBL) and surfactants A and D, promote direct opsonization, 
agglutination, complement activation and phagocytosis (Hickling et al., 2004). 
In addition to transmembrane receptors, there are several classes of intracellular 
(cytosolic) PRR, including RIG-I-like receptors (RLR) and Nod-like receptors (NLR). 
RLR are comprised of three members RIG-I, Mda5 and LGP2, which detect unique 
types of viral RNA structurally different from host RNA, allowing the discrimination 
between viral and self RNA (Brubaker et al., 2015). Accordingly, in the presence of 
viral RNA, RIG-I and Mda5 are activated and induce antiviral immunity mediated by the 
production of type I interferons (Brubaker et al., 2015). The NLR family encompasses 
over 20 members described so far in humans that sense diverse microbial structures – 
important for the detection of intracellular microbes – and recognizes endogenous 
danger signals (Davis et al., 2011; Hancock et al., 2012). NLR sensing triggers 
signalling pathways that lead to the production of pro-inflammatory cytokines, 
chemokines and recruitment of neutrophils (Davis et al., 2011; Lupfer and Kanneganti, 
2013). In addition, some NLR members oligomerize to form a large protein complex 
termed inflammasome that induces the proteolytic cleavage and activation of caspase-
1, which subsequently promotes the maturation and secretion of IL-1β and IL-18 (Davis 
et al., 2011; Lupfer and Kanneganti, 2013). 
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Figure 2. Schematic representation of the pattern recognition receptors (PRR) signalling pathways. PRR 
recognize distinct pathogen-associated molecular patterns (PAMP) and play a critical role in innate 
immune responses. The major PRR are Toll-like receptors (TLR); C-type lectin receptors such as dectin, 
RIG-I-like receptors (RLR) and Nod-like receptors (NLR). PRR signalling activate multiple intracellular 
pathways that lead to the activation of nuclear factor-κB (NF-κB) and mitogen-activated protein kinase 
(MAPK) signalling, as well as IFN-regulatory factors (IRFs). This results in the production of pro-
inflammatory cytokines and chemokines, defensins and reactive oxygen species. In addition, upon 
stimulation by microbial and endogenous signals some NLR members oligomerize to form the caspase 1-
dependent inflammasome required for the processing and secretion of IL-1β and IL-18. (Image adapted 
from (Zhao 2014)). 
NLR
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Altogether, these (and other) PRR generate a diverse repertoire of antimicrobial 
responses that are immediately activated for controlling infection (Kawai and Akira, 
2011; Brubaker et al., 2015). However, these can be insufficient to eliminate pathogens 
and the adaptive immune system is often required to uphold the clearance of microbes.  
 
1.1.2. PRR and activation of adaptive immunity 
Vertebrates have evolved a sophisticated defence mechanism characterized by a high 
diversity of antigen receptors, antigen-derived lymphocyte clonal selection and 
expansion, the capacity to generate long-lasting memory cells that boost host response 
to a recurrent pathogenic attack, and a complex tolerance mechanism to ‘self’ 
(Mackay, 1991; Rajewsky, 1996; Nussenzweig, 1998; Pancer and Cooper, 2006).  
The vast repertoire of antigen receptors in B and T cells, generated by somatic 
recombination, can recognize and bind specifically to an astonishing number of 
antigens (Flajnik and Kasahara, 2010). The generation of this great variety of receptors 
was unravelled through the study of antibodies in the 1970s, namely with the discovery 
of the variable (V), diversity (D) and joining (J) rearrangement of immunoglobulin (Ig) 
genes (Tonegawa, 1983; Flajnik and Kasahara, 2010). A decade later, the 
transmembrane T cell receptor (TCR) was discovered and found to share a similar 
gene domain organization and rearrangement mechanism (Davis et al., 1984; 
Oettinger et al., 1990; Muramatsu, 2000). The process of V(D)J recombination allows 
the recombination of diverse gene segments into sequences encoding functional 
protein chains of immunoglobulins and T-cell receptors that collectively have an 
extraordinary binding diversity (Flajnik and Kasahara, 2010). However, such a diverse 
and random antigen-receptor repertoire must be tightly controlled to prevent harmful 
attacks to ‘self’ molecules (Sakaguchi et al., 2001). Therefore, vertebrates have also 
evolved several immunological self-tolerance mechanisms to maintain a viable immune 
system (Sakaguchi, 2000). For example, during thymic selection T cells that express 
TCRs with high avidity for self-peptides are eliminated through TCR-agonist-induced 
apoptosis, whereas the ones that escape this selection are restrained by a 
subpopulation of mature peripheral T cells, namely CD25+CD4+ regulatory T cells 
(Treg) that supress self-reactive T cell activation and negatively control several 
immune responses (Sakaguchi, 2004; Feng et al., 2015). 
Conventional B and T lymphocytes exist as naïve cells until they encounter a cognate 
antigen to become activated. This activation is only possible because components of 
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the innate system are capable, in an earlier phase, to sense pathogenic structures and 
present them to lymphocytes (Wykes et al., 1998; Villadangos and Schnorrer, 2007). 
Moreover, because adaptive immunity may require several days to develop an 
effective antimicrobial effect, innate immunity acts as the first line of defence (Levy and 
Netea, 2014). 
 
T cells 
The majority of TCRs are heterodimers consisting of an α and a β chain that recognize 
antigenic fragments, resulting from partially digested microbial agents, that are bound 
to the surface of major histocompatibility complex (MHC) class I or class II molecules 
encoded by antigen-presenting cells (APCs). Mature T cells express a complex of CD3 
molecules associated with the TCR and are divided into two linages: CD8+ and CD4+ 
T cells that recognize peptides presented by MHC class I and class II, respectively. 
MHC class I molecules are expressed by all nucleated cells, and present protein 
fragments of cytosolic and nuclear origin, whereas MHC class II molecules are 
primarily expressed by professional APC, such as dendritic cells (DC), macrophages 
and B cells and present peptides derived from endocytic vesicles (Neefjes et al., 2011). 
In addition to directly activating T cells, some APC work as “instructors” for the 
adaptive response. In this case, the microbial structure recognized by PRR will dictate 
the type of T cell response by establishing an association between the antigen 
recognized by the lymphocyte and the microbe (Fearon and Locksley, 1996; 
Medzhitov, 2007). Evidence suggests that this instruction is mainly provided by 
different DC populations that are specialized for the induction of different T cell effector 
responses (Iwasaki and Medzhitov, 2015). For example, DC that express RLR, NLR 
and TLR3 produce type 1 interferons and IL-12 in response to viruses and virus-
infected cells. This in turn leads to the differentiation and activation of CD8+ cytotoxic T 
lymphocytes (CTL), those cells responsible for the clearance of cells presenting 
antigens derived from cytosolic viruses and intracellular bacteria (Iwasaki and 
Medzhitov, 2015). On the other hand, CD4+ T cells or ‘Helper T cells’ can differentiate 
into several types of effector cells, characterized by the production of distinct sets of 
cytokines (Medzhitov, 2007).  
Briefly, Th1 cells are activated through the expression of IL-12 secreted by DC after the 
engagement of PAMP from intracellular bacteria and protozoa with TLR present on 
DC. Afterwards, Th1 cells secrete pro-inflammatory cytokines such as IFNg that 
General Introduction 
10 
activate macrophages and other cell types to induce robust antimicrobial and 
phagocytic responses, including the production of reactive oxygen and nitrogen 
species (Iwasaki and Medzhitov, 2015). Allergens and helminths indirectly activate Th2 
cells differentiation, which produce a myriad of cytokines that instruct B cells to 
produce IgG1 and IgE, activate macrophages, recruit eosinophils and basophils, and 
act on epithelial cells and smooth muscle, to collectively enhance barrier defence, 
tissue repair and expel worms and allergens (Iwasaki and Medzhitov, 2015; Zhu, 
2015). Nevertheless, a sensor for helminth detection is yet to be uncovered and 
differentiation of CD4+ T cells in this subtype remains elusive (though some studies 
correlate Th2 effector responses with a subpopulation of DC (Gao et al., 2013; 
Kumamoto et al., 2013). Finally, Th17 cells secrete IL-17 and IL-22 that mediate host 
defence against extracellular bacteria and fungi, by inducing epithelial cells to produce 
chemokines to recruit neutrophils and production of antimicrobial peptides (Liang et al., 
2006; del Fresno et al., 2013; Segura et al., 2013). For instance, dectin-1 engagement 
stimulates the production of IL-6, IL-23 and IL-1β, critical for Th17 differentiation and 
function (Zielinski et al., 2012; del Fresno et al., 2013). 
However, and despite this protective effect against microbes, under certain conditions 
T cells and their effector molecules are often linked to autoimmune, inflammatory and 
allergic diseases (Hedegaard et al., 2008; Maddur et al., 2012; Harbour et al., 2015). 
 
B cells 
The B cell receptor (BCR) is composed of a membrane bound immunoglobulin (mIg), 
that can recognize exposed antigenic determinants (epitopes) of intact molecules, 
such as surface proteins and carbohydrate moieties of invasive microbes (Klein, 1997). 
In addition, the BCR has an intracellular Igα/Igβ heterodimer responsible for signal 
transduction (Yuseff et al., 2013). Initially, antigen binding to BCR triggers signals that 
stimulate the internalization of the BCR-antigen complex; after endocytosis, the antigen 
is processed within the lysosome, and then the peptide fragments are presented to 
CD4+ T cells (Malhotra et al., 2009; Yuseff et al., 2013). This T cell–B cell cooperation 
provides the stimuli for the activation of B cells that differentiate into antibody-secreting 
plasma cells (that secrete antibodies with the same antigen binding specificity) and 
develop into memory B cell populations (LeBien and Tedder, 2008; Yuseff et al., 2013). 
The secreted antibodies neutralize pathogens through aggregation mechanisms, 
hamper microbe adhesion to tissues, and interfere with pathogen attachment to host 
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ligands. Moreover, antibodies can activate the complement cascade, which results in 
the lysis of pathogens or infected cells, promotes phagocytosis of antibody-coated 
infected cells and modulates inflammation (Forthal, 2014). 
 
Co-signalling molecules 
In addition to the antigen binding chains of TCR and BCR, other transmembrane 
proteins coupling to the TCR and BCR complexes are fundamental to trigger the 
intracellular signals required for an efficient immune response (Smith-Garvin et al., 
2009). Unlike innate immune cells that can recognize microbial structures and 
immediately initiate a signalling pathway, T and B cells need a close physical 
association with APC to become activated (Bretscher and Cohn, 1970; Grakoui et al., 
1999). This association is a dynamic process and involves the formation of an area of 
intimate membrane contact between the two cells known as the immunological 
synapse (IS) (Grakoui et al., 1999). During IS assembly, a functional structure of multi-
molecular complexes is formed in the T cell-APC interface (Monks et al., 1998). 
Surface molecules include adhesion and co-signalling molecules that have a crucial 
role in regulating T cell activation, subset differentiation, effector function and survival. 
The interaction of adhesion molecules such as the lymphocyte function-associated 
antigen (LFA-1) on T-cells and the intercellular adhesion molecule (ICAM-1) on APC 
enhances the physical interaction of T cells with APC, increasing the TCR avidity for 
MHC/peptide (Bachmann et al., 1997). Moreover, LFA-1 contributes to a characteristic 
organization of the actin cytoskeleton, providing signals that elevate intracellular 
calcium, thereby contributing to T cell activation and MAPK pathway activation (Dustin, 
2007). A similar structure is observed in B cell synapses (Carrasco et al., 2004; Yuseff 
et al., 2013). 
Co-signalling molecules positively (co-stimulatory receptors) or negatively (co-inhibitory 
receptors) modulate TCR signalling. One of the best studied co-stimulatory molecule 
on T cells is CD28 that is constitutively expressed on the naive T cell surface where it 
interacts with its ligands CD80 and CD86 on the APC surface providing a key second 
signal for an efficient activation of T cells (Lenschow et al., 1996). Without this 
interaction, T cells are unresponsive to antigen presentation and no effector functions 
are observed. Interestingly, the CD80 and CD86 molecules are also ligands for the 
inhibitory protein cytotoxic T lymphocyte antigen-4 (CTLA-4), which is responsible for 
shutting down T cell activation (Walunas et al., 1994; Wing et al., 2008). Despite 
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sharing the same ligands and being structurally related, the expression profile and the 
ligand affinities vary remarkably between CD28 and CTLA-4. Accordingly, CD28 is 
constitutively expressed in T cell surfaces, whereas the surface levels of CTLA-4 are 
extremely low, though these can be rapidly up-regulated following T cell activation 
(Chambers et al., 2001). Moreover, CTLA-4 has approximately a 10-fold higher affinity 
for CD80 and CD86 compared to CD28 (Chambers et al., 2001). Accordingly, the 
induction of CTLA-4 expression upon T-cell activation works as an important 
mechanism to balance T cell responses and prevent a continuous inflammatory state 
(Saito and Yamasaki, 2003; Rudd et al., 2009). Likewise, additional co-signalling 
receptors are known to contribute to the outcome of an immune response – but little is 
known regarding their downstream signalling events and immunological functions 
(Chen et al., 2013). 
 
2. The Scavenger Receptor Cysteine Rich Superfamily 
and the Immune System 
The Scavenger Receptor Cysteine-Rich superfamily (SRCR-SF) consists of an ancient 
and highly conserved group of proteins that share one or more domain structures 
similar to the C-terminal cysteine-rich domain of the type 1 macrophage scavenger 
receptor (SR-A) (Freeman et al., 1990). Initially identified in the human T cell surface 
receptor CD5 and in the sea urchin echinoidea sperm speract receptor, SRCR 
domains are present in representatives from all animal phyla ranging from vertebrates 
(sea lamprey, avian, amphibian and mammals) to invertebrates (echinoderms, 
sponges and insects) (Sarrias et al., 2004b). Receptors of the SRCR-SF were shown 
to bind a wide range of ligands including endogenous molecules and pathogens and 
were proposed to play a role as PRR and to contribute to organism homeostasis 
mainly by regulating inflammatory signals (Sarrias et al., 2004b). 
Members of the SRCR superfamily can be membrane-associated or secreted and are 
divided in two groups, A or B, depending on the number of cysteine residues and the 
resulting disulphide-bond pattern established (Resnick et al., 1994; Sarrias et al., 
2004b). SRCR domains are approximately 100-110 residues long and in group A 
contain six cysteines that form three disulphide bonds, while in group B these have 
eight cysteine residues forming four disulphide bonds (Sarrias et al., 2004b). The 
relative position of cysteines within each group is conserved giving rise to well-defined 
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intradomain disulphide bonds (Resnick et al., 1996; Sarrias et al., 2004b) (Fig. 3). The 
SRCR domains in group A are encoded by split exons while in group B are coded by 
single exons (Aruffo et al., 1997; Sarrias et al., 2004b). 
The crystal structure of an SRCR domain was first reported for the group A Mac-2 
binding protein, which has a single SRCR domain (Fig. 3A). Structural data analysis 
revealed a compact fold curved six-stranded β-sheet cradling an α-helix (Hohenester et 
al., 1999). This structure is also valid for group B SRCR domains as confirmed by the 
analysis of the membrane-proximal third SRCR domain (Fig. 3B) (Rodamilans et al., 
2007) and the distal SRCR domain one of CD5 (Garza-Garcia et al., 2008). 
  
Figure 3. Arrangement of the disulphide bridges in the SRCR domains of group A (above) and B (below). 
Structural analysis of the Mac-2 binding protein (A) and the 3rd extracellular SRCR domain of CD5 (B) 
(Protein data bank ID: 1BY2 and 2OTT).  
Despite the presence of the highly conserved SRCR domain, members of the SRCR-
SF represent an extremely heterogeneous group that display a great functional 
versatility. This heterogeneity arises from subtle differences in the sequence of the 
SRCR domain that can affect the three-dimensional structure of each receptor 
(Hohenester et al., 1999), and also in the number of SRCR domains existent in the 
receptor, which are found singly or in tandem (up to fourteen SRCR). Also, SRCR 
receptors are frequently multidomain proteins, exhibiting other functional domains such 
as epidermal growth factor (EGF), collagen, complement C1r/C1s, Uegf, Bmp1 (CUB), 
zona pellucida (ZP), among others, that are involved in diverse biological roles 
including growth and developmental patterning, tissue repair, tumour suppression and 
inflammation (Martínez et al., 2011). 
Nevertheless, SRCR domains are common in a wide range of proteins linked to the 
immune system and are thought to mediate protein-protein interactions (Hohenester et 
al., 1999; Bowdish and Gordon, 2009). In fact, mounting evidence strongly supports 
the view that SRCR proteins are relevant in diverse immune mechanisms, including 
A 
B
α-helix
α-helix
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cell activation (Vilà et al., 2001; Gimferrer et al., 2004) pathogen sensing (Kang and 
Reid, 2003; Bikker et al., 2004; Sarrias et al., 2005; Sarrias et al., 2007; Fabriek et al., 
2009; Vera et al., 2009) and inflammation (Soldevila et al., 2011; Moeller et al., 2012; 
Rodriguez et al., 2012; Etzerodt and Moestrup, 2013; Sanjurjo et al., 2015).  
 
2.1. Structure and Function of SRCR-SF Group B members 
To date, the human group B SRCR-SF family is found to be comprised of nine 
members, some with restricted expression in immune cells like CD163, 
M160/CD163L1, CD5, CD6 and Spa/ CD5L, whereas DMBT1, SSC4D, SSC5D and 
SCART1 are also found in nonimmune cells especially in the epithelia of the digestive, 
respiratory, and urinary tracts (Martínez et al., 2011).  
Despite the increasing body of work highlighting the importance of SRCR proteins, the 
biological functions and ligand-binding properties of SRCR domains are poorly 
understood (Hohenester et al., 1999). In the following sections, we cover the current 
knowledge on the role of SRCR receptors in the immune system.  
 
CD5 and CD6 
Lymphocyte accessory receptors 
CD5 and CD6 are close relatives within the SRCR-SF, their genes map to contiguous 
regions of human chromosome 11q12.2 (mouse chromosome 9) and share a similar 
domain organization, which is consistent with a duplication of a common ancestral 
gene (Lecomte et al., 1996; Bowen et al., 1997). CD5 and CD6 genes encode type 1 
lymphocyte transmembrane glycoproteins of 67 kDa and 105 to 130 kDa (depending 
on glycosylation and phosphorylation) respectively, and contain three extracellular 
SRCR domains each, a transmembrane region and cytoplasmic tails well-suited for 
signal transduction (Hassan et al., 2004; Sarrias et al., 2004b). The structural 
differences between CD5 and CD6 rest on the unusual long tail of CD6 (Aruffo et al., 
1997) that can give rise to five isoforms resulting from alternative splicing events 
(Bowen et al., 1997) and on the uncommon SRCR domain 2 of CD5 which, like group 
A members, has six cysteines. CD5 and CD6 are primarily expressed by thymocytes, 
mature T cells and the small B1a subset (Aruffo et al., 1997). In addition, CD6 
General Introduction 
15 
expression has also been reported in various brain regions, especially in basal ganglia 
and cortex cerebellum (Mayer et al., 1990), as well as on NK cells (Zimmerman et al., 
2006). 
CD5 and CD6 physically associate with the antigen specific receptor complexes of the 
T and B cell receptors (Beyers et al., 1992; Lankester et al., 1994) and colocalize with 
the TCR/CD3 complex at the centre of the immunological synapse (Brossard et al., 
2003; Gimferrer et al., 2004; Zimmerman et al., 2006). T cell activation solely through 
TCR signal might be ineffective resulting in a non-responsive state (anergy), in which T 
cells fail to proliferate and secrete cytokines in response to restimulation (Chambers et 
al., 1997; Smith-Garvin et al., 2009). Costimulation by other cell surface receptors, 
such as CD28, delivers additional signals to T cells that activate multiple effector 
pathways necessary for optimal T cell activation (Smith-Garvin et al., 2009). 
Conversely, other receptors transduce inhibitory signals that limit the stimulatory 
signals and negatively regulate TCR signalling leading to a downregulation of T cell 
responses (Chambers et al., 1997; Smith-Garvin et al., 2009). Since many of these 
observations hinted that CD5 and CD6 could have a functional role in T cell 
development and activation (Martínez et al., 2011), functional studies were undertaken 
to evaluate the response of CD5 and CD6 to several stimuli and differentiation stages. 
Initial experiments addressing the functional activity of CD5 and CD6 relied on the use 
of monoclonal antibodies (mAb) and suggested a costimulatory role in lymphocyte 
activation for both accessory proteins regulated by TCR signalling (Gangemi et al., 
1989; Bott et al., 1993; Osorio et al., 1994; Starling et al., 1996; Hassan et al., 2004). 
However, the generation of CD5-deficient mice (CD5-/-) revealed that thymocytes were 
hyperresponsive to TCR stimulation and that signalling through the BCR leaded to 
apoptosis resistance and clonal expansion of B-1 cells, supporting the idea that under 
certain circumstances and maturation states, CD5 acts as a negative modulator of cell 
activation (Tarakhovsky et al., 1995; Bikah et al., 1996; Lozano et al., 2000). 
Interestingly, studies with transgenic mice concluded that CD5 surface expression is 
regulated by the intensity of the TCR signal and by TCR-ligand avidity during 
thymocyte selection, suggesting a fine tuning of TCR signalling by CD5 (Azzam et al., 
1998; Azzam et al., 2001), in which CD5 surface levels on thymocytes and peripheral T 
cells parallel the avidity of their TCRs (Fulton et al., 2015; Orta-Mascaró et al., 2016). 
Moreover, the integral cytoplasmic domain of CD5 is required for its inhibitory function 
suggesting that this effect depends on intracellular effector molecules (Azzam et al., 
2001).  
General Introduction 
16 
The highly conserved cytoplasmic domain of CD5 lacks intrinsic catalytic activity but 
contains multiple Ser/Thr and Tyr phosphorylation sites, including two potential 
immunotyrosine-based inhibition motifs (ITIM) (Jones et al., 1986) that can interact with 
various signalling proteins, including the SH2 domain-containing phosphotyrosine 
phosphatase SHP-1 (Carmo et al., 1999; Perez-Villar et al., 1999), that has been 
implicated in the negative regulation of signalling events (Zhang et al., 2000). 
Conversely, the extracellular domain of CD5 was found to be dispensable for CD5-
mediated inhibition of TCR signalling during thymic selection and development 
(Bhandoola et al., 2002). Still, and although our understanding of CD5 function and 
signalling mechanisms is increasing, a definite counter receptor for CD5 is yet to be 
discovered. Notwithstanding, several groups reported putative ligands for CD5 such as 
CD72 (Van de Velde and von Hoegen, 1991), gp35-40 (Biancone et al., 1996), gp150 
(Calvo et al., 1999b), the framework region of IgVH (Pospisil et al., 2000), and CD5 
itself (Brown and Lacey, 2010); nonetheless, a definitive and independent experimental 
validation of these results is required. 
In contrast to CD5, CD6 has a well-known ligand, the cell surface protein activated 
leukocyte cell adhesion molecule (ALCAM/CD166) (Bowen et al., 1995), a widely 
expressed protein with five immunoglobulin superfamily (IgSF) domains found on both 
hematopoietic and nonhematopoietic cells (Chitteti et al., 2013). The CD6-CD166 
interaction is mediated through the extracellular third (membrane proximal) SRCR 
domain of CD6 (CD6d3) and the N-terminal domain IgSF domain of CD166 (Whitney et 
al., 1995; Bowen et al., 1996). Furthermore, this interaction is critical to localize CD6 to 
the IS (Gimferrer et al., 2004; Castro et al., 2007). 
The structure of CD6 and the binding region of CD166 have been recently resolved by 
X-ray crystallography (Chappell et al., 2015). Chappell and colleagues emphasized 
that the nonlinear domain organization of the three SRCR domains may be important 
to regulate the accessibility of CD166 to the membrane proximal domain of CD6 
favouring the formation of CD6-CD166 heterodimers over an already described 
homophilic CD166-CD166 interaction (Chappell et al., 2015). Notably, the CD6-CD166 
interaction was the first demonstration that SRCR domains were indeed capable to 
interact with proteins (Bowen et al., 1996). 
The function of CD6 in TCR signalling has been a matter of intensive research. The 
complexity of the TCR-mediated activation of T cells and the existence of a cognate 
ligand limited progress on understanding CD6 function during T cell development and 
activation. Previous experiments using anti-CD6 mAb have suggested that CD6 could 
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activate T cells and enhance TCR/CD3-mediated T cell proliferation (Osorio et al., 
1994; F Santos et al., 2016). In addition, the CD6-CD166 interaction was considered 
critical for optimal T cell activation and proliferative responses, as its disruption 
decreased T cell activation responses (Gimferrer et al., 2004; Hassan et al., 2004; 
Zimmerman et al., 2006). Considering these results, CD6 was viewed as a 
costimulatory molecule. However, some of the experiments were considered not to 
mimic the real contribution of CD6 in the observed responses and a role for CD6 
remains unclear. In contrast to the proposed costimulatory role, recent findings showed 
that an increase on the expression levels of CD6 attenuates T cell activation by 
reducing calcium responses and late events such as IL-2 secretion and T cell 
proliferation (Oliveira et al., 2012). Moreover, the presence of CD6 in the IS as well as 
the interaction CD6-CD166 were not necessary for the inhibitory role of CD6 (Oliveira 
et al., 2012). Once again, the inhibitory regulation was dependent of the cytoplasmic 
domain of CD6 (as happens with CD5), but the mechanisms that lead to this inhibition 
are unclear. 
The recent generation of mice deprived of the CD6 gene (CD6-/-) has shed some light 
on the role of CD6 in T cell development and activation in vivo (Orta-Mascaró et al., 
2016). This study showed that CD6-/- mice have increased numbers of immature 
thymocytes, implying a role for CD6 in tymocyte selection, and that immature 
tymocytes were hyperresponsive to TCR crosslinking (measured by intracellular Ca2+ 
flux). In vitro experiments established that the activation of CD6-/- T cells increased the 
expansion of peripheral T cells, especially Treg. The latter presented a lower 
suppressive activity when compared with Treg from CD6+/+ mice, indicating that CD6 
deficiency might hamper Treg cell effector function (Roncagalli et al., 2014; Schmidt et 
al., 2015; Orta-Mascaró et al., 2016). The biological significance of these results was 
further explored in an induced model of T cell–mediated autoimmune disease 
resembling rheumatoid arthritis, where CD6-/- mice revealed a less-favorable clinical 
evolution confirmed by an increase in inflammation and IL-6 and TNF secretion, when 
compared with CD6 +/+ mice (Orta-Mascaró et al., 2016). 
This study reinforced the idea that the expression of CD5 and CD6 is, as already 
suspected, somehow correlated (see below). On one hand thymocytes and T cells of 
CD6-/- mice revealed a slightly reduced expression of CD5 when compared with CD6+/+ 
mice, and on the other in CD5-/- mice the expression of CD6 in T cells was increased 
(Orta-Mascaró et al., 2016). These changes are worthy to further investigate as they 
General Introduction 
18 
might provide insights regarding the regulation of both receptors (Orta-Mascaró et al., 
2016).  
Altogether, these results suggested that CD6 is a negative regulator of thymic and 
peripheral TCR-mediated signalling. Still, the precise mechanisms underlying this 
function are largely unexplored. One hypothesis is that CD5 may be responsible for the 
inhibitory role of CD6 (Oliveira et al., 2012; Orta-Mascaró et al., 2016). Interestingly, 
CD5 and CD6 physically associate at the surface of T cells and CD6 stimulation leads 
to the phosphorylation of tyrosine residues in CD5 (Castro et al., 2003; Gimferrer et al., 
2003; Oliveira et al., 2012), which represents an example of function connectivity 
between these two receptors. 
 
Role as PRR 
Though initial studies focused on the function of membrane-bound CD5 and CD6 in 
lymphocyte activation, there is evidence that the ectodomains of the two proteins, 
containing the SRCR domains, exist as soluble glycoproteins (sCD5 and sCD6) in the 
serum resulting from their proteolytic cleavage of the membrane form (Calvo et al., 
1999a; Ramos-Casals et al., 2001). The extracellular moieties of CD5 and CD6 share 
high homology with the N-terminus domain of DMBT1 and Spα, soluble glycoproteins 
that bind bacteria (Sarrias et al., 2004b), so sCD5 and sCD6 were proposed to have 
the same capacity (Sarrias et al., 2007). Indeed, this hypothesis was confirmed for 
sCD6, which could interact and aggregate Gram-negative and Gram-positive bacteria 
through LPS or LTA and PGN recognition, but not for sCD5, which failed to bind 
bacteria (Sarrias et al., 2007; Martínez-Florensa et al., 2013). In vivo experiments 
showed that the prophylactic administration of recombinant sCD6 improved the survival 
of mice in models of LPS- (Sarrias et al., 2007) and Gram-positive- (Martínez-Florensa 
et al., 2013) induced septic shock as well as in a lethal model of polymicrobial sepsis 
(Martínez-Florensa et al., 2017). rCD6 pre-treated mice exhibited low levels of the 
proinflammatory cytokines TNF-α, IL-1b and IL-6 in serum (Sarrias et al., 2007; 
Martínez-Florensa et al., 2013; Martínez-Florensa et al., 2017). Nonetheless, sCD5 
was later reported to bind pathogenic and saprophytic fungi, through the cell wall 
component b-glucans, while sCD6 could only bind to saprophytic fungi (Vera et al., 
2009). Moreover, sCD5 induced fungal cell aggregation, a mechanism that immobilizes 
and enhances phagocyte uptake of pathogens. Membrane-bound CD5 also binds 
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zymosan and this interaction mediates signalling events such as the activation of 
MAPK cascade and induced IL-8 cytokine release (Vera et al., 2009). 
Similarly to CD6, an anti-inflammatory role for sCD5 was also predicted using a mouse 
model of septic shock-like syndrome induced by zymosan (Genovese et al., 2004; Vera 
et al., 2009). In this experiment, human recombinant ectodomain CD5 (rhCD5) was 
injected in mice prior to zymosan challenge, which resulted in a beneficial outcome 
when compared with untreated mice. The survival rate was improved, and the serum 
levels of IL-6 and IL-1b were reduced and so were peritoneal and liver leukocyte 
infiltrates. Interestingly, rhCD6 did not have a protective effect on the mice response to 
zymosan (Vera et al., 2009). Taken together, these studies clearly indicate that 
although CD5 and CD6 share similar extracellular and soluble protein structures there 
is a clear specificity with regard to their function in pathogen sensing. More recently, 
CD5 was shown to increase the susceptibility of hepatitis C virus infection of human T 
lymphocytes (Sarhan et al., 2012). 
 
Spα/AIM/CD5L 
Spa, also known as AIM (apoptosis inhibitory factor expressed by macrophages), Api6 
(apoptosis inhibitor 6) or CD5L (CD5-like), is a secreted glycoprotein composed of 
three SRCR domains, expressed by tissue macrophages in the lymphoid organs 
including spleen, lymph nodes, thymus, bone marrow and foetal liver, and in lung 
epithelial cells (Gebe et al., 1997). Studies using mAbs revealed the existence of two 
human Spa isoforms of 38 and 40 kDa, whose difference was attributed to different 
sialic acid content (Sarrias et al., 2004a). Spa is a serum circulating protein with a high 
concentration level (2.5-10 µg/ml) that can be further increased upon inflammatory and 
infection conditions (Sanjurjo et al., 2015). In blood, Spa circulates associated with 
IgM, which protects Spa from renal excretion, contributing to the maintenance of its 
high levels in serum (Tissot et al., 2002; Arai et al., 2013). 
Spa expression is positively regulated by the transcription nuclear factors liver X 
receptor/retinoid X receptor (LXR/RXR) heterodimers, which are involved in lipid 
homeostasis (Joseph et al., 2004), and its expression is induced in macrophages by 
25-hydroxycholesterol and oxidized low-density lipoprotein (oxLDL) (Amézaga et al., 
2014; Sanjurjo et al., 2015). Spa is a truly multifunctional protein involved in apoptosis, 
lipid metabolism, inflammation and pathogen sensing (Sanjurjo et al., 2015). 
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Apoptosis inhibition 
The mouse homolog of Spa (~70% identity), better known as AIM (Gebe et al., 2000), 
was linked to an increase in the susceptibility of thymocytes to apoptosis induced by 
both irradiation and dexamethasone stimuli in AIM-deficient (AIM-/-) mice (Miyazaki et 
al., 1999). This observation was further corroborated by experiments in which the 
addition of recombinant AIM (rAIM) improved the survival rate of AIM(-/-) purified 
thymocytes (Miyazaki et al., 1999). One pioneer study, using AIM(-/-) mice, associated 
the anti-apoptotic effect of AIM expression in macrophages to atherosclerosis 
development (Arai et al., 2005). In this condition the fatty deposits on the arterial walls 
are rich in macrophages that uptake oxLDL and accumulate cholesteryl esters inside 
cytoplasmic lipid droplets (Tontonoz et al., 1998). These high-content lipid 
macrophages morph into “foam cells”, which contribute to the initiation and expansion 
of atherosclerosis lesions (Tontonoz et al., 1998). Since the environment at these 
lesions is extremely proapoptotic (Geng and Libby, 2002), macrophages increase AIM 
expression to protect themselves from apoptosis, maintaining a state of chronic 
inflammation that promotes the progression of the disease (Arai et al., 2005). 
Accordingly, during several inflammatory conditions macrophages infiltrate into 
damaged tissues and increase their Spa expression to inhibit apoptosis, resulting in 
diseases such as chronic kidney disease, obesity-associated inflammatory diseases 
and liver cirrhosis (Sanjurjo et al., 2015). 
 
Role in pathogen recognition 
Spa binds and aggregates several Gram-positive and Gram-negative bacteria as well 
as fungi. This receptor recognizes LPS and LTA (through non-overlapping sites in 
humans) (Sarrias et al., 2005) and the fungal cell wall components Zymosan, mannan 
and b-D-glucan (Martinez et al., 2014). In the presence of Spa, monocytes stimulated 
with various PAMP showed a decrease in TNF-a and IL-8 secretion (Sarrias et al., 
2005), which might work as a mechanism to protect tissues from local inflammation 
(Martinez et al., 2014). In addition, secretion of AIM by macrophages could be 
stimulated by the presence of bacterial and fungal PAMP (Martinez et al., 2014). In 
vivo experiments showed that mice challenged with Zymosan or LPS have decreased 
levels of soluble AIM, suggesting that in an early phase of infection soluble AIM might 
bind PAMP to help in their removal (Martinez et al., 2014). Altogether, these 
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observations suggest that AIM might prevent PAMP-induced sepsis and septic shock 
syndrome.  
Interestingly, in vitro experiments showed that Spa upregulates the expression of 
antimicrobial peptides and reactive oxygen species in macrophages infected with 
intracellular Mycobacterium tuberculosis, resulting in a decrease of approximately 
~70% in the number of intracellular bacteria (Sanjurjo et al., 2013). Moreover, as an 
anti-apoptotic protein, AIM protects macrophages against apoptosis induced by several 
pathogens, including Bacillus anthracis, Escherichia coli, Salmonella typhimurium, and 
Listeria monocytogenes (Sanjurjo et al., 2015).  
 
Lipid metabolism 
Soluble Spa typically binds to the endocytic scavenger receptor CD36, a widely 
expressed and multifunctional protein. In adipocytes and hepatocytes, the CD36-Spa 
interaction results in the internalization of Spa, which binds to and inactivates the 
cytoplasmic fatty acid synthase inducing a lipolytic response (Kurokawa et al., 2010). 
This mechanism is important to regulate cellular fat deposition in order to prevent 
diseases such obesity and fatty liver (Sanjurjo et al., 2015).   
 
Spa lipid metabolism and regulation of Th17 profile 
Gaublomme (2015) and Wang (2015) have shown that Spa is the functional switch that 
controls the function of Th17 cells. These cells display a multiplicity of functions that 
include the maintenance of a healthy gut mucosa (Guglani and Khader, 2010) and 
support the host defence against fungi (e.g C. albicans and Aspergillus fumigatus) and 
bacteria (e.g. Staphylococcus aureus and Klebsiella pneumoniae) and invasion 
(Khader et al., 2009; Kolls and Khader, 2010). However, some Th17 cells might be 
considered pathogenic as they relate to numerous autoimmune and inflammatory 
diseases such as rheumatoid arthritis, systemic lupus erythematosus, multiple 
sclerosis, psoriasis, inflammatory bowel disease, allergy and asthma (Maddur et al., 
2012). Surprisingly, the mechanism by which Th17 cells are converted into pathogenic 
cells was found to be associated with T cell lipid metabolism. Wang et al. (2015) 
reported that Spa was expressed preferentially in non-pathogenic Th17 cells and that 
its loss converts Th17 cells into “pathogenic” cells. These studies revealed that Spa 
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regulates Th17 cell function by regulating the fatty acid profile of T cells, which in turn 
modulate the activity of RORgt, the master transcription factor of Th17-cell 
differentiation (Wang et al., 2015).  
 
“Soluble scavenger proteins” and biological garbage clearance  
The so-called “biological garbage” is constitutively produced by our body and includes 
cancer cells, apoptotic or necrotic cells, degenerated cells/proteins and pathogen-
invaded cells (Miyazaki and Arai, 2015). These products must be quickly cleared from 
our system to prevent chronic inflammation and allow normal tissue regeneration. The 
inflammatory environment state is mainly promoted through the release of damage-
associated molecular patterns (DAMP) by impaired cells that activate effector 
scavenging cells, namely, phagocytes. However, the mechanism by which phagocytes 
distinguish and specifically engulf biological debris is not understood. One hypothesis 
is that “marking molecules” accumulate in garbage products and help their clearance 
(Miyazaki and Arai, 2015). Interestingly, Spa was pointed out as candidate (Miyazaki 
and Arai, 2015). Recent studies, showed that during acute kidney injury (AKI), Spa 
interacts with kidney injury molecule (KIM)-1, which is upregulated in injured tubular 
epithelial cells (TEC). KIM-1 binding to Spa promotes the efficient clearance of dead-
cell debris from TEC. In the kidney, apoptotic and necrotic TEC are phagocytosed by 
neighbouring damaged epithelial cells, which differentiate into a phagocytic phenotype 
under the control of KIM-1 (Allison, 2016; Arai et al., 2016). Interestingly, Miyazaki and 
Arai (2015) hypothesize that a number of different proteins might be involved in 
garbage clearance and proposed designating these proteins as “soluble scavenger 
proteins” (SSP). Accordingly, SSP proteins should circulate at high levels, have a 
“sticky nature”, so they can attach efficiently to “garbage” and bind to the specific 
receptors that mediate engulfment through incorporation of the SSP. Excitingly, this 
new concept was proposed as a new therapeutic strategy, whereby SSP administration 
could be effective in treating refractory diseases (Miyazaki and Arai, 2015).  
 
DMBT1/gp340/SAG 
The gene Deleted in Malignant Brain Tumours (DMBT1) was initially described as a 
tumour suppressor gene (Mollenhauer et al., 1997) for brain tumours, and later for 
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other epithelial cancers such as gastrointestinal and lung cancers (Somerville et al., 
1998; Mori et al., 1999; Takeshita et al., 1999). Additionally, functional studies using 
the orthologs rabbit hensin and mouse CRP-ductin correlated DMBT1 to cell 
differentiation and regeneration (Ligtenberg et al., 2007). DMBT1 maps at 10q25.3-
q26.1 and two secreted DMBT1 isoforms with identical amino acid sequences were 
also identified in bronchoalveolar fluid (gp340) (Holmskov et al., 1997) and saliva 
(salivary agglutinin, SAG) (Ericson and Rundegren, 1983). 
DMBT1 contains between 8 and 13 tandem SRCR domains separated by SRCR 
interspersed domains (SID) and at the C-terminus there are two CUB domains 
surrounding an extra SRCR domain, followed by a ZP domain (Mollenhauer et al., 
1997; Holmskov et al., 1999; Prakobphol et al., 2000). The CUB domains can be found 
in complement proteins such as C1s/C1r and together with ZP domains have been 
implicated in protein-protein interactions (Bork and Sander, 1992; Carmona et al., 
2002; Kang and Reid, 2003). Glycosylation corresponds to approximately 25-40% of 
the total molecular weight of the protein (Oho et al., 1998), where twelve potential N-
glycosylation sites are estimated from the DMBT1 protein sequence and a high density 
of O-glycosylation sites was proposed within the SID, which are rich in serine and 
threonine amino residues, resembling mucins (Bikker et al., 2002).  
DMBT1 has a wide range tissue distribution, especially in epithelial surfaces, where it 
is highly expressed in the respiratory system, such as lung and trachea, in the 
gastrointestinal tract, mainly in small intestine, salivary gland and stomach, and at 
lower levels in brain and reproductive system (i.e. testis, uterus and mammary gland) 
(Holmskov et al., 1999). At the mucosal surfaces, DMBT1 is found both attached to the 
epithelium and secreted into the lining fluids, such as saliva, tear fluid, and respiratory 
mucosal secretions (Reichhardt and Meri, 2016). Additionally, in the early stage of live, 
DMBT1 is detected in the amniotic fluid and in the intestines of neonates, and was 
estimated to constitute up to 10% of the total protein amount in meconium and in the 
saliva of children under 3 years old, corresponding to one of the most abundant 
proteins in these milieus (Sonesson et al., 2011; Reichhardt et al., 2014; Reichhardt 
and Meri, 2016). DMBT1 is also expressed in immune cells and tissues including 
alveolar macrophages, peripheral blood leukocytes, spleen, thymus, lymph nodes and 
bone marrow (Palaniyar et al., 2010).  
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Role in pathogen sensing 
DMBT1 was initially described as an agglutinating agent from saliva that could 
aggregate Streptococcus mutans (Ericson and Rundegren, 1983), bacteria resident in 
the oral cavity responsible for the formation of dental caries. The motif responsible for 
binding bacteria was shown to locate in the SRCR domains and consisted on the 
peptide sequence GRVEVLYRGSW, where five residues (xxVEVLxxxxW) were 
essential for bacterial binding and required to mediate bacteria agglutination in a 
calcium-dependent way (Bikker et al., 2002; Bikker et al., 2004). These studies showed 
for the first time that SRCR domains could mediate pathogen binding. Nonetheless, 
other SRCR members that lack this binding motif (e.g., Spa), recognize bacteria as 
well, which indicates that other structures within SRCR domains can interact with 
bacterial components (Sarrias et al., 2005). DMBT1 binds a wide range of Gram-
positive and Gram-negative bacteria including E. coli, Lactobacillus casei, Helicobacter 
pylori, Streptococcus gordonii, S. aureus and Streptococcus agalactiae (Bikker et al., 
2002; Bikker et al., 2004).  
DMBT1 also interacts with viruses, namely influenza A (IAV) and human 
immunodeficiency virus type I (HIV) and inhibits viral infection in vitro (Hartshorn et al., 
2003; Wu et al., 2004; Hartshorn et al., 2006; Wu et al., 2006). The DMBT1-IAV 
interaction is not calcium dependent, and IAV binds to the sialic acid-bearing 
carbohydrates on the DMBT1 surface (Hartshorn et al., 2003; Hartshorn et al., 2006). 
Regarding HIV infection, DMBT1 interacts with the viral envelope glycoprotein gp-120 
of HIV in a calcium-dependent manner disturbing HIV capacity to infect T cells in saliva 
(Wu et al., 2004; Wu et al., 2006). Interestingly, this inhibitory effect was shown to be 
mediated by the first SRCR domain of DMBT1 (Wu et al., 2006; Chu et al., 2013). On 
the other hand, membrane-associated DMBT1 in the vaginal epithelium facilitates 
transcytosis of the virus through epithelial cells (Madsen et al., 2010). This dual effect 
emphasizes the role of protein location and structure in biological processes including 
disease outcome.  
 
Role in mucosal defence and homeostasis 
Mucosal surfaces are vulnerable barriers that permit the essential contact between the 
organism and the environment; however, microbes or other agents can cross this 
delicate epithelial barrier causing infection and allergies. Therefore, these surfaces are 
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highly protected by specific proteins, including mucins or surfactants, tissue resident 
immune cells as well as commensal microbiota. DMBT1 binds several endogenous 
proteins such as secretory IgA, MUC5B, surfactant proteins A and D, proteins from the 
complement factor system, trefoil factor (TFF) and galectin-3 (Ligtenberg et al., 2007; 
Madsen et al., 2010; Rossez et al., 2011), to increase the eradication of bacteria and 
viruses (Ligtenberg et al., 2007).   
Salivary DMBT1 forms complexes with IgA, which bind to a surface protein of S. 
mutans. The DMBT1-IgA interaction is mediated by the same motif within the SRCR 
domain responsible for bacteria binding (Ligtenberg et al., 2004). In addition, DMBT1 
binds SP-D and SP-A (Holmskov et al., 1997), which are modulators of pulmonary 
defence; they promote microbial agglutination while regulating inflammatory responses 
(Gardai et al., 2003).  
DMBT1 regulates the early steps of complement activation on mucosal surfaces 
(Reichhardt and Meri, 2016). Although complement is predominantly present in blood, 
it is also found in serous exudates on mucosal surfaces, such as in the oral cavity or 
the airways (Boackle, 1991; Persson et al., 1991; Reichhardt and Meri, 2016). During 
inflammatory and/or infectious conditions, for example upon mechanical injury, the 
serous exudates and blood infiltrate in the mucosal surfaces (Reichhardt and Meri, 
2016), where complement components such as C1q, mannose-binding lectin (MBL), 
and ficolins can bind to DMBT1. These interactions activate complement cascades that 
lead to inflammatory responses and increase bacteria clearance (Tino and Wright, 
1999; Reichhardt and Meri, 2016).  
During microbial infections, a severe inflammation response may damage the mucosal 
epithelia; therefore, rapid regeneration strategies are important to restrain the 
spreading of microbial agents and the further damage of the tissue (Podolsky, 2000; 
Kang and Reid, 2003). Trefoil factors are small proteins that are abundantly secreted 
onto the mucosal surface by mucus-secreting cells and are involved in tissue 
homeostasis and epithelial repair upon tissue injury (Taupin and Podolsky, 2003). 
DMBT1 binds recombinant dimeric TFF3 in a calcium dependent manner, suggesting 
that this interaction may have a role in the homeostasis of mucosal surfaces (Madsen 
et al., 2013). Moreover, the CUB and ZP domains of DMBT1 can also interact with 
growth factors, cell surface molecules and cytokines (Kang and Reid, 2003) and 
modulate the local environment to promote mucosal defence and regeneration (Bork 
and Sander, 1992; Carmona et al., 2002; Kang and Reid, 2003). Interestingly, DMBT1 
expression is increased in the epithelial cells of small intestine and colon in patients 
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diagnosed with inflammatory bowel diseases, namely ulcerative colitis (UC) and 
Crohn’s disease (CD), and proinflammatory stimuli such as TNF-α and LPS up-
regulate DMBT1 expression by epithelial intestinal cells (Renner et al., 2007; 
Rosenstiel et al., 2007; Madsen et al., 2013). In addition, Dmbt1 mice are more 
susceptible to dextran sulphate sodium (DSS)–induced colitis. This model of intestinal 
inflammation prospects that the cytotoxic effect of DSS damages the mucosa, and that 
the exposure of the membrane to microbial microflora will result in inflammation 
pointing out to a possible role for DMBT1 in intestinal mucosal protection (Renner et 
al., 2007; End et al., 2009). Moreover, an allelic variant of DMBT1, which lacks five 
SRCR exons is correlated with an increased risk for CD (Renner et al., 2007), 
suggesting that the SRCR domains of DMBT1 are important for its function. Another 
interesting observation is that the addition of recombinant DMBT1 reduces the 
intracellular invasion of intestinal epithelial cell lines by Salmonella enterica, and 
inhibits TLR4- and NOD2-mediated IL-8 release. This dual effect suggests that DMBT1 
may limit bacterial invasion, while preventing an inflammatory outcome, which directly 
contributes to the maintenance of a healthy mucosa (Rosenstiel et al., 2007).  
 
CD163  
The scavenger receptor CD163 was first described as a 130-kDa glucocorticoid-
regulated transmembrane glycoprotein with restricted expression in monocytes and 
tissue resident macrophages (Zwadlo et al., 1987; Pulford et al., 1992). Structurally, 
CD163 consists of nine tandem SRCR domains, a transmembrane segment and a 
short C-terminal cytoplasmic tail (Law et al., 1993), and is believed to descend from 
CD163L1 (M160), a 160-kDa protein with twelve SRCR domains that shares a similar 
structural organization (Grønlund et al., 2000). Alternative splicing of CD163 results in 
three isoforms with different cytoplasmic tail sizes (Law et al., 1993; Ritter et al., 1999; 
Schaer et al., 2006), with all splice variants containing phosphorylation target 
sequences for creatine kinase and protein kinase C (Van Gorp et al., 2010a); the 
isoform with the shortest tail is the most abundant. In addition to the membrane-bound 
CD163, a soluble version of CD163 (sCD163) can be found in plasma (~1-3 mg/liter) 
(Møller et al., 2002). During sepsis or inflammatory conditions that affect macrophage 
activity, the levels of sCD163 in serum might raise many-fold (Madsen et al., 2004; 
GaÏNi et al., 2006; Weaver et al., 2006; Etzerodt et al., 2010; Etzerodt and Moestrup, 
2013). The molecular weight of sCD163 is equivalent to the ectodomain of surface 
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CD163 pointing to a complete shedding of the extracellular domain (Møller et al., 
2002), which arises from the cleavage of the cell surface CD163 by the enzymes 
ADAM17 and ADAM10 (Etzerodt et al., 2010; Kneidl et al., 2012). 
 
Clearance of the Hp-Hb complex 
CD163 is a multifunctional protein best-known for its role in the clearance of the 
complex of haptoglobin (Hp) and haemoglobin (Hb) formed after the lysis of red blood 
cells (Kristiansen et al., 2001). The removal of haemoglobin by CD163 constitutes an 
important defence mechanism as it prevents the toxic effect of the heme molecule. 
During intravascular haemolysis, haemoglobin from erythrocytes is released into 
circulation where it binds haptoglobin forming the Hp-Hb complex (Graversen and 
Moestrup, 2015). The Hp-Hb complex interacts with surface CD163, through a region 
involving the second and third SRCR domain with extremely high affinity and in a 
calcium-dependent manner (Madsen et al., 2004). The complex is endocytosed by 
macrophages and the heme molecule is degraded by hemeoxygenases into 
biliverdin/bilirubin, carbon monoxide (CO) (Ryter et al., 2007) and iron. 
Biliverdin/bilirubin are potent antioxidants whereas CO exerts anti-inflammatory 
responses (Philippidis et al., 2004; Couper et al., 2008; Soares and Bach, 2009; 
Martínez et al., 2011; Maddur et al., 2012). Furthermore, the binding of CD163 to Hp-
Hb complexes triggers cytokine secretion, especially IL-10, which limits T cell activation 
and proliferation as well as the production of proinflammatory cytokines (Philippidis et 
al., 2004; Couper et al., 2008; Martínez et al., 2011; Maddur et al., 2012). IL-10 release 
in turn up-regulates both CD163 and hemeoxygenase-1, thus further potentiating Hb 
uptake, creating a positive loop (Graversen and Moestrup, 2015). This proficient 
mechanism prevents tissue damage resultant from the toxic and oxidative heme 
molecule and might help to control infection by reducing iron availability to haemolytic 
bacteria and trypanosomes (Weaver et al., 2006; Vanhollebeke et al., 2008; Graversen 
and Moestrup, 2015).  
CD163 has also been identified as an erythroblast adhesion receptor, which promotes 
the growth and/or survival of erythroblasts during erythropoiesis (Fabriek et al., 2007) 
and is scavenger receptor for the cytokine TNF-like weak inducer of apoptosis 
(TWEAK) (Bover et al., 2007; Moreno et al., 2009). 
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Role in pathogen sensing 
Amongst all the members of the SRCR-SF group B members, CD163 is the only 
surface receptor with restricted expression on monocytes/macrophages. Fabriek and 
colleagues first identified human CD163 as a macrophage surface receptor for 
recognition of intact Gram-positive and Gram-negative bacteria, namely S. mutans and 
E. coli, respectively (Fabriek et al., 2009). The authors supported the idea that bacterial 
recognition by CD163 generates signals that trigger macrophage cytokine production 
including TNFa, IL-1a and IL-6, all pro-inflammatory cytokines that could mediate a 
local immune response, but excluded a role for CD163 in bacteria phagocytosis. 
CD163 interaction with bacteria was mapped to the second SRCR domain, which 
included the binding motif xxVEVLxxxxW. Supporting a pathogen-sensing role for 
CD163, a subsequent study showed that in the presence of S. aureus, CD163 is shed 
from monocytic membranes and binds to the host fibronectin (FN) bound to the 
bacteria surface fibronectin-binding proteins (FnBP) (Kneidl et al., 2012). This event 
enhances the phagocytosis of bacteria and activates endothelial infected cells, 
reducing bacteria viability inside these cells. Indeed, this is a highly sophisticated 
mechanism to reduce bacteria spreading as the adhesion of S. aureus to FN is 
essential for cell infection (Kneidl et al., 2012). Also, CD163 was shown to bind several 
types and strains of bacteria with different affinities, for example it bounds S. aureus 
and Streptococcus pyogenes, but not Staphylococcus epidermidis, E. coli, or 
Streptococcus agalactiae (Kneidl et al., 2012). 
During coevolution of host-microbe interactions, pathogens have evolved mechanisms 
to exploit host surface receptors to invade cells so they can replicate and/or escape 
from immune surveillance (Van Gorp et al., 2010a). CD163 is one of such receptors In 
pigs, the African swine fever virus (ASFV) and the porcine reproductive and respiratory 
syndrome virus (PRRSV) have been shown to enter into monocytes and macrophages 
through CD163 (Sanchez-Torres et al., 2003; Van Gorp et al., 2009; Van Gorp et al., 
2010a; Van Gorp et al., 2010b). In the PRRSV infection, the fifth SRCR of CD163 is 
indispensable for viral infection (Van Gorp et al., 2010b; Ma et al., 2016). In addition, 
the levels of CD163-expressing macrophages are upregulated in patients with HIV 
(Fischer-Smith et al., 2008), and the rate of HIV infection is enhanced in macrophages 
that express high-levels of CD163 (Tuluc et al., 2014). Moreover, upon HIV infection, 
CD163 is shed from the monocytes membrane into the plasma and is positively 
correlated with the pathogenesis of HIV infection (Burdo et al., 2011). 
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 CD163L1/M160 
As previously mentioned, CD163L1 shares a high structural similarity with CD163, with 
the two genes mapped at chromosome 12p13.3 and next to each other, compatible 
with a gene duplication event (Grønlund et al., 2000; Moeller et al., 2012). The domain 
organization of CD163L1 is composed of a large extracellular region containing twelve 
SRCR domains, followed by a transmembrane region and a cytoplasmic tail with two 
alternative isoforms (Grønlund et al., 2000; Moeller et al., 2012). The tissue distribution 
profile of CD163L1 is similar to CD163 in the lymphoid and intestinal tissues as well as 
in the chorionic placental villi resident macrophages (Moeller et al., 2012). However, 
CD163L1 is absent or weakly expressed in long-lived macrophages with self-renewal 
properties such as the Kupffer cells from liver, alveolar macrophages from lung and 
cells from cerebellum in opposition to CD163. Moreover, CD163L1 is not capable of 
Hp-Hb complex endocytosis and preliminary data indicate that CD163L1 lacks the 
ability to bind bacteria, pointing out that CD163 and CD163L1 are functionally distinct. 
Nevertheless, though a ligand for CD163L1 remains to be identified, CD163L1 has 
endocytic properties and its expression is also regulated by cytokines; for instance, 
pro-inflammatory stimuli such as LPS, TNFa and IFNg downregulate CD163L1, while 
IL-10 upregulates CD163L1, leading to an immunomodulatory/anti-inflammatory 
macrophage phenotype (Moeller et al., 2012). 
 
Role in inflammatory bowel diseases 
Resident macrophages in the intestinal mucosa derive from blood monocytes that 
differentiate in the gut mucosa influenced by local environment factors (Bain et al., 
2013; Bain and Mowat, 2014). In healthy individuals, macrophages are stimulated by 
the immunosuppressive/anti-inflammatory cytokine IL-10, to promote a “tolerant” 
environment to commensal gut microbiota while protecting intestine epithelial 
monolayer against pathogens (Bain and Mowat, 2014). One subset of protective 
macrophages, highly abundant in the colon of heathy individuals, are resident 
macrophages expressing CD163L1 that produce IL-10. However, in severe 
inflammatory conditions, other subsets of macrophages, namely CLEC5A+ 
macrophages, rise their levels and are stimulated by pro-inflammatory cytokines 
engaging in aberrant immune responses towards commensal gut bacteria. 
Interestingly, in inflammatory bowel disease the expression of IL-10 by resident 
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CD163L1+ macrophages is somehow lost and these cells are unresponsive to pro-
inflammatory stimuli (González-Domínguez et al., 2015).  
 
SCART1 
A recent cloned member of the human group B SRCR-SF is SCART1, a gene that is 
mapped to chromosome 10 and encodes three splice variants containing 2, 4, or 5 
SRCR domains (Holm et al., 2013). In addition, one other transcript displaying a 
transmembrane domain was detected but remains to be cloned. This observation 
suggests that, like its mouse homologue (mSCART1), hSCART1 may exist as a 
membrane-bound receptor (Holm et al., 2009; Holm et al., 2013). Two of the cloned 
hSCART1 transcripts encode a cytoplasmic tail, which contains several potential 
phosphorylation and internalization motifs and that like CD5 and CD6, may be involved 
in signal transduction (Holm et al., 2009; Holm et al., 2013). Quantitative real-time PCR 
analysis showed that hSCART1 is mainly expressed on T lymphocytes and analysis of 
tissue distribution showed highest expression levels in the intestinal anatomical barrier 
(Holm et al., 2013). Interestingly, immunohistochemistry (with a peptide sequence 
unique for hSCART1) showed a prominent staining of the brush borders of placental 
villi resembling the high expression of SSC5D in placenta (Gonçalves et al., 2009; 
Holm et al., 2013). Altogether, the hSCART1 expression prolife suggests a role in 
immune defence (Holm et al., 2013). Nonetheless, the function of hSCART1 remains to 
be clarified. Despite initial studies having indicated that mSCART1 was not able to bind 
to a selection of PAMP and bacteria (Fink et al., 2010), it cannot be ruled out that 
mSCART1 or hSCART1 might bind to other microorganisms such fungi, mycobacteria, 
or parasites and behave as PRR (Fink et al., 2010; Holm et al., 2013).  
 
SSC4D 
Human SSC4D/S4D-SRCRB is a soluble member of the SRCR-SF composed of four 
SRCR domains separated by Pro-, Ser- and Thr-rich polypeptides. Northern blot 
analysis showed that SSC4D is expressed as two major mRNA species: one of 2.8 kb, 
with a restricted tissue expression pattern (mainly kidney and placenta) and having a 
predicted molecular mass (Mr) of 55,600, and the other of 1.5 kb, with a broader 
distribution (Padilla et al., 2002). Recombinant SSC4D was reported to bind several 
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microorganisms, including Gram-positive and Gram-negative bacteria, through the 
recognition of LTA or LPS, respectively, and fungi (Miró et al., 2012). However, its 
function remains unclear.  
 
SSC5D 
Studies carried out in our laboratory revealed the existence of a new member of the 
SRCR-SF. The Soluble Scavenger with 5 SRCR Domains (SSC5D) receptor is 
encoded by a gene located in chromosome 19q13.4 and is composed of 14 exons that 
code for a 1573-aa polypeptide with a predicted molecular mass of 165.7 kDa, details 
of the genomic organization are shown in Fig 4. (Gonçalves et al., 2009). 
 
Figure 4. Genomic organization of the SSC5D gene. The gene spans over 30.6 kb in chromosome 
19q13.4. Coding regions are represented as boxes, and introns as connecting lines. SRCR domains are in 
orange, internal exons in grey, the coding regions containing the stop codons are in yellow, and that 
containing the start codon is in green. Black areas represent proline and threonine-rich sequences. The 
localization of the signal peptidase cleavage is indicated by a black triangle (Gonçalves et al., 2009). 
Full-length SSC5D consists of two structurally distinct parts: an N-terminal domain 
(exons 1-12), which contains five SRCR domains, and a C-terminal domain (exons 13-
14) composed of a high number of repetitive sequences rich in Pro and Thr residues, 
e.g., PDPTTT or PHPTTT, reminiscent of similar sequences present in mucins 
(Gonçalves et al., 2009). Mucins are large glycoproteins with many O-linked glycans 
that are found in mucus, where they are responsible for the protection of epithelial 
surfaces from dehydration, mechanical injury and pathogens (Perez-Vilar and Hill, 
1999). In addition, this post-translational modification helps proteins to maintain an 
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extended conformation, producing a long filamentous structure, where O-glyans can be 
packed very tightly (Dekker et al., 2002). The SSC5D mucin-like domain is putatively 
highly O-glycosylated, with 144 potential O-glycosylation sites (Fig. 5), which can 
contribute for its biological function. Indeed, O-glycans are important in a wide range of 
biological processes, including immune responses, where they can that act as ligands 
for receptors that mediate host-pathogen interactions (Varki, 1993). 
 
 
Figure 5. Predicted O-glycosylation of SSC5D using the NetOGlyc 3.1 Server 
(http://www.cbs.dtu.dk/services/NetOGlyc-3.1/). The C-terminal region of SSC5D, which includes 
sequences encoded by exons 13 and 14, is putatively extensively glycosylated, with 144 potential O-
glycosylation sites in a 476-long amino acid stretch, i.e. approximately 30% of amino acids with a 
glycosylation potential above the calculated threshold (Gonçalves et al., 2009). 
 
Northern blotting analysis of SSC5D revealed an abundant mRNA species of 4.8 kb in 
placenta and spleen, and at lower levels in colon and lung (Gonçalves et al., 2009). 
In addition, a transcript of 3 kb was also observed in placenta and spleen, probably 
corresponding to an alternative spliced variant. Moreover, qPCR analysis of SSC5D 
revealed its expression in immune cells such as monocytes, CD4+ T cells and at lower 
levels in CD8+ cells. Interestingly, soluble SSC5D was found to be upregulated in the 
synovial fluid of osteoarthritis patients (Balakrishnan et al., 2014), which insinuates a 
role in inflammation. Altogether, the peculiar characteristics of SSC5D suggest a role in 
immune defence, tissue homeostasis and foetal development. 
In recent studies, the mouse homologue of SSC5D (S5D-SRCRB/Ssc5d) was 
characterized as a secreted glycoprotein exclusively expressed in the genitourinary 
and digestive tract that was able to interact and aggregate bacteria and fungi (Miró-
Julià et al., 2011). Also, S5D-SRCRB binds bacterial and fungal cell wall components 
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and its presence was shown to inhibit IL-8 secretion induced by a cell line expressing 
TLR2 and exposed to PGN (Miró-Julià et al., 2011). Moreover, in a study using a 
mouse model of urinary tract infection, the mRNA levels of S5D-SRCRB in kidneys 
were increased after bacterial aggression, suggesting that S5D-SRCRB may have a 
protective role in the urinary system (Miró-Julià et al., 2014).  
Like other members of the SRCR-SF, S5D-SRCRB binds endogenous extracellular 
matrix components including laminin, galectin-1 and galectin-3 (Miró-Julià et al., 2014). 
Galectin-3 interacts with S5D-SRCRB through its carbohydrate-binding region, which 
suggests that S5D-SRCRB glycosylation pattern may be important for this interaction. 
This ubiquitously expressed lectin recognizes β-galactoside structures and is involved 
in various biological processes, including cell development and immune reactions 
(Dumic et al., 2006). However, the significance of the S5D-SRCRB-galectin 3 
interaction is yet to be explored. 
Nevertheless, information about human SSC5D is scarce and there can exist 
interspecies differences in the function of proteins. For example, the mouse orthologue 
of CD163, which shares 70% of amino acid similarity is resistant to endotoxin- and 
phorbol ester-induced shedding (Etzerodt et al., 2014). Therefore, a deeper study to 
understand this peculiar human SRCR member is required to provide insights into the 
biological function of SSC5D. 
 
3. Molecular approaches to study PRR-pathogen 
interactions 
During the last years, there is an increased interest in the field of PRR research and 
their ligands (Kumagai and Akira, 2010; Levy and Netea, 2014). Innate immunity is no 
longer considered a ‘non-specific’ event, as several PRR have shown to specifically 
interact with well-defined structures (Akira et al., 2006; Levy and Netea, 2014). As 
already mentioned, innate components shape adaptive responses to efficiently clear 
pathogens. Moreover, with the recent discovery of the enhanced ability of innate 
immunity to respond to secondary infection, the study of novel vaccine formulations is 
expanding (Levy and Netea, 2014). This capacity is known as trained immunity 
(modulated by epigenetic reprograming) and is defined as an enhanced response to a 
reinfection (by the same microorganism) that may also provide cross-protection to 
different pathogens (Netea et al., 2011). This memory-like mechanism is independent 
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of B and T cells, and involves macrophages and NK cells. Trained immunity builds on 
phenotypic changes in innate immune cells that probably involves differential 
expression of PRR, differences in the monocyte/macrophage cell subpopulations 
and/or different functional responses (Netea et al., 2011).  
In addition, several PRR, including some SRCR members, were shown to have a 
therapeutic value in animal models of diseases, and are potential markers for the 
diagnosis and pathogenesis of several conditions (Martínez et al., 2011). As mentioned 
earlier, SRCR receptors bind several pathogens and microbial structures; still, the list 
of new molecules binding SRCR proteins continues to expand. However, the 
components on microbe surfaces and their secreted virulence factors present a great 
structural diversity that pose some challenges in the analyses of complex interactions. 
Therefore, to gain a better insight into specific interactions it is important to use not 
only conventional molecular biology techniques, but also to develop more sensitive 
approaches (Kumagai and Akira, 2010) to elucidate PRR-pathogens interactions.  
Surface plasmon resonance (SPR)-based biosensors have emerged as a promising 
technique to detect biomolecular interactions (Piliarik et al., 2009; Singh, 2016) (details 
of this method are described in chapter 2). Briefly, in an SPR analysis, a ligand 
(biorecognition element) is immobilized on a sensor chip, then its putative binding 
partners (analytes) are flowed along the sensor surface, where specific interactions are 
transduced into measurable signals (Homola, 2008). SPR–based biosensors can be 
used to detect interactions with whole bacteria cells, usually by using specific and high 
affinity antibodies (Byrne et al., 2009). However, besides antibodies researchers are 
also exploring new ligands to detect whole cell bacteria (Ahmed et al., 2014; Templier 
et al., 2016). Some of these ligands not so commonly used include host proteins. 
Fibronectin is a host matrix protein that is a common target for bacteria, including S. 
aureus and Staphylococcus epidermidis (Vaudaux et al., 1993; Foster and Höök, 1998; 
Francois et al., 1999; Williams et al., 2002). In one pioneer study, SPR biosensors 
were capable of detecting the binding of S. aureus to fibronectin, and a much lower 
affinity interaction of fibronectin with S. epidermidis (Holmes et al., 1997). In addition, 
using different fibronectin fragments, the authors observed that the S. aureus and S. 
epidermidis interacted with fibronectin through different binding sites. This observation 
was later confirmed by additional studies using a shotgun phage display cloning tool 
that unveiled a new fibronectin-binding protein for S. epidermidis (Williams et al., 
2002). Intriguingly, we found a single study using a PRR, namely DMBT1, to perceive 
interactions with bacteria (Oli et al., 2006). In this study, DMBT1 was shown to bind S. 
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mutans but not a S. mutans mutant (PC3370) that lacks the bacterial P1 antigen, which 
is presumed to interact with DMBT1 (Demuth and Irvine, 2002).  
Surface plasmon resonance (SPR), has been successfully used for the rapid detection 
of pathogens and presents several advantages when compared with conventional 
studies. SPR approaches allow the rapid detection of interactions without labelling 
steps of both proteins and bacteria, is more sensitive, and one can observe the binding 
events in real-time (Lundström, 1994; Dudak and Boyacı, 2009). Moreover, it is also 
less time consuming and not so laborious, comparing with conventional techniques, 
such as immunoprecipitation assays, agglutination tests or flow cytometry (Lundström, 
1994; Boozer et al., 2006; Dudak and Boyacı, 2009; Wilson et al., 2011). It usually 
requires less reagents, and one major advantage is that by using a multi-channel 
device, one can perform simultaneously various analyses (Boozer et al., 2006).  
These advantages make SPR biosensors strong candidates for investigating PRR 
interactions with whole bacteria.  
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4. Aims  
Our laboratory has been interested in studying the function of the SRCR-SF members 
upon immune challenges. One important achievement was the cloning of a new SRCR 
glycoprotein named SSC5D. The predicted structural characteristics of SSC5D hint at 
a role as an innate immune receptor. Also, initial studies showed the expression of 
SSC5D transcripts in mucosal tissues and in placenta. In these locations, complex 
immune interactions are responsible not only for protecting the host and the developing 
foetus against the potential harmful effects of pathogens, but also to control 
exacerbated immune responses. Therefore, the characterization of a new protein 
potentially relevant in these milieus holds the prospect of furthering our knowledge of 
immune events at these interfaces.  
Accordingly, this work aims to  
1) determine the binding specificities of the scavenger receptor domains, and of the C-
terminal domain of SSC5D,  
2) explore the ability of SSC5D to bind to different strains of bacteria and  
3) to comprehend the biological relevance of SSC5D by performing an extensive 
characterization of the expression of SSC5D in several tissues and by initiating the 
generation of a mouse strain with a disrupted Ssc5d gene. 
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1.1. Introduction 
It is now appreciated that the multitude of functions exhibited by SRCR-SF members 
are indispensable for the organism homeostasis. Although a precise biological function 
of SRCR domains has not yet been clearly established, several lines of evidence 
suggest that these domains are important for mediating protein-protein interactions 
(Martínez et al., 2011). These are vital for many cellular processes and their affinities 
and specificities are finely tuned to the functions they undertake (Chen et al., 2013). 
Since the biological role of a protein is also defined by its interactions in the cell, the 
discovery and characterization of potential ligands and interaction partners for SSC5D 
would, on, one hand help to elucidate its function, and one the other contribute for the 
understanding the biological significance of SRCR domains. 
SSC5D is found in several tissues and circulates at high levels in the bloodstream, 
where it can potentially interact with a variety of cells and molecules. Therefore, it is 
conceivable that specific interactions between SSC5D and cell surface receptors may 
occur. The soluble SRCR protein Spa, which is also highly present in the serum, was 
reported to interact with several cells. Flow cytometric analysis of the interaction of 
recombinant Spa with several immune cell types showed that Spa bound to myeloid 
cell lines  and lymphocyte-derived cell lines as well as to peripheral blood monocytes 
(Gebe et al., 1997; Sarrias et al., 2004). However, the ligand or ligands responsible for 
the aforementioned interactions were not identified.  
In fact, the T cell surface receptor CD6 is the only SRCR member having a well-
stablished cell surface ligand, ALCAM/CD166 (Bowen et al., 1995), a protein 
expressed by various cell types. Interestingly, the CD6-CD166 interaction is relatively 
strong with a dissociation constant (Kd) of ~0.4–1.0 μM (Hassan et al., 2004), so the 
identification of the CD6 ligand probably benefited from this resistant physical 
association. Importantly, a second ligand was reported to interact with CD6 (Joo et al., 
2000; Saifullah et al., 2004) suggesting that SRCR proteins may have multiple ligands. 
On the contrary, attempts to identify ligands for CD5, the closest relative of CD6 were 
unsuccessful. Despite several surface binding partners for CD5 being reported, namely 
CD72 (Van de Velde and von Hoegen, 1991), gp40-80 (Biancone et al., 1996), gp150 
(Calvo et al., 1999) and even CD5 itself, all results lacked confirmation by independent 
studies (Brown and Lacey, 2010; Santos, 2012). Although much effort has been 
devoted to find cell surface receptors for SRCR, especially for membrane-bound 
receptors, the immense complexity of such interactions poses a real challenge. 
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SSC5D is a 1573 amino acid-long glycoprotein with a predicted molecular mass of 
approximately 165 kDa (Gonçalves et al., 2009). SSC5D can be divided into two well-
defined fragments: an N-terminal domain (N-SSC5D), which contains the five SRCR 
domains, and the C-terminal domain (C-SSC5D), a mucin-like domain due to the high 
number of repetitive sequences rich in proline and threonine residues. These residues 
are putatively heavily O-glycosylated, a typical feature of mucins that are known for 
their high carbohydrate content (Julenius et al., 2005). For the purpose of investigating 
putative interactions of SSC5D and given the distinctive characteristics of the N- and 
C-SSC5D moieties, we decided to produce and characterize each domain 
independently. Furthermore, if a positive interaction between SSC5D and a cell is 
observed, it can be assigned to either the N- or C-terminal SSC5D domains. 
However, cell surface molecules interact with generally low affinities, with Kd between 1 
and 100 μM (Davis et al., 2003). Therefore, it is expected that SSC5D interactions with 
cell surface receptors may have a short lifetime and be transient, meaning that putative 
complexes are dynamic and may dissociate rapidly (Nooren and Thornton, 2003). As 
this particularity may hamper the identification of cells that could express a ligand for 
SSC5D, we used an approach designed to improve the binding of SSC5D to eventual 
cell surface receptors. This experimental method consisted in producing our receptors 
in tetrameric form to increase the avidity of receptors for its ligands, and analyse 
interactions using flow cytometry. Multimeric forms are used to increase the sensitivity 
of detection and were initially designed to identify low affinity interactions (Altman et al., 
1996; Ogg and McMichael, 1998), and given that in our system tetrameric avidin is 
coupled to fluorescent dye, binding of the ligands to cells can easily be followed in flow 
cytometry. This research protocol builds on previous experimental designs developed 
by our group to identify putative ligands for CD5 (Santos, 2012). In the event of finding 
cells that interact with SSC5D, a subsequent approach using genomic sequencing 
combined with bioinformatics tools will be applied to find putative ligands in the 
interacting cells (Santos, 2012).  
 
1.2. Materials and Methods  
Cloning of the N-terminal (N-SSC5D) and C-terminal (C-SSC5D) domains of 
SSC5D 
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First strand cDNA was synthesized using 1 μg of total placenta RNA, 0.5 μg oligo(dT) 
primer and SuperScript III reverse transcriptase (Invitrogen) following the 
manufacturer’s instructions. To amplify the N-terminal domain (N-SSC5D) containing 
the 5 SRCR domains (exons 1-12), first a nested polymerase chain reaction (PCR) 
was performed using the sense primer 5’-
TATAATGGATCCGAGCGCCTGCGCCTGGCCGAT-3´ and anti-sense 5’-
AATAGGATCCCTCTTGTGTCCGGCAGGCGCCTTATTGCTGG-3’ (BamHI site 
underlined), in a 50 μl mixture containing 1 μM of each primer, 100 ng of placenta 
cDNA, 10 mM dNTPs, 0.5 μl DMSO and 1 U of phusion enzyme (FINNZYMES) with 
the following cycling conditions: 98 oC (60 s) and 25 cycles of 98 oC (15 s) and 72 oC 
(90 s), followed by a final extension of 72 ºC for 5 min. The amplified sequence was 
subsequently purified with the QIAquick PCR purification kit (Qiagen), digested with 
BamHI and cloned into the BamHI/BclI–digested pEE14-BirA vector, a lab modified 
version of the pEE14 vector (Lonza biologics), using the T4 DNA Ligase (Roche). The 
ligation products were transformed into TOP10 E. coli-competent cells (Invitrogen) and 
the resulting clones were checked by sequencing. The final construct contained 
chimeric cDNAs encoding, in the following order, a signal peptide, a hemagglutinin 
(HA)-tag, N-SSC5D, a BirA recognition sequence and a 6 × histidine (His)-tag. 
The C-terminal domain (C-SSC5D), which contains exons 13 and 14, was amplified 
from placenta cDNA by PCR with the sense primer 5’- 
AACCCTCTACTAGGTCTAGATTCTACAGGCAGCAAAGATGGTTACAAGCTT- 3’ and 
anti-sense 5’-TAAGATATCTCACACGTCTCCCCTC-3’ in a mixture similar to the 
aforementioned using different cycling conditions:  98 ºC (30 s) and 25 cycles of 98 ºC 
(10 s), 60 ºC (30 s) and 72 ºC (90 s), followed by a final extension of 72 ºC (7 min). The 
DNA product was purified and cloned into the pGEM-T vector (Promega). After 
bacterial transformation a single colony was picked (miniprep 19), purified and 
sequenced with the universal primer SP6 and T7. A second PCR for adding the BamHI 
restriction sites was performed with the sense 5’ – 
CATGCAGGATCCGGCAGCAAAGATGGTTACAAG 3’ and anti-sense 
ATGTATCGGATCCCACGTCTCCCCTCAGG primers in the specified mixture: 1 μM of 
each primer, 200 ng of miniprep 19, 10 mM dNTPs and 2.5 U pwo polimerase (Roche) 
in a final volume of 50 μl. The temperature profile was: 95 ºC (2 min) and 30 cycles of 
95 ºC (30 s), 60 ºC (30 s) and 72 ºC (4 min), followed by a final extension of 72 ºC for 7 
min. The purified C-terminal domain sequence (C-SSC5D) was inserted into the BamHI 
and BclI sites of the pEE14-BirA vector in order to obtain a C-SSC5D construct 
equivalent to the one described for N-SSC5D. 
Chapter 1 
62 
Cloning of Spa 
Human Spα was amplified from spleen cDNA by nested PCR using two sets of 
different primers, one localized in an external region of the gene and a second 
containing the restriction sites to insert the Spα sequence into the pEE14-BirA vector. 
The first PCR was performed in a 50 μl mixture including 1 μM of the sense primer 5’- 
TGGCTCTGCTATTTCTCCTTG and the anti-sense 5’ – 
AGGTCAAGCAACACCAGGATA, 100 ng of spleen cDNA, 10 mM dNTPs, 1.5 μl 
DMSO and 1 U of phusion enzyme (FINNZYMES) with the following cycling conditions: 
98 ºC for 30 s, 35 cycles of 98 oC for 10 s, 62 ºC for 30 s and 72 ºC for 1 min, followed 
by a final extension of 72 ºC for 10 min. The amplified product was purified using 
GeneClean kit (MP Biomedicals) and 5 μl of this amplicon was used as a template to 
perform a second PCR using the sense primer 5’ – 
TTAGGATCCTCTCCATCTGGTGTGCGGCTG and the anti-sense 5’ – 
CAAGGATCCACCTGAGCAGATGACAGCCAC (BamHI site underlined) with the PCR 
conditions described previously. The amplified sequence was subsequently digested 
with BamHI and cloned into the BamHI/BclI–digested pEE14-BirA vector, using the T4 
DNA Ligase (Roche). The ligation products were transformed into TOP10 E. coli-
competent cells (Invitrogen) and the resulting clones were checked by sequencing. The 
final construct contained chimeric cDNAs encoding, in the following order, a signal 
peptide, a HA-tag, Spα, a BirA recognition sequence and a 6 × His-tag.  
 
Cell lines 
Cell lines JTAg E6.1, K562 and THP-1 were maintained in Roswell Park Memorial 
Institute medium (RPMI) 1640 supplemented with 10% dialyzed foetal calf serum 
(FCS) (First Link), 1 mM sodium pyruvate, 2 mM L-glutamine, penicillin G (50 U/ml) 
and streptomycin (50 μg/ml) at 37 °C in a 5% CO2 humidified incubator. RPMI 1640 
and all supplements were obtained from (Gibco, Life Technologies) except for FCS 
(First Link). Cell lines Caco-2, HeLa, HCT-116, JEG-3, HEK 293 and CHO-K1 were 
maintained in Dulbecco's Modified Eagle's medium (DMEM), supplemented with 10% 
FCS, 1 mM sodium pyruvate, 2 mM L-glutamine, penicillin G (50 U/ml) and 
streptomycin (50 μg/ml) at 37 °C in a 5% CO2 humidified incubator. DMEM and all 
supplements were obtained from (Gibco, Life Technologies) except for FCS (First 
Link).  
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Transient protein expression in HEK 293 cells 
HEK 293 cells were grown in DMEM supplemented with 10% FBS, glutamine and 
antibiotics. For each construct, cells were plated on the day prior to transfection at 5 × 
105 into 6-well plates and then transfected with 2 μL of Lipofectamine 2000 (Invitrogen) 
and 1 μg of the N or C-terminus constructs. As a transfection control we used a CD5-
pEE14 construct that coded for the extracellular domain of CD5. Protein expression 
was analysed 2-3 days after transfection by Western blotting (WB) with a mouse 
monoclonal antibody anti-His6 (0.2 μg/ml, Roche). 
 
Stable transfection of N-SSC5D, C-SSC5D and Spα 
CHO-K1 cells were cultivated in DMEM supplemented with 10% FBS, 1 penicillin G (50 
U/ml) and streptomycin (50 μg/ml), 4 mM of L-glutamine, 50x amino acids (AA) and 
nucleoside supplement and 1 mM sodium pyruvate. The day before transfection, cells 
were detached from the flasks using trypsin-EDTA (Sigma), divided into two 25 cm3 
flasks and plated at 4 × 106 cells per flask in the growth medium. One flask contained 
the cells to be transfected with each construct and a second flask was reserved for 
mock transfection. Cells were incubated overnight at 37 °C, 5% CO2, to be 80% 
confluent on the following day. On the transfection day, the medium was removed and 
replaced with complete Glasgow Minimum Essential Medium (GMEM) (First Link) 
supplemented with 10% of dialyzed FCS (First Link), 50x AA and nucleoside 
supplement, antibiotics and deprived of L-glutamine. Cells were transfected with a 
mixture of 9 μL Lipofectamine 2000 (Invitrogen) in 500 μL Opti-MEM I (Gibco, Life 
Technologies) and 3 μg of each construct diluted in 500 μL of Opti-MEM I (final volume 
= 1 ml) according to the manufacturer’s instructions. For the mock transfection, ddH2O 
was used instead of DNA. 
The DNA-Lipofectamine complex was added directly to the cells medium and mixed 
gently by rocking the flask back and forth. Cells were incubated at 37 °C in the CO2 
incubator overnight. 
On the following day, cells were trypsinized and plated into 96-well flat-bottomed plates 
at 1 × 106 cells per plate in 100 μl volume per well. The plates were incubated 
overnight before the addition of the selection medium. Next, 100 μl of supplemented 
medium (no L-glutamine) containing the desired concentration of the selection reagent 
methionine sulphoximine (MSX) was added to each well. The final concentrations used 
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were 40 and 60 μM of MSX in 200 μl volume per well. Plates were incubated for one 
week at 37 °C in the CO2 incubator. Afterwards, 100 μl of medium was removed from 
each well and replaced with 100 μl supplemented GMEM with the desired 
concentration of MSX. The plates were incubated at 37 °C for two additional weeks.  
 
Selection of stable transfectants by dot-blot  
The surviving colonies of CHO-K1 transfected cells were counted and compared with 
the mock transfection. Then,15 μl of the medium from stable pools were directly 
transferred to nitrocellulose membrane and tested for N-SSC5D, C-SSC5D or Spa 
recombinant expression by a dot-blot immunoassay using a mouse monoclonal 
antibody anti-His (0.2 μg/ ml, Roche) and a peroxidase-conjugated goat anti-mouse 
IgG antibody (1:20,000, Santa Cruz) and revealed using Amersham ECL detection 
reagent (GE Healthcare Life Sciences) and exposed to BioMax MR films (Kodak). 
N-SSC5D-, C-SSC5D- and Spa-expressing clones were expanded in selective 
supplemented GMEM and were tested by western-blotting to confirm both protein 
expression and size. The high-expressing clones of each recombinant protein were 
frozen in liquid nitrogen. Additionally, one of each clone was grown to confluence in 10- 
tray cell factories (Nunc, Roskilde, Denmark) at 37 °C. Meanwhile, sodium butyrate 
was added to these factories to prevent cell overgrow. After 4 weeks, one litre of tissue 
culture supernatants (TCS) containing recombinant N-SSC5D and Spa were collected 
and stored at 4 ºC for protein purification.  
 
Western blotting 
Tissue cultures supernatants (TCS) of N-SSC5D, C-SSC5D and Spα were analysed by 
Sodium Dodecyl Sulfate Poly-Acrylamide (acrylamide 7.5%) Gel Electrophoresis (SDS-
PAGE) under reducing conditions. To prepare each sample, 16 μl of TCS were mixed 
with 4 μl 5x SDS loading buffer with 10% mercaptoethanol and boiled at 95 ºC for 10 
min. The gel was run for 1 h at 150 V with Tris/glycine/SDS running buffer (Bio-Rad 
Laboratories). In order to identify protein size, a protein standard (Bio-Rad 
Laboratories) was also loaded. Proteins were transferred to the nitrocellulose 
membrane (Hybond-C-extra) by electroblotting with ice-cold transfer buffer (1 h at 100 
V). Membranes were blocked with TBS, 0.1% Tween 20 (TBS-T), containing 5% nonfat 
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dried milk for 1 h at RT. Then, the membrane was incubated with mouse monoclonal 
antibody anti-His6 (0.2 μg/ml, Roche) in TBS-T with 3% nonfat dried milk, for 1 h at RT. 
Membranes were washed thoroughly with TBS-T and then incubated with peroxidase-
conjugated goat anti-mouse IgG in TBS-T with 3% nonfat dried milk (Santa Cruz, 
1:20,000) for 1 h at RT. Immunoblot was developed using Amersham ECL detection 
reagent (GE Healthcare Life Sciences) and exposed to BioMax MR films (Kodak). To 
confirm byotinylation, nitrocellulose membranes were directly incubated with 1:5000 
ExtrAvidin-Peroxidase® (Sigma) in TBS-T. 
 
N-SSC5D immunoblotting using anti-SSC5D 
For N-SSC5D immunoblotting, samples were run in SDS- PAGE for 1 h at 150 V with 
Tris/glycine/SDS running buffer (Bio- Rad Laboratories). Samples were transferred to 
the nitrocellulose membrane using the iBlotTM Gel Transfer Device (Invitrogen) 
following the manufacturer’s instructions. Then, the membrane was blocked with TBS, 
0.1% Tween 20 (TBS-T), containing 5% non-fat dried milk, for 1 h with shaking. N-
SSC5D was subsequently detected with rabbit anti-SSC5D (Abgent, 1:5,000) primary 
antibody in TBS-T with 3% non-fat dried milk, for 1h at RT, followed by peroxidase-
conjugated goat anti-rabbit IgG antibody (Sigma, 1:30,000) for 1h at RT. The 
immunoblot was developed using ECL detection reagent (GE Healthcare Life 
Sciences), and the image was acquired in a ChemiDoc XRS+ system (Bio-Rad 
Laboratories). 
 
Protein purification 
N-SSC5D and Spα TCS were harvested and phenylmethylsulfonyl fluoride (PMSF) 
(Sigma) was added at 1 mM final concentration. Next, TCS were centrifuged at 
10,000g, 20 min at 4 ºC, to remove cell debris and diluted 4 x in PBS. The histidine-
tagged recombinant proteins N-SSC5D and Spα proteins were purified by immobilized 
metal affinity chromatography using Ni SepharoseTM High Performance HisTrapTM HP 1 
ml column, (GE Life Sciences) using a BioLogic DuoFlow QuadTec10 System (Bio-
Rad Laboratories). The imidazole gradient was run from 10 mM to 500 mM. The purest 
fractions containing N-SSC5D and Spα were collected and further purified by anionic 
chromatography (UNO Q column Bio-Rad) with a linear salt gradient (0–1.0 M NaCl) in 
PBS using AKTA Purifier (GE Life Sciences). Fractions containing the desired protein 
Chapter 1 
66 
were pooled and concentrated to 1 ml using Amicon® Ultra Centrifugal filters with 10 
kDa cutoff (Milipore) (4000g, 20 min). Proteins concentrations were calculated using 
the Beer-Lambert equation (A = ε * l * c), where c is the molar concentration (M), l is 
the path length of the cuvette (units cm), ε is the molar extinction coefficient (units 
M−1cm−1) and A is the absorbance at a 280 nm wavelength. Absorbance was measured 
using a NanoDrop spectrophotometer (Thermo Fisher Scientific) and the molar 
extinction coefficients were predicted using the ExPASy Protparam.  
 
Coomassie staining 
N-SSC5D and Spa protein purity was analysed by SDS-PAGE (7.5 % acrylamide). To 
prepare each protein sample, 5-20 μl of the fractions obtained previously in the 
chromatography were mixed with 2x loading buffer containing SDS and 5% 
mercaptoethanol (Sigma). Next, the samples were boiled at 95 ºC for 10 min and 
loaded into the gel. The gel was run for 1 h at 150 V with Tris/glycine/SDS running 
buffer (Bio-Rad) to separate protein samples. In order to identify proteins by size, a 
protein standard (Bio-Rad) was also loaded. Once the proteins had separated, the gel 
was stained with Bio-Safe Coomassie Premixed Staining Solution (Bio-Rad) for 1 h 
and washed thoroughly with deionized water. 
 
Proteins biotinylation and tetramers formation 
Proteins were changed to biotinylation buffer (Tris-HCl 10 mM pH 8) using Amicon® 
Ultra Centrifugal filters with 10 kDa cutoff (Milipore) and biotinylated using the BirA 
enzyme (Avidity LLC) at 26 ºC overnight, following manufacturer’s instructions. Next, 
buffer was exchanged to HBS buffer (25 mM HEPES, 140 mM NaCl, 1.42 mM 
Na2HPO4, 0.01% NaN3 pH 7). To form the tetramers 200 μg/ml of proteins were 
incubated with 50 μg/ml (Alexa Fluor 647)-streptavidin (Invitrogen) in HBS buffer for 15 
min at room temperature using a rotating wheel.  
 
Flow cytometry  
For the screening of cell surfaces ligands using the tetrameric forms of proteins, 1×106 
cells per sample were collected, centrifuged at 450g for 10 min and washed twice with 
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FACS buffer (PBS containing 0.2% BSA and 0.05% NaN3). Cells were then plated in 
96-well plates round bottom, centrifuged at 450g, 5 min at 4ºC to remove media and 
incubated with 30 μl of tetramers for 45 min in the dark on ice. Next, cells were washed 
twice with FACS buffer (450g, 5 min, 4ºC). Finally, cells were resuspended in PBS, 
0.05%, NaN3, 1% paraformaldehyde. As controls we used unstained cells and cells 
incubated with (Alexa Fluor 647)-streptavidin (no protein added). Flow cytometric 
analysis was performed using a FACS Calibur I flow cytometer (BD Immunocytometry 
Systems). 
 
1.3. Results 
The N-SSC5D (encoded by exons 1-12) and C-SSC5D (encoded by exons 13-14) 
polypeptides were produced individually due the structural and potentially functional 
differences between both domains (Fig. 1.1). In addition, Spa was also analysed 
because it resembles N-SSC5D. Spa is composed exclusively of SRCR domains and 
like SSC5D is a secreted protein abundant in serum. Therefore, we sought to know 
whether these proteins had a similar binding profile, which could indicate a common 
ligand for SRCR domains in soluble proteins. 
 
Production of the N- and C-terminal domains of SSC5D 
 
Figure 1.1. Schematic representation of the N-terminal (N-SSC5D) and C-terminal (C-SSC5D) domains of 
SSC5D. The molecular weight (MW) of the N-SSC5D and C-SSC5D domains were predicted based 
on their amino acids composition using the bioinformatics resource portal ExPASy.org 
(http://web.expasy.org/compute_pi/). The predicted MW of the N-SSC5D and C-SSC5D domains are 
of 100 and 65 kilodaltons (kDa), respectively. 
The cDNA fragments encoding N-SSC5D and C-SSC5D were cloned into a modified 
version of the commercial mammalian expression vector pEE14-BirA (Lonza Biologics) 
(Fig. 1.2). The selected vector permits the permanent integration of foreign genes into 
chromosomes of mammalian cell lines, which are then replicated. Moreover, eukaryotic 
3’  5’ SSC5D – 4833 bp  
Pro-Thr rich sequences 
5’ and 3’ ends 
SRCR domain 
N-SSC5D C-SSC5D
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systems are capable of expressing and secreting post-translational modified proteins, a 
fundamental requisite especially regarding the C-terminal domain of SSC5D that is 
predicted to be extensively O-glycosylated. pEE14-BirA vector contains an N-terminal 
CMV promotor and hemagglutinin (HA) affinity tag, followed by C-terminal biotin ligase 
(BirA) recognition site and hexahistidine (6x His) affinity tag. 
 
Figure 1.2. Cloning strategy of the constructs encoding the N-SSC5D, C-SSC5D or Spa for stable 
expression of recombinant proteins. A modified version of pEE14 plasmid was used to clone N-SSC5D, C-
SSC5D or Spα constructs for soluble recombinant protein expression in HEH293 and CHO-K1 cells. The 
final product is translated as a single string of amino acids with the following order, a signal peptide 
(RaduSP), a HA-tag, the N-SSC5D or C-SSC5D or Spa sequences, a BirA (BirA) recognition sequence 
and a 6x His tag (His6xtag).  
N- and C-SSC5D plasmids were transiently transfected into HEK 293 cells using a 
cationic lipid-based transfection reagent (Lipofectamine). This small-scale analysis 
intended to confirm the expression and molecular weight of N-SSC5D and C-SSC5D. 
As proteins are expected to be secreted, tissue culture supernatant (TCS) was 
harvested 3 days after transfection and WB analysis using an antibody anti-His was 
performed. As a transfection control, we used a similar construct encoding the 
extracellular domain of CD5. Nonetheless, we could not detect the expression of the N-
SSC5D or C-SSC5D using this fast strategy. However, we observed CD5 expression 
suggesting that the transfection protocol was efficient (Fig. 1.3). The predicted MW of 
CD5 corresponds to approximately 46 kDa. 
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Figure 1.3. SDS-PAGE (7.5 %) immunoblotting of the TCS of C-SSC5D, N-SSC5D and CD5 using an 
anti-His antibody followed by a peroxidase-conjugated goat anti-mouse. The supernatant of CD5 presents 
a single band at approximately 50 kDa. 
 
Since we were not able to induce strong protein expression using transient 
transfections, we attempted a stable transfection system using CHO-K1 cells. For the 
production of large amounts of proteins, a long-term gene expression is usually 
preferred. To develop a stable transfection system, it is necessary to use a selection 
method, for example by co-expressing a specific gene that allows the selection of the 
gene that produces the desired recombinant protein. pEE14 codes for glutamine 
synthetase (GS), an enzyme that in the presence of the substrates glutamate and 
ammonia is able to produce glutamine, an essential amino acid required for cell growth 
and survival. The activity of the GS enzyme is selectively inhibited by methionine 
sulphoximine (MSX), so only the cells that incorporate the vector and express GS at 
adequate levels in a glutamine-free media will survive in long-term cultures, allowing 
for the selection and expansion of the cells expressing the recombinant protein 
(Cockett et al., 1990, Blochberger 1997). After stable transfection, cells were cultured 
into 96-well plates and selected with MSX (see Methods). To confirm protein 
expression by MSX resistant clones, we performed a dot-blot (see Methods). However, 
once more we could not observe protein expression. One hypothesis was that the 
proteins could be retained within cells; therefore, we decided to expand clones in T25 
cm3 culture flasks. At this stage, we collected both TCS and lysate from the clones. 
The cell lysates were negative for both N- and C-SSC5D expression; however, the 
TCS of one N-SSC5D clone - E6 - presented a very faint band with a MW above 150 
kDa that could correspond to the N-terminal domain (Fig. 1.4)  
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Figure 1.4. SDS-PAGE (7.5%) immunoblotting of the lysates (A) and TCS (B) of eight N-SSC5D clones 
using an anti-His antibody followed by a peroxidase-conjugated goat anti-mouse. The supernatant of E6 
presents a single faint band with a MW above 150 kDa. 
 
Purification of N-SSC5D 
To confirm whether the faint band corresponded to N-SSC5D, the E6 clone was grown 
to confluence in a T75 cm3 culture flask. In order to concentrate the protein, the TCS 
was run over a nickel affinity column and proteins were eluted with imidazole (Fig. 1.5). 
To detect the presence of N-SSC5D in the eluted fractions we run a SDS-PAGE 
immunoblotting using an anti-His antibody. 
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Figure 1.5. The TCS of the E6 clone expressing N-SSC5D was run over a nickel affinity column. A. N-
SSC5D protein was eluted with 50 mM imidazole in PBS. B. SDS-PAGE (7.5 %) immunoblotting of 7-12, 
21, 28 and 32 fractions using an anti-His antibody followed by a peroxidase-conjugated goat anti-mouse. 
 
N-SSC5D expressing cells were then cultivated in cell factories for large-scale protein 
production, then secreted N-SSC5D was purified from TCS by nickel affinity 
chromatography using increasing concentrations of imidazole. Fractions from 20 mM – 
500 mM were run in SDS-PAGE and stained with Coomassie blue. However, N-
SSC5D began to be eluted with low imidazole concentrations (20-40 mM), which 
resulted in a higher number of contaminants in the fractions containing N-SSC5D. To 
remove all contaminants, the purest fractions were collected to perform an ionic 
exchange chromatography (Fig. 1.6). The fractions obtained with this technique yielded 
pure N-SSC5D, which was concentrated and quantified, the final yield being of 
approximately 0.3 mg per one liter of culture medium. 
 
Figure 1.6. Anion exchange chromatography purification of N-SSC5D using an Uno-Q column. A. The 
purest fractions resulting from the metal-chromatography were collected and subsequently loaded onto an 
Uno-Q column. The slope is the conductivity of the eluate, representing the salt gradient (0 - 1 M NaCl in 
PBS). B. SDS-PAGE (7.5 %, under reducing conditions) of 43-46 fractions. The fractions were stained with 
Coomassie blue to confirm protein purity. C. SDS-PAGE immunoblotting using an anti-SSC5D antibody 
followed by peroxidase-conjugated goat anti-rabbit IgG antibody. 
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Production of C-SSC5D 
Regarding the mucin-like domain, WB analysis of single clones TCS showed a pattern 
of several bands with different sizes (predicted MW ~ 65 kDa). This pattern could be 
explained by C-SSC5D O-linked oligosaccharides, protein aggregation or degradation 
(Fig. 1.7). Protein purification was not feasible, so we abandoned the C-SSC5D screen 
analysis and production. 
 
Figure 1.7. Analysis of C-SSC5D protein expression. TCS from five MSX resistant C-SSC5D clones were 
run in SDS-PAGE, 7.5 %, under reducing conditions. Detection of C-SSC5D was performed using an anti-
His antibody followed by a peroxidase-conjugated goat anti-mouse.  
 
Production and purification of Spα 
CHO-K1 cells were transfected with the Spα plasmid and cultured on 96-well plates. 
After MSX selection, 15 µl of TCS from the surviving clones were tested for Spa 
expression (dot blot) (Fig. 1.8A). Seven clones were selected and grown to 6-well 
plates (Fig. 1.8B). Next, to confirm protein size, TCS samples were loaded on an SDS-
PAGE gel to perform WB using an anti-His antibody. 
We observed that all clones presented a band of 50 kDa with a higher size than the 
expected (predicted MW ~ 38 kDa) probably derived from complex glycosylation. 
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Figure 1.8. Dot blot analysis of Spα protein expression and immunoblotting of Spα. A. Nitrocellulose 
membrane was blotted with the TCS of MSX resistant Spα clones. B. TCS from seven different clones 
were run in SDS-PAGE, 7.5%, under reducing conditions. Detection of Spα was performed using an anti-
His antibody followed by a peroxidase-conjugated goat anti-mouse. 
 
The A1 clone was selected and grown until the cell factory phase. Next, TCS was 
harvested and pure protein was obtained by following the 2-step purification protocol 
described for N-SSC5D (Fig. 1.9). The final yield of Spα was approximately 1 mg per 
one liter of culture medium. 
 
 
 
Figure 1.9. Anion exchange chromatography purification of Spα using an Uno-Q column. A. The purest 
fractions resulting from the metal-chromatography were collected and subsequently loaded onto an Uno-Q 
column. The slope is the conductivity of the eluate, representing the salt gradient (0 - 1 M NaCl in PBS).    
B. SDS-PAGE (7.5%, under reducing conditions) of C-1 – D10 fractions. The fractions were stained with 
Coomassie blue to confirm protein purity. 
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Screening of cell lines with tetramers of N-SSC5D and Spa  
To increase the sensitivity of potential SSC5D and Spa interactions with cell surface 
ligands, multimeric forms of both proteins were assembled. N-SSC5D and Spa 
recombinant proteins have a biotin ligase (BirA) recognition site that was then 
biotinylated using a biotin ligase enzyme. Next, biotinylated N-SSC5D and Spa were 
incubated with streptavidin, a tetrameric protein composed of four identical subunits, 
where each subunit can bind with high affinity one biotin molecule independently. This 
ligation allowed the formation of N-SSC5D and Spa tetramers. To confirm protein 
biotinylation we performed an immunoblotting using the biotin binding protein 
ExtrAvidin-Peroxidase ® (Fig. 1.10). 
 
Figure 1.10. Analysis of N-SSC5D and Spα biotinylation. Following biotinylation, proteins were run in a 
SDS-PAGE, 7.5%, under reducing conditions. After transferring N-SSC5D and Spα from the gel to the 
nitrocellulose membrane, proteins were directly incubated with ExtrAvidin-Peroxidase ®. The W.B. show 
the bands corresponding to the biotinylated N-SSC5D (left) and Spα (right).  
 
Mucosal surfaces of the body are especially vulnerable to infection. They are thin and 
permeable barriers to the interior of the body and are in contact with the exterior 
because of their physiological activities such as food absorption (the gut) and 
reproduction (uterus). Accordingly, cell surface ligands derived from colon (Caco-2, 
HCT-116) and uterus (HeLa) appeared as prospective candidates for SSC5D and Spa 
binding. Moreover, taking into account the high expression of SSC5D in placenta and 
of its mouse homologue in the urogenital tract, cell lines derived from these tissues 
(JEG-3 and HEK293) were also screened. In addition, the tetramers of SSC5D and 
Spa were also incubated with cells of immune origin (Jurkat E6.1, K562, THP-1) (Table 
1.1). 
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Table 1.1. Cell lines used in the flow cytometry screening. 
Caco-2 Human epithelial colorectal adenocarcinoma  
HCT-116 Human colon carcinoma 
HEK 293 Human embryonic kidney 
HeLa Human epithelial cervix carcinoma 
JEG-3 Human placental choriocarcinoma 
Jurkat E6.1 Human acute T cell leukemia 
K562 Human erythromyeloblastoid leukemia  
THP-1 Human monocytic leukemia 
 
From the results obtained we were not able to see any detectable binding of N-SSC5D 
to the cell lines selected (below the detection level of this assay) (Fig 1.11) 
Nonetheless, we cannot exclude the existence of a cell surface receptor for N-SSC5D 
in other cell types; it may therefore be relevant to perform a wider screen analysis. 
Interestingly, tetrameric Spa binds to JEG-3 and Caco-2 cells, which suggests that 
there is a putative ligand for Spa in placenta and intestine cells. On the contrary, we 
were expecting an interaction between Spa and K562; however the Spa-K562 
interaction is practically negligible. Possible reasons for this result are addressed in the 
discussion section. 
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Figure 1.11. Flow cytometry screening of different cell lines with N-SSC5D and Spa tetramers. Cells were 
incubated with N-SSC5D and Spa tetramers. N-SSC5D (grey), Spa (blue) and uncoupled (Alexa Fluor 
647)-streptavidin (purple). 
 
1.4. Discussion 
Protein interactions control the outcome of most cellular processes, including immunity 
and disease aetiology. Therefore, identifying and characterizing protein recognition 
events is essential to understand the biological function of immune receptors. Despite 
most protein-protein interactions being highly specific, many proteins form transient 
complexes that are difficult to identify (Shoemaker and Panchenko, 2007). Hence, to 
identify potential interactions between SSC5D and cell surface ligands, we used a 
100 101 102 103 104
0
20
40
60
80
100 E6.1
100 101 102 103 104
0
20
40
60
80
100
Caco-2
100 101 102 103 104
0
20
40
60
80
100 K562
100 101 102 103 104
0
20
40
60
80
100 HEK 293
100 101 102 103 104
0
20
40
60
80
100 HCT-116
100 101 102 103 104
0
20
40
60
80
100
JEG-3
100 101 102 103 104
0
20
40
60
80
100 THP-1
100 101 102 103 104
0
20
40
60
80
100 HeLa
%
 o
f M
ax
%
 o
f M
ax
%
 o
f M
ax
%
 o
f M
ax
%
 o
f M
ax
%
 o
f M
ax
%
 o
f M
ax
%
 o
f M
ax
FL4-H
FL4-H
FL4-H
FL4-H
FL4-H
FL4-H
FL4-H
FL4-H
Alexa Fluor 647
Streptavidin (SA)
Spα + SA
N-SSC5D + SA
Chapter 1 
77 
systematic approach that consisted on the production of recombinant proteins 
assembled in a multimeric form to increase the assay sensitivity.  
However, using eukaryotic expression systems to produce functional recombinant 
proteins in satisfactory quantities can be time-consuming and difficult. In our 
experiments we used two cell lines, CHO-K1 and HEK293, with the capacity for 
carrying out posttranslational modifications, a feature essential for the analysis of 
rSSC5D that is predicted to be heavily glycosylated (Gonçalves et al., 2009). We 
started by using transient transfection (HEK293), because it requires less time to 
express proteins (Brondyk, 2009). However, we could not observe the expression of 
SSC5D, even though we assume that the protocol worked, as we could detect sCD5 
expression. Although a stable transfection system can take 2–3 months to generate a 
single cell line expressing proteins (Brondyk, 2009), we attempted to obtain N- and C-
SSC5D by integrating these genes in the CHO-K1 cell genome. This strategy was 
successful, albeit the yield of N-SSC5D obtained after protein purification was very low 
(0.3 mg), when compared with Spa (1 mg) and with sCD5 (18 mg) (which was 
previously expressed using the same expression system by Santos (2012)). We did 
several attempts to increase protein recovering, including adapting cells to serum free 
media to minimize the loss of protein during purification steps, and tried other 
commercial transfection reagents; still, the yield of N-SSC5D was significantly low. One 
possible explanation is that the insertion of the N-SSC5D gene fragment in the CHO-
K1 genome was not in a high-quality locus.  
Regarding C-SSC5D, we observed several clones expressing the protein; however, we 
were not able to purify C-SSC5D due of its intrinsic nature. Its high glycosylation 
pattern that confers SSC5D a mucin-like structure formed massive aggregates that 
would hardly correspond to the native C-terminal domain of SSC5D. Glycosylation 
affects the outcome of a protein by changing its biophysical properties, such as charge, 
folding, solubility or sensitivity to proteases (Varki, 1993). 
The screening assay showed that none of the cell lines analysed bound N-SSC5D. 
Nonetheless, at this stage it is not possible to draw definitive conclusions about SSC5D 
interactions with cell surfaces. Firstly, we cannot exclude that cells from other origins 
would give a different result. Secondly, as we could not fully address C-SSC5D 
interactions, one cannot discard cell interactions through this domain. Thirdly, N-
SSC5D is a recombinant protein, so it may present a conformation that hampers the 
binding of potential ligands. Moreover, protein–protein complexes can have high 
dissociation constants, therefore the binding affinity of recombinant proteins may not 
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be enough to perceive an interaction. Nevertheless, this was the first genuine attempt 
to find a cell surface ligand for SSC5D using a systematic protocol. This study was 
intended to discover cell surface ligands, so in the eventually of SSC5D not binding to 
cells, there is still a myriad of soluble proteins and molecules that can interact with 
SSC5D and contribute to its biological function.  
Interestingly, mouse SSC5D was shown to bind galectin-3 (Miró-Julià et al., 2014), a 
30-kDa protein that is ubiquitously expressed and is present in the cytoplasm, nucleus, 
extracellular space, and cell surface (Dumic et al., 2006). Galectin-3 binds β-
galactoside sugars and is involved in diverse cellular processes including the 
modulation of signal transduction events on the cell surface. One of its ligands is the 
Mac-2-binding protein (M2BP) (Inohara et al., 1996), a heavily N-glycosylated secreted 
protein that is a class A SRCR-SF protein. This glycoprotein is also found in sera and 
has a predicted molecular weight of 97 kDa; however, it has a high tendency to 
associate and therefore oligomers can exhibit average molecular masses between 
1000 and 1500 kDa (Müller et al., 1999). In a pioneer study using a melanoma cell line, 
affinity purified M2BP bound cell surface galectin-3 in a specific carbohydrate-
dependent manner (Inohara et al., 1996). One other study showed that MUC2, an 
intestinal mucin, is a major ligand for galectin-3, whose interaction is much associated 
with colon cancer (Dudas et al., 2002). Therefore, we may suspect that galectin-3 
could bind, as its mouse counterpart, native human SSC5D (probably through the 
mucin-like domain). However, as it happens with the CD6-CD166 interaction, we 
cannot discard the existence of a specific cell ligand for SSC5D, which could interact 
through SRCR domains. 
On another note, we showed for the first time the binding of Spa to nonimmune 
epithelial cells, Caco-2 and JEG-3, a colon and a placenta derived cell lines, 
respectively. Despite that two studies have observed that Spa bound to the myeloid 
cell line K562, in our hands this interaction was practically negligible (Gebe et al., 1997; 
Sarrias et al., 2004). Curiously, there is a noteworthy difference between our study and 
the previous ones. In the studies where Spa interacts with K562 cells, the interaction 
happens in the presence of calcium, which may help to modulate specific ligand 
interactions.  
Current views suggest that the multifunctional and widely expressed CD36 molecule is 
a cell receptor for Spa (Sanjurjo et al., 2015). However, CD36 recognizes a multitude 
of ligands, ranging from bacterial cell-wall components to endogenous lipoproteins, and 
therefore the biological significance of the interaction between Spa and CD36 is 
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unclear (Sanjurjo et al., 2015). Nonetheless, there are cells that do not express CD36 
but are still susceptible to Spa actions (Maehara et al., 2014; Sanjurjo et al., 2015). 
Therefore, other cell surface receptors, namely from the complement system, have 
been proposed as ligands for Spa. Moreover, a study conducted to localize CD36 in 
the human gastrointestinal tract showed that CD36 transcripts were absent in Caco-2 
cells (Lobo et al., 2001). Altogether, these studies suggest that Spa may indeed have 
alternative cell surface ligands. 
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2.1. Introduction 
The early detection of pathogens by the immune system is mediated by germline-
encoded pattern-recognition receptors (PRR), which recognize a variety of conserved 
pathogen-associated molecular patterns (PAMP) that range from bacterial and fungal 
cell-wall components to viral nucleic acids (Janeway Jr, 1989; Iwasaki and Medzhitov, 
2015). Microbes have evolved diverse traits that enhance their ability to spread and 
foster disease in a susceptible host (Casadevall and Pirofski, 1999; Casadevall and 
Pirofski, 2001). This capacity to cause infection is provided by diverse virulence factors 
that include surface membrane proteins, responsible for adhesion, colonization and 
invasion e.g., pili and adhesins, polysaccharide capsules with anti-phagocytic 
properties, and secretory proteins, like toxins and enzymes (Finlay and Falkow, 1997; 
Wu et al., 2008). Such diversity of structures is specifically recognized by membrane-
bound, cytosolic or secreted molecules belonging to several classes of PRR, including 
Toll-like receptors (TLR), nucleotide-binding oligomerization domain (NOD)-like 
receptors, retinoic acid-inducible gene I (RIG-I)-like receptors, and C-type lectin 
receptors (CLR), among others (Areschoug and Gordon, 2009; Blander and Sander, 
2012; Iwasaki and Medzhitov, 2015).  
Accumulating evidence suggests that members of the SRCR superfamily represent an 
important part of the innate immune defence by acting as PRR, exploiting diverse 
mechanisms that may help to ward off infection (Areschoug and Gordon, 2009; 
Martínez et al., 2011; Blander and Sander, 2012; Kneidl et al., 2012). Accordingly, four 
of the nine human receptors belonging to the group B of the SRCR superfamily have 
been shown to bind bacteria or bacterial components. Bacterial interactions were 
reported for the T cell receptor CD6, the monocyte/macrophage receptor CD163, 
DMBT1, which has a broad expression profile, and Spα, a soluble glycoprotein 
expressed by macrophages in the lymphoid tissues and highly present in the serum 
[detection levels of microgram per millilitre (Sarrias et al., 2004)] (Prakobphol et al., 
2000; Sarrias et al., 2005; Sarrias et al., 2007; Fabriek et al., 2009; Madsen et al., 
2010; Martínez-Florensa et al., 2013; Polley et al., 2015). Conversely, the T cell 
receptor CD5 lacked the ability to bind bacteria, but was shown to interact with 
conserved fungal components and to aggregate fungal cells (Vera et al., 2009).  
 
After bacterial challenges, the soluble mouse homologue of Spα (AIM) is immediately 
released from macrophages to control bacteria spreading and, similar to Spα, reduces 
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inflammatory cytokine secretion by PRR-expressing innate cells (Sarrias et al., 2005; 
Martinez et al., 2014). In vivo studies of PAMP-induced septic shock have shown that 
the levels of the AIM increase rapidly upon injection of LPS or Zymosan, further 
suggesting that this SRCR protein can act as a circulating PRR (Martinez et al., 2014). 
SSC5D is a less-explored soluble member of the SRCR family that shares many 
features with Spα. SSC5D is expressed in macrophages, T cells, and several epithelial 
cells, especially from placenta, spleen, and colon (Gonçalves et al., 2009). It is also 
highly abundant in the serum with increasing levels in inflammatory conditions 
(Balakrishnan et al., 2014). The mouse homologue of SSC5D [S5D-SRCRB] is also 
upregulated upon infection and seems capable to bind bacteria (Miró-Julià et al., 
2014); however, for the human counterpart this capacity has not been reported. A 
major difference between SSC5D and Spα relates not only to the number of SRCR 
domains (5 and 3, respectively) but also to the existence of a large mucin-like 
sequence located at the C-terminus of SSC5D. In the human molecule, this domain 
represents about 40% of the amino acid content of the whole protein and it is expected 
that, similar to other O-glycosylated mucin-like proteins, it may bind and modulate 
pathogen behaviour (Linden et al., 2008; van Kooyk and Rabinovich, 2008; McGuckin 
et al., 2011). 
Since the late 1990's, a leading tool for the study of biomolecular interactions both in 
life science and pharmaceutical research are biosensors (Piliarik et al., 2009). Label-
free biosensors have revolutionized the qualitative and quantitative analysis of 
biomolecular interactions (e.g., protein–protein or protein–nucleic acids interactions) 
and are increasingly being adopted in medical diagnostics, environmental monitoring, 
or food safety and security (Homola, 2008; Mariani and Minunni, 2014). Briefly, 
biosensors consist of analytical devices that perceive biomolecular interactions and 
transduce these interactions into digital signals that can be interpreted by the users.  
Today, one of the leading devices used in biomedical research are optical sensors 
based on surface plasmon resonance (SPR), a phenomenon arising from the 
interaction of light with free electrons, the surface plasmons (SP), at a metal-dielectric 
interface (Homola, 2008). Surface plasmons are a collective oscillation of free 
electrons inherently coupled to an electromagnetic wave, propagating at the interface 
of a thin metal layer (~50 nm), usually gold, and a dielectric medium (e.g., aqueous 
solution) (Kretschmann and Raether, 1968; Homola, 2008). The charge density wave, 
named surface plasmon wave (SPW), is maximum at the interface and decays 
evanescently into both media. When a light wave hits a thin metallic surface, photons 
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of the incident light can, at specific conditions, resonantly transfer energy to the surface 
plasmons (Wood, 1902; Homola et al., 1999). This transfer of the energy appears as a 
narrow dip in in the spectrum of the reflected light. Owing that the propagation constant 
of the electromagnetic waves are highly sensitive to changes in the refractive index in 
the vicinity of the metal surface, the binding of biomolecules (analytes) to surface 
immobilized receptors (ligands) may induce changes in the propagation constant of the 
surface plasmon waves (Homola et al., 1999). The change in the propagation constant 
is determined by measuring changes in one of the characteristics of the light wave 
interacting with the surface plasmons, such as the wavelength, the incident angle or 
the intensity of the reflected light (Homola, 2008). The principle of SPR biosensing is 
therefore measuring changes in the refractive index at the sensor surface, caused by 
analyte binding to the chip surface-immobilized receptor. The most common interacting 
molecules include antibodies, peptides, DNA or RNA aptamers, and polymers, which 
are chosen depending on the target (analyte) to be bound (Homola, 2008).  
There are several configurations of SPR apparatus that are capable of generating and 
measuring surface plasmon resonance. Figure 2.1 illustrates a multi-channel SPR 
sensor based on the Kretschmann configuration of the attenuated total reflection (ATR) 
method (Kretschmann and Raether, 1968) and wavelength modulation (Homola, 
1995). In the Kretschmann geometry, a thin a metal layer, typically gold with 50 nm of 
thickness, is placed on the top of a highly refractive glass prism surface (Kretschmann 
and Raether, 1968). When parallel polarised light totally reflects internally at the base 
of the prism generates an evanescent wave that passes through the metal layer and 
excites the surface plasmon waves at the interface of the metal (Homola et al., 1999; 
Homola, 2008). Interactions between the receptors immobilized on the chip surface 
and the target biomolecules in aqueous solutions change the refractive index resulting 
in a shift in the resonant wavelength of the incident light (Fig. 2.1B) The shift in the 
resonant wavelength is measured in real time and is proportional to the refractive index 
change at the sensor surface and thus to the surface concentration of captured 
biomolecules (Fig. 2.1C) (Homola et al., 1999; Homola, 2008).  
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Figure 2.1. A. Scheme of a four-channel prism-based SPR sensor with wavelength modulation (adapted 
from Taylor 2006). A polychromatic light wave is directed through the prism at a fixed angle to the gold-
coated surface where it excites SPs at the metal–dielectric interface. The strength of coupling between the 
incident wave and SPs is observed at multiple wavelengths and the wavelength yielding the strongest 
coupling is measured and used as a sensor output (Homola 2006). B. The SPR spectrum is shown in 
terms of reflectivity as a function of wavelength. The interaction between molecules immobilized on the 
chip surface and their targets increases the refractive index of the incident light resulting in a shift in the 
resonant wavelength. C. The increase in the refractive index is measured in real time and the result plotted 
as response or resonance units (RU) versus time (a sensorgram).  
 
This highly sensitive detection technology that allows label-free and real-time studies of 
molecular binding processes is also employed in the detection of bacteria and other 
microbial pathogens (Homola et al., 2002; Bergwerff and Van Knapen, 2006; Taylor et 
al., 2006; Ahmed et al., 2014). SPR-based sensors for bacteria detection usually rely 
on the use of high-affinity antibodies recognizing particular components of bacterial 
surfaces (Dudak and Boyacı, 2009). Despite the considerably weaker binding affinities 
for common receptor–ligand pairs when compared with antibody–antigen interactions, 
we hypothesized that an analogous strategy could be set up to scrutinize the 
interaction of secreted SRCR proteins with bacteria if these interactions were strong 
enough, reflecting a potential PRR nature of SRCR proteins.  
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Given that we did not find cellular targets for SSC5D binding (Chapter 1), we 
conjectured that, given the potential of a PRR-like function assigned to the SRCR 
family, SSC5D might interact with bacteria. In this work, we have developed a multi-
channel SPR-based protocol to test 1) the ability of SPR biosensor technology to 
monitor the interaction of secreted SRCR proteins with whole cell bacteria of different 
types and 2) the bacteria-binding capacity of the N-terminal moiety of SSC5D 
(excluding the mucin-like sequence likely to bind bacteria per se (Linden et al., 2008; 
van Kooyk and Rabinovich, 2008; McGuckin et al., 2011) and compared with the 
equivalent domains of other SRCR-family proteins, namely Spα and the extracellular 
domains of CD5 and CD6. 
 
2.2. Materials and Methods 
Recombinant protein production and purification 
N-SSC5D and Spα production and purification is described in chapter 1. The soluble 
extracellular domain of CD6 (sCD6) and CD5 (sCD5) were produced as previously 
described (Oliveira et al., 2012; Santos, 2012). The protein purity of sCD6 and sCD5 is 
demonstrated in Figure 2.4. Protein purity was analysed by SDS-PAGE. Samples of 
the fractions obtained by chromatography were run for 1 h at 150 V, and the gel was 
stained with Coomassie Premixed Staining Solution (Bio-Rad Laboratories) for 
visualization of the protein product.  
 
Bacteria strains  
Listeria monocytogenes EGD-e was grown in brain heart infusion (BHI) medium (BD-
Difco) at 37 °C to an optical density of 0.6 at 600 nm (OD600; exponential phase), and 
Escherichia coli strains [BL21(DE3), IHE3034, RS218] were grown in Luria broth 
medium at 37 °C to an OD600 of 0.45.  
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2.2.1. Conventional bacteria–protein binding assays  
Recombinant proteins Spα, N-SSC5D, sCD6, and sCD5 (5 μg per assay) were 
incubated for 1 h at 4 °C with the indicated cell suspensions of live bacteria (1 × 108 
cells) in binding buffer (TBS, 1% BSA, 5 mM CaCl2). Suspensions were centrifuged at 
4,000g for 5 min at 4 °C. Cell pellets were washed thoroughly, then resuspended in 40 
μl Laemmli’s sample buffer, and denatured by heating at 95 °C for 10 min. Next, 20 μl 
of this lysate and pure recombinant proteins (25 or 100 ng) were separated in 6% SDS-
PAGE. The gel was run for 1 h at 150 V with Tris/glycine/SDS running buffer (Bio-Rad 
Laboratories). After the SDS-PAGE, proteins were transferred to the nitrocellulose 
membrane using the iBlotTM Gel Transfer Device (Invitrogen) following the 
manufacturer’s instructions. Then, the membrane was blocked with TBS-T containing 
5% non-fat dried milk, for 1 h. Cell-bound protein was subsequently detected using 
mouse IgG1 anti-HA (clone 16B12) from Covance (0.1 μg/ml) in TBS-T with 3% non-fat 
dried milk, for 1 h at RT, followed by goat anti-mouse HRP-conjugated (Santa Cruz 
Biotechnology) (0.02 μg/ml) in the same conditions. The immunoblot was developed 
using ECL detection reagent (GE Healthcare Life Sciences), and the image was 
acquired in a ChemiDoc XRS+ system (Bio-Rad Laboratories). 
 
2.2.2. SPR-based detection of whole bacterial cell interaction with SRCR 
proteins  
Reagents 
11-Mercapto-tetra(ethyleneglycol)undecanol (HSC11(EG)4OH) and 16-mercapto-
hexa(ethyleneglycol) hexadecanoid acid (HSC11(EG)6OCH2COOH) were purchased 
from Prochimia (Gdansk, Poland). Ethanolamine hydrochloride (EA), 3-
(ethyliminomethylideneamino)-N,N-dimethyl-propan-1-amine (EDC), and 1-
hydroxypyrrolidine-2,5-dione (NHS), all included in the Amine Coupling Kit, were 
purchased from Biacore (Uppsala, Sweden). All other chemicals were of analytical 
grade. Buffers used were SA10 (10 mM sodium acetate, pH 4.0/5.0), PBS (10 mM 
phosphate, 2.9 mM KCl, 137 mM NaCl, pH 7.4), PBNa (PBS** : 10 mM phosphate, 2.9 
mM KCl, 750 mM NaCl, pH 7.4), and Tris (10 mM Tris-HCl, pH 7.4). All buffers were 
prepared using double glass-distilled and deionized water on Milli-Q50 (Millipore, 
Prague, Czech Republic). 
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SPR sensor 
We used a laboratory four-channel SPR platform based on the wavelength 
spectroscopy of surface plasmons (Plasmon IV) (Pimková et al., 2012) developed at 
the Institute of Photonics and Electronics, Czech Republic. In this SPR biosensor, the 
sensor response is expressed as a shift in the wavelength of SPR resonance and is 
directly proportional to the mass of biomolecules attached to the surface of the sensor. 
Using the calibration procedure described in (Homola, 2006), the surface density of 
both the immobilized receptors and the subsequently attached molecules can be 
determined. For an SPR resonance of around 750 nm, the shift of 1 nm in the SPR 
wavelength represents a change in the protein surface coverage of 17 ng/cm2 
(Homola, 2006). All the experiments were performed at 25 °C.  
 
Immobilization of proteins on SPR chip  
The sensor chip was functionalized with a mixed self-assembled monolayer (SAM) by 
incubating the cleaned gold chip in degassed absolute ethanol with a mixture (7:3) of 
HSC11(EG)4OH and HSC11(EG)6OCH2COOH alkanethiols at a final concentration of 
200 μM. The HSC11(EG)6OCH2COOH alkanethiols terminated with a carboxylic head 
group were used to anchor a receptor by amino coupling, while HSC11(EG)4OH 
alkanethiols terminated with hydroxylic group were used to form a stable non-fouling 
background. For that purpose, the sensor chip was immersed in a mixed thiol solution 
at a temperature of 40 °C for 10 min and then stored overnight in the dark at RT. After 
the formation of the mixed SAM, the chip was removed from the solution, rinsed with 
absolute ethanol and deionized water, and dried with nitrogen. The chip was then 
immediately mounted to the prism on the SPR sensor. The activation of carboxylic 
terminal groups was performed in situ by injecting deionized water followed by a 1:1 
mixture of NHS and EDC for 5 min and deionized water again. Conditions for 
immobilization have been optimized in terms of running buffer composition and pH, as 
well as sufficient surface coverage. Immobilization of proteins via covalent attachment 
to COOH/OH SAM was performed at a flow rate of 30 μl/min and a temperature of 25 
°C. To immobilize the receptors, sodium acetate (SA10) pH 4.0 (Spα, N-SSC5D, and 
sCD6) or 5.0 (sCD5) was flowed through the activated surface until a baseline was 
achieved. Then, the SA10 solutions containing the receptors (2–5 μg/ml) were flowed 
across the activated surface until a desired surface coverage was achieved. To remove 
the non-covalently bound receptors, the high ionic strength PBNa (PBS**) buffer was 
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flowed along the sensor surface. Finally, the sensor surface was treated with 1 M EA to 
deactivate residual carboxylic groups. 
 
Detection of the Interaction of the SRCR receptors with bacteria 
Bacteria cells were pelleted from the culture media by centrifugation (4,000g, 5 min) 
and resuspended in PBS. To preserve bacterial cell morphology and to increase the 
sensitivity of the detection, cell aliquots were exposed to isopropanol (final 
concentration, 70% v/v) for 20 min at RT. The pellets of isopropanol-fixed cells were 
obtained by centrifugation at 7,000g for 5 min and washed twice with PBS. 
To detect bacteria-protein interactions we used the following protocol: first a continuous 
flow of buffer (in the absence of bacteria), termed running buffer, was flowed along the 
sensor surface until a stable baseline was achieved. Next, bacteria resuspended in the 
running buffer at a concentration of 1 × 107 CFU/ml (or as indicated in the text) were 
delivered at a flow rate of 50 μl/min to the surface-immobilized proteins to allow the 
contact between the biomolecules and finally, the sensor surface was washed with 
running buffer (in the absence of bacteria) to dissociate receptor-bacteria complexes. 
Two different running buffers were tested for delivering the proteins, Tris and PBS. For 
E. coli the Tris buffer made better conditions for bacteria binding and for L. 
monocytogenes, the PBS was more suitable. 
The binding of bacteria to the sensor surface was detected as the difference in the 
sensor response between the level obtained after the complete wash of the sensing 
surface after the flow of bacteria and the initial baseline level obtained before the 
injection of the bacteria solution (Fig. 2.5).  
To account for potential artifacts that could affect SPR data analysis, we used 
reference-compensated measurements (Myszka, 1997; Ober and Ward, 1999; van der 
Merwe, 2001). Several different surfaces were tested to be used as a reference 
surface. These include a deactivated surface without ligands, surfaces covered with 
BSA, casein, NeutrAvidin or Streptavidin, and a surface with immobilized sCD5 (a 
protein known not to interact with bacteria). The study revealed that there was 
considerable adsorption of bacteria to bare alkylthiolate SAM (used as a functional 
layer) without any molecules immobilized and that the binding of bacteria to the surface 
coated with other molecules was significantly higher than that observed in case of 
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surface coated with sCD5. Therefore, one of the sensing channels was immobilized 
with sCD5 as reference channel.  
 
2.3. Results 
2.3.1. Detection of N-SSC5D binding to bacteria in conventional bacteria–
protein binding assays  
We first assessed the binding of the SRCR-containing extracellular domains of Spα, 
SSC5D, CD6, and CD5 (respectively, Spα, N-SSC5D, sCD6, and sCD5) to E. coli 
strains BL21(DE3), IHE3034, and RS218, and to L. monocytogenes strain EGD-e, 
using conventional bacteria-protein binding assays. Although Spα, sCD5, and sCD6 
had previously been tested for bacteria binding, no experiments had been performed 
for SSC5D. We incubated 5 μg of each recombinant SRCR protein with bacterial 
suspensions of 1 × 108 live cells (colony-forming units, CFU) at 4 °C, followed by 
centrifugation and immunoblotting of the pelleted bacteria.  
We confirmed the interaction of recombinant Spα with all bacterial samples tested, 
having an enhanced capacity to bind E. coli RS218 comparing with the other bacteria 
strains (Fig. 2.2). However, and in contrast with previous studies, no detectable sCD6 
was recovered in association with the bacterial pellets, using our experimental setup. 
There was also no bacteria-bound sCD5 detected, but this was expected, given that 
CD5 was reported not to bind to bacteria (Vera et al. 2009). As observed from the 
experiments, N-SSC5D distinctly detected E. coli RS218 and IHE3034, although there 
was no conclusive evidence at this stage that it could bind to E. coli BL21(DE3) or to L. 
monocytogenes. 
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Figure 2.2. Spα and N-SSC5D bind bacteria. Recombinant Spα, N-SSC5D, sCD6, and sCD5 were 
incubated (5 μg each sample) with suspensions of 1 × 108 CFU of live E. coli, strains BL21(DE3), 
IHE3034, or RS218, or with L. monocytogenes, strain EGD-e. Cell-bound proteins were detected by 
immunoblotting using anti-HA mAb. Pure recombinant proteins were also run (100 and 25 ng, left lanes) to 
determine the sensitivity of the assay. 
 
2.3.2. Use of SPR to probe bacteria binding 
The results from the previous experiment suggested that different SRCR proteins had 
distinct binding properties to different bacterial strains, which might not have been 
highlighted in previous publications, each addressing a different SRCR protein at a 
time. Aware that western blot detection might not be the most sensitive method to 
emphasize these differences, we designed a new SPR-based assay to enhance the 
sensitivity of detection of extracellular proteins binding to bacteria. 
A typical SPR experiment involves several tasks including ligand and analyte 
preparation (selection of buffers, concentration, purity, etc.), the selection of a sensor 
chip and ligand immobilization strategies, selection of a reference surface, analyte 
injection (checking for mass transfer limitation by using different flow rates), surface 
regeneration (if possible) and measurement of the sensor response and data analysis.  
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Immobilization of proteins via covalent attachment to a mixed self-assembled 
monolayer (SAM) of alkanethiols  
Biosensing using SPR is highly dependent on the surface selected to immobilize the 
biomolecular recognition elements. The sensor surface should be properly covered 
with the biorecognition elements, while safeguarding their biological activity, and 
importantly, strategies to avoid non-specific adsorption to the surface must be 
anticipated (Homola, 2008). Self-Assembled Monolayers (SAMs) are organized 
unidirectional layers of molecules which spontaneously forms on a solid surface, 
producing a high-density background that can be regarded as the interface between 
metals, on one hand, and organic and biological materials such as polymers or 
biomolecules (peptides, antibodies, etc.) on the other (Homola, 2008). Due to their 
intrinsic characteristics, SAMs are easily prepared and are the most commonly used 
organic system to perform SPR-based assays with biological samples. In this thesis, 
we used a mixed SAM of alkanethiolates deposited on the chip gold layer. SAM 
surfaces constituted by alkanethiol molecules can be divided in three distinct parts 
(Love et al., 2005): 1) a sulphur group used to form a metal-thiol interaction (gold is 
often used because it is practically inert) (Nuzzo and Allara, 1983) 2) a spacer chain, 
typically made up of methylene groups (CH2)n; n>10), that orient and stabilize the 
monolayer through Van der Waals forces, forming a crystalline structure (Bain et al., 
1989) and 3) a functional head group that can be tailored to produce surfaces with 
different chemical properties (Wink et al., 1997). Alkanethiols terminated with 
carboxylic head groups were used to couple the proteins to the sensor chip via amino 
coupling. In amino coupling, the carboxylic groups of alkanethiols are activated with 
EDC/NHS forming activated esters, that react with the primary amines (–NH2) of lysine 
residues to covalently couple proteins to the SAM (Fig. 2.3). A biosensor surface must 
also offer resistance to nonspecific adsorption of non-target molecules, especially 
proteins. A non-fouling background can be achieved by using a mixture of 
oligo(ethyleneglycol) terminated alkanethiols (Prime and Whitesides, 1993), where the 
hydroxylic group maintains a hydrophilic surface, which is known to significantly reduce 
protein adsorption. 
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Figure 2.3. Schematic description of SPR chip surface functionalization and receptor immobilization. Here, 
a gold-coated glass plate was functionalized with a mixed SAM of alkanethiols that were used to covalently 
anchor the receptors by amino coupling and to form a stable non-fouling surface.  
 
The nature of proteins has a crucial role in determining the best conditions for an 
appropriate immobilization After the activation step (EDC/NHS), the immobilization 
conditions for sCD5, sCD6, Spa and N-SSC5D were optimized regarding running 
buffer composition and pH, appropriate surface coverage and protection of the 
biological activity. Amino coupling is initially promoted by electrostatic interactions 
between the negatively charged carboxylic groups of SAMs and positively charged 
protein. To that end, proteins are diluted into a buffer with a low ionic strength buffer (to 
minimize charge screening) with a pH slightly lower than its isoelectric point or pI (to 
give the protein net positive charge) (van der Merwe, 2001). Accordingly, the 
theoretical isoelectric pIs of sCD5 (pI, 8.18), sCD6 (pI, 5.21), Spa (pI, 5.14) and N-
SSC5D (pI, 6.11) were predicted from the amino-acid sequence using the ExPASy 
software (Gasteiger et al., 2003). We started by optimizing the immobilization 
conditions of sCD6 and sCD5 by diluting the proteins in 10 mM sodium acetate (SA10) 
buffer pH 5 and observed the surface coverage (Fig. 2.4A). The SPR sensor response 
to the immobilized proteins should be about 7 nm (the shift in the resonant 
wavelength). In these conditions, a suitable immobilization level was achieved for 
sCD5; however, the level of immobilized sCD6 protein was very low, which was not 
unexpected because the pI of sCD6 was very close to the pH of the buffer used. 
Therefore, we tried more acidic conditions (pH 4) for sCD6, which resulted in an 
appropriate surface coverage (Fig. 2.4B). Similarly, to CD6, the coupling of Spa and N-
SSC5D to the chip surface was found to be optimal when proteins were flowed in 
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(SA10) buffer pH 4 (Fig. 2.4C, D). After the establishment of the immobilization 
conditions, we proceeded to protein-bacteria interaction analyses. 
 
Figure 2.4. SPR sensor response to the immobilization of sCD5, sCD5, Spa and N-SSC5D using 10 mM 
sodium acetate (SA10) buffer with different pHs (4, 5). A. Coomassie staining of pure sCD5 (left) and 
sCD5 and sCD6 immobilization response using SA10 pH 5 (right). B. Coomassie staining of pure sCD6 
(left) and immobilization response using SA10 buffer pH4 and 5. C, D. Evaluation of the Spa and N-
SSC5D immobilization levels using SA10 buffer pH4 and 5. Following protein covalent coupling to the 
mixed SAM, high ionic strength PBS** buffer was flowed along the sensor surface to remove non-
covalently bound protein, and ethanolamine (EA) was used to block the remaining activated sites to 
reduce non-specific binding. The sensor response is proportional to the quantity of the ligand bound to the 
surface.  
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N-SSC5D and Spα binding to bacteria is measurable by SPR 
To confirm the suitability of our SPR approach to detect bacteria-receptor binding, Spα 
and sCD5 (reference channel) were immobilized in alternate flow chambers until a 
proper surface coverage was achieved. Next, suspensions of isopropanol-fixed 
bacteria, resuspended at a concentration of 1 × 107 CFU/ml were delivered to the 
sensor surface containing the immobilized proteins and SPR plots registered (Fig. 
2.6A). The output of the SPR sensor (expressed in nanometer of resonant wavelength) 
is directly proportional to the amount of biomolecules attached to the surface of the 
sensor. The difference in the sensor output before the injection of bacteria (baseline 
level) and after washing the surface with the captured bacteria in running buffer is 
therefore proportional to the amount of bacteria captured (irreversibly bound) by the 
proteins immobilized on the sensor surface (Fig. 2.5). This quantity was used to 
characterize the ability of the respective immobilized proteins to bind bacteria. 
 
Figure 2.5. Sensor response to continuous measurement of analyte binding to immobilized receptors. 
Upon bacteria injection there is an increase in response due to protein-bacteria interaction. After the 
equilibrium is reached, running buffer is flowed over the surface, where a decrease in sensor response is 
observed due to the dissociation of the receptor-analyte complex. The amount of captured molecules D is 
determined as the difference between the level after the complete wash of the bound surface and the initial 
baseline sensor response of buffer (prior to bacteria injection).  
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neuropathogenic E. coli RS218 and with L. monocytogenes EGD-e and (b) the null 
interaction of sCD5 with both bacteria species. 
As illustrated in Figure 2.6B, the interaction levels of N-SSC5D with bacteria were 
lower than those of Spα in both cases (between 15 and 40% across several 
experiments), but quite distinct from the profiles obtained for sCD5. These results 
confirmed the WB detection of the N-SSC5D-E. coli RS218 interactions seen in Figure 
2.2, but further advanced in the detection of a subtle interaction between N-SSC5D 
with L. monocytogenes.  
The results were reliable and qualitatively consistent among experiments, with only 
small variations in the absolute values of the responses. The chip-to-chip 
reproducibility of the interaction was >82% and >95% for N-SSC5D and sCD5 binding, 
respectively. The reproducibility values were determined from three independent 
experiments for each protein. 
 
Figure 2.6. SPR detection of N-SSC5D binding to E. coli RS218 and L. monocytogenes EGD-e. 
Recombinant Spα (A) or N-SSC5D (B), as well as the control sCD5 were immobilized in sensorchips and 
flowed with E. coli RS218 (left) or L. monocytogenes EGD-e (right) suspensions of 1 × 107 CFU/ml. After 
injection stopped, bacteria were retained in the different surfaces containing the SRCR proteins according 
to the strength of binding. Data are representative of multiple experiments with similar results.  
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N-SSC5D can distinguish between bacterial strains  
To test whether N-SSC5D could have a different capacity to bind different E. coli 
strains, we immobilized N-SSC5D and simultaneously injected, in separate flow 
channels, the non-pathogenic laboratory BL21(DE3) strain, and the meningitis-causing 
RS218 and IHE3034 strains. As another control of null-binding, we used in the fourth 
flow channel, heat-killed IHE3034. In parallel, we performed the same experiment with 
immobilized Spα. As seen in Figure 2.7, E. coli RS218 gave the best binding curve to 
N-SSC5D, followed by IHE3034, and finally BL21(DE3). Heat-killed IHE3034 only 
marginally bound to N-SSC5D, suggesting that the bacterial determinants recognized 
by N-SSC5D are destroyed by heat. The binding profile of Spα to the different E. coli 
strains was not too different, binding marginally better to RS218 and BL21(DE3) than 
N-SSC5D, and less to IHE3034 than N-SSC5D, indicating that these proteins have 
slightly distinct recognition profiles but can nevertheless distinguish between different 
bacterial strains. 
 
 
Figure 2.7. Temporal sensor response to the differential binding of N-SSC5D and Spα to different E. coli 
strains. Recombinant N-SSC5D (and Spα in parallel experiments) was immobilized in the four sensing 
channels and simultaneously injected suspensions of 1 × 107 CFU/ml of E. coli RS218, E. coli IHE3034, or 
E. coli BL21(DE3). The fourth flow channel was used to flow heat-killed IHE3034. After 10 min of injection, 
bacteria were differently retained in the four different sensor chambers. Data are representative of multiple 
experiments with similar results.  
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Differential binding of SRCR proteins to a same bacterial strain  
To directly assess the differential binding capacity of the different SRCR receptors to a 
same bacterial preparation, we immobilized Spα, N-SSC5D, sCD6, and sCD5 in the 
four sensing channels and simultaneously injected E. coli RS218 at 1 × 107 CFU/ml to 
all channels. As depicted in Figure 2.8A, RS218 bound with the highest level to Spα, 
followed by N-SSC5D. As expected, sCD5 displayed the lowest level of RS218 
binding; however, binding of the bacteria to immobilized sCD6 was, although relatively 
low, noticeably higher than that binding to sCD5. This indicates that despite the 
apparent negative result of Figure 2.2, there is some above-background level of 
binding of sCD6 to E. coli RS218 measurable by this SPR-based method.  
Finally, we evaluated the sensitivity of the method by analysing the interaction of E. coli 
RS218 with N-SSC5D using suspensions with decreasing bacteria concentration. 
Figure 2.8B represents again the profiles of binding of E. coli RS218 at 1 × 107 CFU/ml 
to immobilized N-SSC5D and sCD5. Then, the specific binding was obtained by 
subtracting the signals arising from the measuring channels with immobilized N-
SSC5D from those measured in the sCD5-immobilized reference channels. Three 
different concentrations of bacteria were used, 3, 5, and 10 × 106 CFU/ml, and for each 
concentration, the subtractive plots are represented in Figure 4C, indicating that the 
method clearly detects specific binding of E. coli RS218 to N-SSC5D even when using 
bacteria concentrations as low as 3 × 106 CFU/ml. 
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Figure 2.8. Temporal sensor response to the binding of SRCR proteins to E. coli RS218. A. Recombinant 
Spα, N-SSC5D, sCD6, and sCD5 were immobilized in the four sensing channels and simultaneously 
injected with an E. coli RS218 suspension of 1 × 107 CFU/ml.B. Recombinant N-SSC5D and sCD5 were 
immobilized on alternate chambers, and E. coli RS218 was flowed at 1 × 107 CFU/ml. C. The specific 
binding of E. coli RS218 to N-SSC5D was obtained by the subtraction of the non-specific response 
registered for sCD5 from the measured signals ofE. coli RS218 binding to N-SSC5D, for bacterial 
concentrations of 3, 5, and 10 × 106 CFU/ml.  
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2.4. Discussion  
The SRCR-B family comprises a group of proteins that have a very high level of 
genetic conservation and remarkable structural similarity of the SRCR domains. 
However, each member has been described with very exclusive functions, as diverse 
as roles in signal transduction, regulation of inflammation, cell survival and apoptosis, 
differentiation, detoxification in iron metabolism, to name just a few, to such an extent 
that the structural properties of the SRCR modules may be so far the only proven 
unifying feature of the family. This diversity in functions can be in part explained by the 
fact that each protein has unique features (different number of SRCR domains), is 
expressed in different contexts and architectures (membrane bound in different cell 
types, carrying cytoplasmic domains of variable lengths and compositions, or is 
secreted), may have additional domains of other types, and can display different 
degrees of posttranslational modifications, such as O- and/or N-glycosylation.  
Recently, the description of a physical interaction between Spα, which is a small 
soluble protein almost exclusively composed of the three SRCR domains, and several 
strains of bacteria (Sarrias et al., 2005) projected an explicit PRR function for such type 
of domain. Similar microbe-binding properties of other SRCR proteins have indeed 
been assigned to their own SRCR domains (Prakobphol et al., 2000; Sarrias et al., 
2007; Fabriek et al., 2009). To further explore this possible unifying role for SRCR 
domains, we thus investigated the PRR-type properties of the recently described 
protein SSC5D, and more specifically of its N-terminal SRCR-containing moiety. For 
this purpose, we designed an SPR-based assay for rapid, direct and real-time 
observation of immune receptor–bacteria binding events.  
Conventional methods used previously to assay the interaction of bacteria with 
secreted recombinant SRCR (or other) proteins, such as flow cytometry or 
immunoblotting, rely on the labelling of proteins with a fluorescent dye, such as FITC 
(Kneidl et al., 2012), or with biotin targeting the sulfhydryl groups of cysteine residues 
(Sarrias et al., 2005; Sarrias et al., 2007; Vera et al., 2009). Among the many practical 
advantages of the SPR method compared with conventional ones, there is no 
requirement for receptor labelling, and only minute amounts of protein are needed to 
generate distinct or differential signals. In our conventional assays shown in Figure 2.2, 
we used 5 μg of recombinant protein and 1 × 108 CFU per individual receptor–bacteria 
assay, and some of these interactions were on the borderline of western blot 
sensitivity. By comparison, 2 μg of recombinant protein could be used in a single SPR 
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assay testing the interaction with up to four bacteria types, these also used at smaller 
amounts (typically at 1 × 107 CFU/ml, but feasibly down to 3 × 106 CFU/ml), which 
represent an improvement of the detection of protein–bacteria interactions. Moreover, 
the versatility of our setup allows having up to four different immobilized proteins and 
simultaneously comparing the binding of each protein to the same bacterial suspension 
as analyte, or conversely, comparing directly in the same assay suspensions of four 
different bacteria binding to the same immobilized protein. 
Surface plasmon resonance biosensor technology-based affinity and kinetic 
measurements are typically performed with analytes that are monovalent (van der 
Merwe, 2001). Although through complex analyses it is possible to obtain such 
parameters in the case of multivalent (bacterial) contacts (Chung et al., 2007), here we 
have utilized SPR to detect interaction per se and to make synchronized 
measurements, obtaining direct comparable data for sets of four different receptors, or 
four different bacteria samples. It should be noted that we chose to consider the 
amount of captured (irreversibly bound) bacteria to characterize the ability of the 
respective proteins to bind selected bacteria, as the reported experiments with bacteria 
are complex, and the binding curves in response to bacteria are not determined only by 
kinetic parameters of the interactions; they are also affected by other factors, such as 
background refractive index changes (due to differences in the composition of samples 
containing bacteria and running buffer), the non-specific adsorption of bacteria onto the 
sensing surface, and especially by mass transport limitations (due to rather slow 
diffusion of bacteria to the sensing surface) (Myszka, 1997; Ober and Ward, 1999; van 
der Merwe, 2001). 
An important aspect in the design of the assay is the choice of a reference, which 
allows for the compensation of changes in the refractive index due to unspecific 
events. In the context of our study, sCD5 was defined as such based on the literature 
and on the result obtained with our conventional assay. Additionally, we chose to use 
sCD5 in experiments, as this protein is genetically and structurally related with the 
query molecules N-SSC5D and Spα, and thus it would account for intrinsic unspecific 
binding features that can be particular to the SRCR family of molecules.  
From the experiments described in the present work, we show for the first time that, 
like some other human SRCR proteins, SSC5D, through its set of SRCR domains, has 
the capacity to bind bacteria and, from the direct comparisons established using the 
multichannel SPR apparatus, that N-SSC5D and Spα can distinguish between different 
types of bacteria on one hand and different strains of one type of bacteria on the other. 
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Binding of N-SSC5D and Spα to E. coli RS218 gave higher sensor responses than 
binding to BL21(DE3). While BL21(DE3) is a well-characterized non-pathogenic 
research model commonly used in academic laboratories and in the biotech industry, 
RS218 is a pathogenic strain belonging to the serotype O18ac:H7:K1 and displaying 
virulence factors that contribute to the onset of meningitis. The IHE3034 strain also 
belongs to the same serotype and although N-SSC5D binds better to IHE3034 than to 
BL21(DE3), the same behaviour is not observed for Spα, suggesting that SRCR 
proteins may have very defined discriminatory properties on different, still undefined, 
extracellular components of bacteria. Likewise, the response signals for N-SSC5D and 
Spα binding to L. monocytogenes were significantly lower than to E. coli, possibly 
reflecting a differential sensing of Gram-positive vs. Gram-negative bacteria, but at this 
stage and with very few bacteria types tested, it is premature to establish any 
categorization.  
The interactions of N-SSC5D and Spα with E. coli RS281 were relatively strong and 
specific and, as shown for N-SSC5D, the sensor responses increased proportionally to 
the concentration of the bacterial suspensions used. Comparing with the conventional 
assays, binding to E. coli IHE3034, also a meningitis-causing pathogen, did not give 
the same precise results, as N-SSC5D bound less and Spα bound better in the SPR 
experiments than in the bacteria-binding assays. SPR offers substantial benefits when 
compared with these methods, because it allows real-time detection of bacteria and, 
moreover, since bacteria are delivered under conditions of continuous hydrodynamic 
flow, the SPR technique is expected to better mimic the protein–bacteria interaction 
under physiological conditions where shear forces promoted by the body fluids are 
likely present (Bustanji et al., 2003; Salminen et al., 2007). As measurements are 
obtained simultaneously for the different proteins/bacteria within the same experiment, 
we can be confident that they truly reflect quantitative differences in binding of SRCR 
proteins to bacteria.  
CD6, on the other hand, was reported to bind to Gram-positive and Gram-negative 
bacterial strains (Sarrias et al., 2007). CD6 is a receptor of T lymphocytes that has 
characterized roles in the regulation of T cell signalling and in inflammatory responses 
(Oliveira et al., 2012; Pinto and Carmo, 2013), so its role as a pathogen sensor was 
unexpected. From the results of our conventional assay shown in Figure 2.2, we would 
have concluded that either sCD6 does not bind to the tested bacteria or that it binds 
with such low affinity that the interaction does not survive the pelleting and washing of 
the bacteria. However, our improved SPR assays may highlight a slightly different 
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conclusion: although the level of binding of sCD6 to E. coli RS218 (Fig. 2.8) was 
significantly lower than that of either N-SSC5D or Spα, it stayed clearly above the level 
of the sCD5 negative profile. Apart from the higher sensitivity over the previous 
methods, SPR is run at the more adequate temperature of 25 °C, whereas 
conventional protein–bacteria binding assays are customarily performed at 4 °C. 
Notwithstanding the fact that the bacteria-binding capacities of sCD6 are reduced 
comparing with N-SSC5D or Spα, it is nonetheless very plausible that sCD6 may have 
true microbe-sensing properties, which are highlighted by its capacity to protect 
animals from LPS-induced septic shock and in a lethal model of polymicrobial sepsis 
(Sarrias et al., 2007; Martínez-Florensa et al., 2017). 
In conclusion, we have demonstrated through the use of a dynamic, antibody-free, 
SPR-based assay that N-SSC5D, like Spα, is capable to physically interact with whole 
bacteria cells. This new approach can be adapted to screen for interactions with a wide 
range of bacteria and once the best bacterial targets of N-SSC5D are identified, this 
will hopefully allow to better characterize and more deeply explore the role of this 
SRCR protein in pathogen sensing and in driving immune responses. The results 
obtained in this study using the SRCR-containing moiety of SSC5D will undoubtedly 
further our understanding of the specific function of SRCR domains as the functional 
parts of a family of mammalian proteins that have enhanced capabilities to recognize 
and eventually fight bacterial pathogens. 
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3.1. Introduction 
In the previous chapter, we observed that N-SSC5D could bind and discriminate 
between different strains of bacteria. This capacity is essential in certain body locations 
such as intestine, lung and genitourinary tract where PRR, albeit being in permanent 
contact with beneficial resident microbiota, can also contact invading virulent 
microorganisms that have to be effectively neutralized. Mucosal tissues are therefore 
well-equipped with both innate and adaptive immune components, and its defence is 
highly dependent on the PRR expressed not only by immune cells, but also by the 
epithelia (Tlaskalová-Hogenová et al., 2011). Previous results revealed that the SSC5D 
gene is expressed in the placenta, spleen and more weakly in the colon and lung 
(Gonçalves et al., 2009), which suggests a biological function in placental and mucosal 
immunity.  
Trophoblast cells are the main structural and functional components of placenta. These 
are implicated in the maternal-foetal interface formation (Red-Horse et al., 2004), which 
allows the exchange of oxygen and nutrients, and has also an important 
immunomodulatory role (Mor and Cardenas, 2010; Mor and Kwon, 2015). Trophoblasts 
directly interact with maternal decidual immune cells, including NK cells, macrophages 
and regulatory T cells, which direct placentation and regulate maternal-foetal tolerance 
(Munoz-Suano et al., 2011). In addition, the trophoblast layer is also important to 
resolve uterine infections that often result in pregnancy complications such as preterm 
delivery, abortion or preeclampsia (Koga et al., 2009; Mor and Cardenas, 2010). To 
protect the embryo from the detrimental effects of pathogenic agents, trophoblasts 
work as innate immune cells through the expression of PRR that sense not only 
virulent agents but also host damage signals (Koga et al., 2009; Mor and Cardenas, 
2010). Trophoblasts cooperates with maternal immune cells to mediate immune 
responses and their PRR include TLR and cytoplasmic-based NLR (Abrahams, 2011). 
Interestingly, the expression profile of TLR and NLR varies according to the placenta 
development phase; and the nature of each immune response is influenced by the type 
of stimuli perceived, which can derive mild inflammatory responses to severe cell 
apoptosis (Koga et al., 2009; Abrahams, 2011; Pudney et al., 2016). Accordingly, a 
successful pregnancy upon microbial challenge is intrinsically related to an adequate 
innate trophoblast immune response (Mor and Cardenas, 2010), for instance elevated 
levels of the inflammatory cytokine IL-1β may trigger prematurity (Abrahams, 2011). In 
addition, the trophoblast is itself capable to produce anti-microbial peptides such as the 
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secretory leukocyte protease inhibitor (SLPI), a major anti-viral factor (McNeely et al., 
1997; Sallenave, 2002). Interestingly, a study proposed the existence of a low 
abundant commensal ‘placenta microbiome’ (Aagaard et al., 2014). Nevertheless, 
owing to the complexity of the studies required to further this matter, the existence of a 
placental microbiota is still a controversial issue (Hornef and Penders, 2017). 
As above-mentioned, mucosal tissues, including the intestine where SSC5D is 
expressed, are rich in PRR expressed by immune and epithelial cells. However, so far 
the evaluation of the expression of SSC5D expression has been limited to the mRNA 
analysis of immune derived cell lines and peripheral blood monocular cells. Therefore, 
we sought to investigate SSC5D protein expression in cells from diverse origins, using 
a novel antibody, and to evaluate its distribution in different parts of biological tissues. 
Moreover, to fully understand the physiological importance of SSC5D, an important 
part of our proposed studies included the generation of SSC5D-deficient mice. As 
already mentioned in the general introduction, KO mice have been essential to the 
acknowledgment of TLR as PRR, and to predict some of the functions of the SRCR 
members, such as the anti-apoptotic role of Spα (Miyazaki et al., 1999). Hence, in vivo 
studies in mice depleted of SSC5D should help to clarify its putative functions, and in 
particular its role as a PRR and in mucosal homeostasis.  
  
3.2. Material and Methods 
Cell lines 
Cell lines JTAg, E6.1, K562, KG-1, Raji and THP-1 were maintained in Roswell Park 
Memorial Institute medium (RPMI) 1640 supplemented with 10% dialyzed foetal calf 
serum (FCS) (First Link), 1 mM sodium pyruvate, 2 mM L-glutamine, penicillin G (50 
U/ml) and streptomycin (50 μg/ml) at 37 °C in a 5% CO2 humidified incubator. RPMI 
1640 and all supplements were obtained from (Gibco, Life Technologies) except for 
FCS (First Link). Cell lines A498, A549, ACHN, Caco-2, HeLa, MCF-7 and TCCSUP 
were maintained in Dulbecco's Modified Eagle's medium (DMEM) supplemented with 
10% (20% TPC-1) FCS, 1 mM sodium pyruvate, 2 mM L-glutamine, penicillin G (50 
U/ml) and streptomycin (50 μg/ml) at 37 °C in a 5% CO2 humidified incubator. DMEM 
and all supplements were obtained from (Gibco, Life Technologies) except for FCS 
(First Link).  
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Peripheral blood mononuclear cells isolation 
Human peripheral blood mononuclear cells (PBMCs) were isolated from healthy adult 
blood donors from Hospital de São João (Porto, Portugal) by density gradient 
centrifugation using Lympholite®-H (Cedarlane). Erythrocytes were lysed by using a 
red blood cell lysis buffer (0.01 M Tris, 0.15 M NH4Cl, pH 7.2) for 8 min at 37 ºC. 
Monocytes were separated from peripheral blood lymphocyte by adherence for 1 h at 
37 °C in a 5% CO2 humidified incubator. Monocytes were differentiated into 
macrophages with macrophage colony-stimulating factor (M-CSF) at 50 ng/ml (Immuno 
Tools) and to dendritic cells with granulocyte-macrophage colony-stimulating factor 
(GM-CSF) (Immuno Tools) and IL-4 (Immuno Tools) at 25 ng/ml. Cells were 
maintained in culture for 7 days in RPMI- 640 medium supplemented with 10% FCS 2 
mM L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin and maintained at 
37 °C in a 5% CO2 humidified incubator.  
 
Cell lysis 
Cells at a density of 50 × 106 cells/ml were used to prepare the lysates. For adherent 
cells (80% confluence), medium was discarded and cells were washed with ice-cold 
PBS and detached by scrapping. Then, both adherent cells and suspension cells were 
collected by centrifugation at 450g for 5 min and washed twice with ice-cold PBS twice. 
The supernatant was discarded and cells were treated with lysis buffer (1% Triton X-
100, 1 mM PMSF) on ice for 15 min. Next, cell lysates were transferred for 
microcentrifuge tubes and centrifuged at 20,000g at 4°C for 10 min. The supernatant 
was collected and the pellet was discarded. To perform the immunoblotting, the 
supernatant was diluted (1:1) in Laemmli Sample Buffer (Bio-Rad) with β-
mercaptoethanol at 10% and boiled at 95 ºC for 5 min, then 20 μl were loaded into the 
gel. 
 
Western blotting analysis of SSC5D 
Cell lysates were run in SDS- PAGE for 1 h at 150 V with Tris/glycine/SDS running 
buffer (Bio-Rad). Samples were transferred to the nitrocellulose membrane using the 
iBlotTM Gel Transfer Device (Invitrogen) following the manufacturer’s instructions. 
Then, the membrane was blocked with TBS, 0.1% Tween 20 (TBS-T), containing 5% 
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non-fat dried milk, for 1 h with shaking. SSC5D was detected with rabbit anti-SSC5D 
RB36409 (Abgent, 1:500) and in TBS-T with 3% non-fat dried milk, for 1 h at RT, 
followed by peroxidase-conjugated goat anti-rabbit IgG antibody (Sigma, 1:30,000) for 
1 h at RT. Immunoblot was developed using Amersham ECL detection reagent (GE 
Healthcare Life Sciences) and exposed to BioMax MR films (Kodak). The protein α-
tubulin was used as a loading control and was detected with anti-α-tubulin (Sigma, 
1:10,000) followed by goat anti-mouse-HRP (Santa Cruz, 1:20,000). 
 
Immunohistochemistry (IHC) protocol  
Human tissues for IHC were obtained from Hospital Pedro Hispano with the local 
ethical approval. For IHC assays, 4 µm sections from neutral buffered formaldehyde-
fixed paraffin-embedded human tissue were deparaffinised in xylene, hydrated in an 
ethanol gradient (100%, 96%, 70%) until water. Antigens were retrieved with 10 mM 
sodium citrate pH 9 for 30 min at 96 ºC. After heating, slides were left in buffer for 
15 min at RT. The following steps for the immunostaining were done using the kit Ultra 
Vision LP Value Detection System – HRP Polymer and DAB Chromogen (Dako). 
Primary polyclonal antibody rabbit anti-SSC5D (Abgent) was incubated for 1 h at RT 
(1:500 dilution in Ab Diluent S2022; Dako). Sections were counterstained in Mayer's 
haematoxylin, dehydrated using graded alcohols (70%, 96% and 100%) and xylene. 
Finally, cover slips were mounted with DPX (Sigma). No immunostaining was observed 
when the primary antibody was omitted or substituted with a pre immune rabbit serum. 
 
Flow cytometry staining protocol 
Cells were harvested by centrifugation at 450g, 5 min, 4 ºC and adjusted to 1 × 106 
cell/ml. Then, cells were washed twice with ice cold FACS Buffer (PBS, 2% FCS, 
0.05% NaN3). For surface staining, anti-SSC5D was diluted in FACS Buffer (1:100) and 
cells were incubated for 30 min on ice, in dark conditions. Cells were then washed 
twice and incubated with anti-rabbit-PE (1:100, Invitrogen) 30 min on ice, dark 
conditions. After cell 2-step washing, cells were fixed with fixing buffer (PBS, 1% 
paraformaldehyde) 15 min at RT, washed twice and resuspended in PBS buffer. Cells 
were analysed in a FACS Calibur I flow cytometer (BD Immunocytometry Systems). 
Data were analysed using the FlowJoTM software (Tree Star). For intracellular staining 
(ICS), cells were fixed with fixing buffer (PBS, 1% paraformaldehyde) for 15 min at RT 
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and washed twice with FACS buffer. Then, anti-SSC5D (Abgent) was diluted in ICS 
Buffer (PBS, 2% FCS, 0.4% saponin, 0.05% NaN3) (1:100), and cells were incubated 
for 30 min on ice, dark conditions. Cells were then washed twice and incubated with 
anti-rabbit-PE diluted in ICS buffer (1:100) for 30 min on ice, dark conditions. Cells 
were washed twice with FACS buffer, resuspended in PBS and analysed in a FACS 
Calibur I flow cytometer (BD Immunocytometry Systems). Data were analysed using 
FlowJoTM software (Tree Star). Isotype control (IgG) rabbit SC 2027 (Santa Cruz). 
 
Confocal microscopy analyses of Caco-2 cells 
Cells were seeded at density of 1 × 105 in µ-Dish 35 mm ibiTreat surface (ibidi) 
overnight in DMEM, supplemented with 10% FCS, 1 mM sodium pyruvate, 2 mM L-
glutamine, penicillin G (50 U/ml) and streptomycin (50 μg/ml) at 37 °C in a 5% CO2 
humidified incubator. On the following day, cells were washed twice with PBS and fixed 
with 3.7% paraformaldehyde for 15 min. Then, cells were washed with PBS and 
incubated for 30 min with buffer (PBS, Triton 0.1%, BSA 1%). Anti-SSC5D (Abgent) 
was diluted in buffer (1:500), and cells were incubated for 1 h on ice, dark conditions. 
Cells were then washed twice with PBS, 0.1% Triton. Then, goat anti-rabbit conjugated 
Alexa Fluor® 647 (Life technology) was diluted (1:500) in buffer and cells were 
incubated for 30 min on ice, dark conditions. Cells were washed twice with PBS. 
Nucleus were stained with 4',6-diamidino-2-phenylindole (DAPI) for 5 min (1:1000, 
Molecular Probes). Finally, one drop of VECTASHIELD® Mounting Media (Vector 
Laboratories) was delivered onto the cells to preserve fluorescence. Cells were 
analysed with Laser Scanning confocal microscope Leica TCS SP5 II (Leica 
Microsystems, Germany). 
 
Targeting vector construction  
 To create the 5’ homology arm of the construct to delete mouse Ssc5D, we needed to 
introduce 1) consensus 34 base pair DNA recognition sites (loxP sites) located at 600 
bp upstream the start codon of Ssc5d and 2) to amplify the genomic region 
corresponding to exons 1-5. To insert the loxP site, we performed a chimera PCR with 
two fragments of mice genomic DNA To amplify the first fragment (900 bp), which 
included a NotI restriction site upstream loxP and part of the loxP site we performed a 
PCR using the sense primer 5´-CTGGCGGCCGCTAGAGACCATGCCCACTGGATAG-
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3´ (NotI site underlined) and anti-sense 5´-
CGTATAGCATACATTATACGAAGTTATTTATTACCAGTTCCCAGAACAAAG-3´ in a 
50 μl mixture containing 1 μM of each primer, 250 ng of mice genomic DNA, 10 mM 
dNTPs, 0.2 μl MgCl2 and 1 U of phusion enzyme (FINNZYMES) with the following 
cycling conditions: 98 oC for 30 s and 25 cycles of 98 oC for 10 s, 65 oC for 20 s and 72 
ºC for 30 s, followed by a final extension of 72 ºC for 7 min. Next, we performed a 
second two-step PCR to insert the SmaI restriction site (2800 bp) using the following 
primers 5´-CTTCGTATAATGTATGCTATACGAAGTTATGTTCAGACACTCTTTTCTCGAATC-
3´ and 5´-CTACCCGGGATCTGAAGGGGCACTGTGAACGC-3´ (SmaI site underlined) in a 
50 μl mixture including 1.5 μM of each primer, 250 ng mice genomic DNA, 10 mM 
dNTPs and 2.6 U of Expand High Fidelity PCR System (Roche) with the following 
cycling conditions: 94 oC for 2 min, 10 cycles of 94 oC for 15 s, 65 ºC for 30 s and 68 oC 
for 2.5 min, followed by additional cycling conditions 20 cycles of 94 oC for 15 s, 65 ºC 
for 30 s and 72 oC for 2.5 min and final extension of 72 ºC for 7 min. The two fragments 
(NotI-loxP) and (loxP-SmaI) were purified with GeneClean kit (MP Biomedicals) and 
the total 5’ homology (3.7 kb) arm was amplified using 2 μM of 5´-
CTGGCGGCCGCTAGAGACCATGCCCACTGGATAG-3´ (NotI site underlined) and 5´-
CTACCCGGGATCTGAAGGGGCACTGTGAACGC-3´ (SmaI site underline) primers, 10 mM 
dNTPs and 2.6 U of Expand High Fidelity PCR System (Roche) with the following 
cycling conditions: 94 oC for 2 min, 10 cycles of 94 oC for 15 s, 65 ºC for 30 s and 68 oC 
for 4 min, followed by additional cycling conditions 20 cycles of 94 oC for 15 s, 68 ºC for 
30 s and 72 oC for 4 min and final extension of 72 ºC for 7 min. The 5-homology arm 
was subsequently purified with the GeneClean kit (MP Biomedicals), digested with NotI 
and SmaI and cloned into the–NotI/SmaI digested mammalian expression, Cre/Lox 
PGKneoF2L2DTA vector (Adgene). To amplify the 3’ homology arm (4 kb) 
corresponding to the genomic region between exons 6-8 including SalI and HindIII 
restriction sites, we used the following primers 5´-
GCTGTCGACCAGTCAGGGCTGGCCACCTCC-3´ (SaII underlined) and 5´-
AGTAAGCTTTGTCCAGGCAGGCAGCTGTCTCC-3’ (HindIII underlined) in a 50 μl 
mixture including 2 μM of each primer, 250 ng mice genomic DNA, 10 mM dNTPs and 
2.6 U of Expand High Fidelity PCR System (Roche) with the following cycling 
conditions: 94 oC for 2 min, 10 cycles of 94 oC for 15 s, 60 ºC for 30 s and 68 oC for 2.5 
min, followed by additional cycling conditions 20 cycles of 94 oC for 15 s, 60 ºC for 30 s 
and 72 oC for 2.5 min and final extension of 72 ºC for 7 min. The amplified fragment 
was subsequently purified with the GeneClean kit (MP Biomedicals), digested with SalI 
and HindIII and cloned into the SalI/HindIII digested PGKneoF2L2DTA vector. 
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Electroporation and selection of ES cells  
After cloning the Ssc5d fragments into the PGKneoF2L2DTA vector, we linearized the 
DNA construct (restriction enzyme) to obtain a targeting vector. For the electroporation 
of CJ7 mouse embryonic stem cells (Swiatek and Gridley, 1993), we used 25 ug of the 
previously linearized DNA, purified by phenol:chloroform extraction, ethanol 
precipitated and resuspended in 50 μl of PBS. A single cell suspension of 10 x 106 cells 
from an 80% confluent culture was obtained by trypsinization, then washed twice with 
PBS at room temperature and resuspended in 800 ul of PBS. Afterwards, the cell 
suspension was mixed with the DNA and loaded onto an electroporation cuvette (0.4 
cm gap). Electroporation was performed with a pulse at 0,24 kV, 500 uF. Cells were 
then removed from the cuvette, diluted into 25 ml of complete ES cell medium 
(Robertson, 1989) (without selection) and distributed into five 60 mm plates, coated 
with feeder cells (Stewart et al., 1992). Selection was done with 350 μg/ml of G418 
(Geneticin, an analog of neomycin) added to the complete ES cell medium. Selection 
started 24 hours after electroporation and was maintained for 6 days (the G418-
containing medium was changed every day), then individual colonies were picked for 
further analysis. 
 
Cloning and labelling of KO probe NAT14 
The genomic DNA fragment to be used as probe (NAT14) was amplified in a 50 μl 
mixture including 300 nM of the sense primer 5’- GCTCTGACACGACCTCCA -3’ and 
300 nM of the anti-sense 5’-TTGCTGAATTCCCTAACCAG-3´, 250 ng mouse genomic 
DNA, 10 mM dNTPs and 2.6 U of Expand High Fidelity PCR System (Roche) with the 
following cycling conditions: 94 oC for 2 min, 30 cycles of 94 oC for 15 s, 55 ºC for 30 s 
and 72 oC for 45 min, followed by a final extension of 72 ºC for 7 min. The amplified 
product corresponding to a band of 500 bp was purified using GeneClean kit (MP 
Biomedicals) and 4 μl of purified amplicon was inserted into p-GEMT (T4 DNA ligase - 
Roche).  
 
To label the probe we repeated the PCR and added 4 μl of the PCR reaction to 41 μl of 
ddH20, then the DNA probe was heated for 5 min at 98 ºC and then rapidly cooled in 
ice to prevent renaturation of the complementary strands. The probe was purified with 
Illustra NICK columns (GE health care). The column was first washed with 2.5 mL 
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Tris/EDTA buffer (TE) and then equilibrated with 2.5 mL TE.	 The DNA probe was 
eluted with 50 μl of TE buffer. In the radioactive safe room, the probe was labelled with 
[α-32P]dCTP using Redi prime II DNA labelling system (Amersham) and incubated for 1 
h at 37 ºC. To purify the radioactive probe, the Illustra NICK column was first washed 
with 400 μl of TE and then the probe was eluted with 400 μL of TE. The probe was next 
heated at 99 ºC for 5 min and then rapidly cooled in ice. Next, the 400 μL of TE 
containing the probe were added to the membrane with the digested DNA clones and 
incubated under rotation (biometra ov 3) overnight at 65 ºC to hybridize with DNA. This 
probe hybridizes specifically with the last exon of NAT14, the gene preceding SSC5D. 
 
Southern-blotting  
Fifty-tree neomycin-resistant clones were selected and digested with HindIII and SpeI 
or SpII. Next, the digested DNA was run on an 0.8% agarose gel. The gel was treated 
with 1) 0,25 M HCl 20 min – to depurinate the DNA fragments to improve the 
transference 2) 0.5 M NaOH/ 1.5 M NaCl for 45 min to denature the double-stranded 
DNA and 3) 0.5M Tris 7.5/3 M NaCl for 45 min to neutralize the gel. Then, the DNA 
was transferred from the gel to the nylon membrane (Bio-Rad #162-0196 zeta-Probe 
(30 x 3,3)) and treated according to the manufacturer’s instructions.  
 
3.3. Results 
The SSC5D protein is widely expressed in cells from diverse origins 
Protein expression was evaluated by WB using a novel antibody anti-SSC5D and 
immortalized cell lines derived from kidney (A498, ACHN), bladder (TCCSUP), lung 
(A549), colon (Caco-2), cervix (HeLa), breast (MCF-7), thyroid (TPC-1); and from 
immune cells, T cell (E61), B cell (Raji), monocytic (THP-1), and lymphoblast-like 
(K562) and myeloblast-like myelogenous leukemia cell lines (KG-1) (Fig. 3.1)  
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Figure 3.1. SDS-PAGE (7.5%) immunoblotting of the cell lines lysates using the anti-SSC5D antibody 
followed by peroxidase-conjugated goat anti-rabbit IgG antibody.  
The WB analysis of SSC5D revealed a broad expression in several types of cells. 
Interestingly, SSC5D is found in cells derived from mucous tissues, including lung and 
gastrointestinal tract, and in kidney, where mouse Ssc5d was shown to be highly 
expressed (Miró-Julià et al., 2014). All the cell lines presented a band of ~100 kDa with 
the exception of TCCSUP, no bands, and THP-1, which presented an additional 
smaller band. The predicted MM of native SSC5D is ~165 kDa, still we were expecting 
a band with a superior size due to the predicted heavy glycosylation. This unexpected 
result is consistent with alternative splice events that are common feature in SRCR 
members (Sarrias et al., 2004). Additionally, we also evaluated SSC5D expression in 
the primary immune cells PBL, monocytes, macrophages and dendritic cells (Fig. 3.2).  
 
Figure 3.2. SDS-PAGE (7.5%) immunoblotting of the primary cells using the anti-SSC5D antibody 
followed by peroxidase-conjugated goat anti-rabbit IgG antibody.  
Concerning primary cells, we observed two bands representing SSC5D expression 
with a similar pattern to THP-1. The only exception were dendritic cells where we could 
observe one band above 100 kDa and an additional faint band at approximately 250 
kDa, which could correspond to native full-length SSC5D. Altogether, we conclude that 
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SSC5D is widely expressed and that a smaller alternative isoform is preferentially 
expressed over the full-length protein in the cells and conditions analysed. 
 
IHC analysis revealed that SSC5D is preferentially expressed in epithelial cells 
To better understand the function of SSC5D, we performed a IHC assay to get detailed 
information about the localization of this receptor in several human tissue sections (Fig. 
3.3).  
 
Figure 3.3. Immunohistochemical localization of SSC5D in human tissues. The tissues were stained using 
a polyclonal antibody directed against SSC5D and counterstained with Mayer’s hematoxylin. A positive 
signal is shown by brown colour. 
In the gastrointestinal tract (colon and stomach), SSC5D is expressed in goblet cells, 
which are glandular epithelial cells that secrete mucins and other mucus components 
to form a mucosal barrier. This barrier is important to prevent the bacteria invasion of 
epithelial surface and trigger inflammatory responses (Johansson et al., 2013). In the 
liver, SSC5D is expressed in hepatocytes, the metabolic cells that are involved in 
diverse biochemical functions and in the synthesis and secretion of blood proteins, 
cholesterol, and bile components, among others (Hoekstra et al., 2013). The 
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expression of SSC5D in the female reproductive tract, is confined to the fallopian tube 
and ovary follicular epithelia. Intriguingly, there is no evidence of SSC5D expression 
in uterus. SSC5D is also expressed in the breast lobules (milk producing glands). In 
testis, SSC5D is expressed in the spermatogencic cells of the seminiferous tubules 
(epithelial cells). We also observed the expression of SSC5D in the urinary system, 
namely in the kidney distal collecting ducts (epithelial cells), which is in agreement with 
its mouse homologue reported results (Miró-Julià et al., 2014). However, in the 
bladder the expression was not so obvious. In the central nervous system, the 
frontal cortex, hippocampus and thalamus exhibit an intense staining in neurons, but 
no staining in glial cells. In the cerebellum no expression of SSC5D was observed. In 
lymphoid organs, SSC5D is expressed in a diffuse way in the red pulp of spleen, a 
region containing mainly composed of innate immune cells. Conversely, in thymus 
there is no SSC5D expression. 
 
SSC5D is highly expressed in syncytiotrophoblast  
SSC5D is highly expressed in chorionic villi (foetal part), mainly in the cytoplasm of 
syncytiotrophoblast cells (the outer layer of trophoblast). Interestingly, in a placenta 
with an undetermined infection, SSC5D expression is undetectable (Fig. 3.4).  
 
Figure 3.4. Immunohistochemical localization of SSC5D in a typical placenta (A) and in a placenta with an 
unspecified infection (B). Negative control rabbit pre-immune serum (C). Tissue sections were stained 
using a polyclonal antibody against SSC5D and counterstained with Mayer’s hematoxylin. A positive signal 
is shown by brown colour.  
 
SSC5D is intracellularly expressed in E6.1 cells 
The protein sequence of SSC5D predicts a signal peptide 
(http://www.cbs.dtu.dk/services/SignalP/) that usually directs proteins to the secretion 
apparatus. In the secretory pathway, proteins can be secreted, target to certain 
A B C
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organelles (endoplasmic reticulum, Golgi or endosomes) or be inserted into the 
membrane. In addition, SSC5D can be attached to the cell membrane by binding 
integral membranes. Therefore, to assess whether the protein could be on the cell 
surface, we performed a flow cytometric analysis using a cell line (E6.1) positive for 
SSC5D expression. The protocol consisted on using two different buffers, one for 
surface and other for intracellular staining, which contains saponin a detergent used to 
permeabilize cell membranes. Cell staining was performed with anti-SSC5D and a 
secondary antibody coupled to phycoerythrin (PE) fluorescent dye. In the 
permeabilized cells there is a shift on the intensity of PE meaning that SSC5D is 
exclusively found intracellularly in E6.1 cells and not at the cell membrane (Fig. 3.5).  
 
Figure 3.5. Flow cytometric analysis of SSC5D expression in E6.1 cells under nonpermeabilizing (left) or 
permeabilizing conditions (right). Cells were stained using a polyclonal antibody against SSC5D, followed 
by the secondary antibody coupled to (PE) to visualize SSC5D (red) or with the (isotype control (IgG), 
surface) and the PE labelled goat anti-rabbit as a control (blue). 
 
SSC5D localizes to cytoplasmic and nuclear puncta in Caco-2 cell  
To study the distribution of SSC5D inside cells, we carried out confocal microscopy 
analysis of Caco-2 cells, which have been extensively used as a model of the intestinal 
barrier (Sambuy et al., 2005). We found that SSC5D localises to discrete cytoplasmic 
puncta (or spots) and not diffuse throughout the cytoplasm. Still, it is unclear whether 
SSC5D is inside/or associated with endocytic vesicles or whether rather the 
punctuated distribution represents protein aggregates. Intriguingly, strong nuclear 
puncta were also observed, in this case likely representing protein aggregates (Fig. 3. 
6).  
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Figure 3.6. Caco-2 cells were imaged using a confocal laser scanning microscope. Cells were stained with 
anti-SSC5D. Nuclei were counterstained with DAPI (blue) (bars -25 microns).  
 
Generation of SSC5D Knockout Mouse 
This task was performed in collaboration with Moises Mallo from the Instituto 
Gulbenkian de Ciência (IGC), Lisbon. Our strategy to generate a conditional Ssc5d KO 
mouse was through gene targeting using the Cre/loxP and Flp/Frt recombinase system 
to selectively inactivate Ssc5d. The first step includes the production of a targeting 
vector to be electroporated into murine embryonic stem (ES) cells and the identification 
of the targeted ES cell line(s). After establishing the homologous recombinant ES 
clones, these are microinjected into mice blastocysts to generate chimeric mice. The 
chimeras can be crossed to an engineered mouse that expresses the bacteriophage 
gene Cre-recombinase (Cre), which can excise loxP-flanked DNA segments (Nagy, 
2000) to produce heterozygous mice without the Ssc5d allele. Cre recombinase 
catalyses the recombination between two recognition loxP sites, which are 34 bp 
consensus sequences consisting of a core spacer of 8 bp and two 13 bp palindromic 
flanking sequences (Nagy, 2000). The heterozygous mice can subsequently be 
crossed to produce homozygous Ssc5d knockout mice. 
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To construct the targeting vector, we started by retrieving the genomic sequence of the 
Mus musculus homologue of SSC5D from the Ensemble database 
(http://www.ensembl.org/) and inserted the 5’- and 3’ homology arm DNA fragments 
into the PGKneoF2L2DTA vector. The plasmids containing the two fragments of Ssc5d 
were identified by digestions assays, sequenced and sent to the Moises Mallo 
laboratory to be electroporated into CJ7 embryonic stem (ES) cells. 
The targeting vector was composed of: 
1) A 5’ homology arm of 3.7 kb (exons 1-5) flanked by two loxP sites, one at 600 bp 
upstream the start codon and other after exon 5 to be targeted by the Cre 
recombinase; 
2) A neomycin (neo) resistance cassette to allow the selection of recombinant ES 
clones. The cassette is flanked by FRT sites to allow its removal by Flp recombination 
after neo selection; 
3) A 3’ homology arm of 4 kb (exons 6-8) for homologous recombination. 
To establish homologous recombinant ES cell clones, the CJ7 embryonic stem (ES) 
cells were electroporated with the linearized targeting vector and selected with 
neomycin. Ninety-six neomycin resistant colonies were picked into 96-well plates and 
expanded. Next, the genomic DNA of each clone was digested with SphI, HindIII/SpeI 
and HindIII restriction enzymes in independent reactions to identify targeted clones by 
Southern blot analysis using a radioactive 5’ probe. The radioactive probe hybridizes 
specifically with the last exon of Nat14, the gene preceding Ssc5d. Nonetheless, none 
of the clones exhibited the desired pattern (Fig. 3.7). 
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Figure 3.7. Construction of the targeting vector to delete Ssc5d. A. Fragments of Ssc5d genomic DNA 
(exons 1-5) and (exons 6-8) were amplified by PCR and inserted into the PGKneoF2L2DTA vector to allow 
the homologous recombination. B. Linearized targeting vector. C. Expected sizes of the DNA fragments 
after digestion of the wild-type allele of Ssc5d and a homologous recombinant ES clone with SphI, HindIII, 
and double digestion with HindIII and SpeI restriction enzymes. D. Southern blotting analysis of a 
neomycin resistant clone (right) and a wild type control (left) using a radioactive probe. The band patterns 
resulting from the digestions are similar in the neomycin resistant-clone and the wild-type allele of Ssc5d 
E. Schematic representation of a successful targeted ES clone and the generation of a KO allele through 
the action of Cre-recombinase.  
Given the complexity of the experimental procedures, the ever growing obstacles we 
were facing and, above all, the surge of a novel and promising new technology, 
delivering much faster results (CRISPR/Cas9), that was arising and successfully 
demonstrated in many laboratories, including the lab of Moises Mallo, we decided at 
this time to terminate this line of work and swapped, already with success, to the 
CRISPR/Cas9 strategy, performed by other colleagues at our lab. Therefore, these 
developments are not described in this thesis. 
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3.4. Discussion 
Initial studies carried out in our laboratory revealed the existence of an abundant 
mRNA transcript corresponding to what is considered the full-length SSC5D, and the 
existence of other smaller, but less abundant transcripts in placenta, spleen and colon 
(Gonçalves et al., 2009). However, despite the mRNA levels being indicative of the 
presence of proteins, mRNA transcript and protein abundance are only partially 
correlated (Vogel and Marcotte, 2012). This indicates that post-transcriptional 
regulatory mechanisms, translational control, and protein degradation can also affect 
protein concentration (Vogel and Marcotte, 2012). Therefore, to analyse the native 
expression of the SSC5D protein we used a novel antibody against SSC5D to 
determine 1) the expression of SSC5D in cells from diverse origins using 
immunoblotting and 2) the distribution of SSC5D in human tissues using 
immunohistochemistry.  
Immunoblotting revealed the existence of a 100-kDa protein from cells of immune 
origin (T- and B- cells, monocytic and myeloid) and from many tested cells of distinct 
organ origin. However, the molecular weight corresponding to SSC5D was not the 
expected for its full-length expression (165 kDa), which indicates that in these cells we 
may be observing an alternative spliced isoform of SSC5D. In addition, in THP-1 and 
primary cells (PBL, monocytes and macrophages) an additional smaller band is 
detected, suggesting the existence of additional alternative spliced isoforms. 
Interestingly, the expression of SSC5D in dendritic cells follows a different pattern, 
where we can observe three bands including a faint band around 200 kDa, which 
suggests the expression of the heavily glycosylated full-length SSC5D.  
Alternative spliced variants are common in several members of the SRCR-SF and are 
often linked to distinct biological events. For instance, one particular isoform of CD163 
is insensitive to glucocorticoid stimulation in clear contrast with other CD163 variants 
(Hoegger et al., 1998). Additionally, the alternative variant of CD6 that lacks the third 
SRCR does not localize to the immunological synapse (Castro et al., 2007). 
Our immunohistochemistry analysis revealed that SSC5D is mainly expressed in 
epithelial and secretory cells from reproductive and mucosal tissues. This expression 
pattern much resembles DMBT1 (Holmskov et al., 1999), which has an important role 
in tissue homeostasis and in pathogen clearance in mucosal tissues (see general 
introduction). The expression of mouse Ssc5d in kidney was already demonstrated in a 
recent study, where its expression was shown to be up-regulated in a model of urinary 
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tract infection (Miró-Julià et al., 2014). Additionally, SSC5D is also found in the brain 
like CD6 (expressed in basal ganglia and cortex cerebellum) (Mayer et al., 1990) and 
DMBT1, whose down-regulation was related to a higher probability of brain tumours 
(Mollenhauer et al., 1997). 
The spleen is the principal organ responsible for the detection of blood-borne bacterial, 
viral and fungal pathogens (Bronte and Pittet, 2013). It is divided into two regions 
called the red pulp, where SSC5D is expressed, and white pulp, which are separated 
by an interface named the marginal zone (MZ) (Macneal, 1929; Bronte and Pittet, 
2013). The white pulp contains T and B cells, which generate antigen-specific immune 
responses against blood pathogens. Conversely, the red pulp is composed of innate 
immune cells such as resident macrophages that phagocytose aging red blood cells 
and regulate iron recycling and release, natural killer T cells that sense lipid antigens, 
and a reserve of monocytes and dendritic cells (Bronte and Pittet, 2013). In addition, 
the red pulp has a unique subset of B cells called innate response activator (IRA), 
which are the main producers of GM-CSF (Bronte and Pittet, 2013). The unique 
expression of SSC5D in the region containing innate immune cells hints towards its 
possible role as an innate immune receptor against blood-derived pathogens. 
The female reproductive tract consists of several histologically distinct sites and can be 
divided into a lower tract (vagina and ectocervix) and an upper tract (endocervix, uterus 
Fallopian tubes and ovaries). The expression of SSC5D was observed in fallopian 
tubes and ovary epithelia, but was absent in the uterus. However, in HeLa cells (Cervix 
Adenocarcinoma Cells) the expression of SSC5D was observed, probably indicating 
that SSC5D is also expressed in the cervix (no tissue section was available). The 
female reproductive mucosa varies in the lower and upper tract. Accordingly, in upper 
tract mucosa it is composed of single-layered columnar epithelium, whereas the lower 
tract is covered by a stratified squamous epithelium, which potentially provides a more 
effective barrier against invading pathogens than the columnar epithelium (Trifonova et 
al., 2014).  
Epithelial cells, stromal fibroblasts and leukocytes are the main immune components of 
the female reproductive tract; however, the distribution of leucocytes is also different in 
the lower and upper tracts (Givan et al., 1997). For instance, T cells, the most 
abundant cell leukocyte in the reproductive tract, are richer in the lower tract, whereas 
granulocytes and NK cells are more abundant in the upper tract (Wira et al., 2015). In 
addition, PRR such as TLR2, TLR4, cytoplasmic RIG as well as NLR are also unevenly 
distributed. These PRR are more abundant in the upper tract than in the lower tract, 
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suggesting a mechanism to minimize responses against commensal bacteria and an 
effective response to pathogenic bacteria in the upper tract, more sensitive to bacteria 
(Pioli et al., 2004; Ghosh et al., 2013; Wira et al., 2015). The expression profile of 
cytokines is also different, with more pro-inflammatory cytokines, e.g., IL-1β and IL-6, 
being expressed in the upper tract, where the environment should be sterile (Wira et 
al., 2015). The secretion of mucins by the endocervical epithelial cells is also an 
important immune mechanism to protect epithelia from the contact with pathogens 
such as HIV (Wira et al., 2015). It is therefore tempting to speculate that SSC5D may 
have a role as a PRR, namely during viral invasion. The breast expression of SSC5D is 
also of interest as lactating mothers are more prone to bacterial infections. 
Currently, the placenta is viewed as an immune regulatory organ that modifies 
maternal immunologic responses to microorganisms (Racicot et al., 2014). Accordingly, 
foetal-placenta immune responses must be tightly controlled to prevent pregnancy 
complications that often result from exacerbated inflammatory reactions. The 
expression of SSC5D in syncytiotrophoblast epithelial cells, which are in direct contact 
with maternal blood, may suggest that SSC5D senses microbes that escape cervix 
protection and reach the uterus, or that are present in maternal blood (Racicot et al., 
2014). In addition, SSC5D may also function as damage receptor and promote tissue 
repair through the interaction with host molecules. Accordingly, a recent study showed 
that DMBT1 is abundantly observed in injured syncytiotrophoblast areas and was 
suggested to contribute to tissue repair (Reichhardt et al., 2016). Curiously, SSC5D is 
apparently absent in a placenta having an infection of unknown aetiology. One possible 
explanation is that SSC5D is downregulated when challenged with specific microbes. 
For instance, the treatment of whole blood with E. coli results in a significant down-
regulation of TLR1 and TLR6 in monocytes and granulocytes (Zarember and 
Godowski, 2002). Similarly, TLR5 and TLR6 are also down-regulated by Poly(I:C), an 
analogue of viral dsRNA, and a ligand of TLR3 in primary lung epithelial cells (Ritter et 
al., 2005). One other study observed that the stimulation of TLR2 with Borrelia 
burgdorferi (responsible for Lyme disease) mediated the down-regulation of TLR5 
(recognizes flagellin) (Cabral et al., 2006) in monocytes. The authors suggested that 
the TLR expression patterns may change in response to diverse environments, 
including inflammatory conditions, and that these changes might be useful for either 
the pathogen or the host (Cabral et al., 2006).  
The bioinformatics analysis of SSC5D protein sequence does not predict a 
transmembrane region (Gonçalves et al., 2009). Still, SSC5D can be attached to the 
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membrane lipid layer through noncovalent interactions with membrane proteins. To test 
this hypothesis, we used a cell line positive for SSC5D expression (E6.1) and observed 
SSC5D expression staining under non-permeabilization conditions, and after cell 
membrane permeabilization. However, we only observed SSC5D intracellularly. This 
suggests that SSC5D is not expressed at the cell surface and that potential interactions 
with cell membrane proteins will be of transient nature or it would require an 
intermediate. 
Using confocal microscopy, we noticed a punctuated distribution of SSC5D in the 
cytoplasm (probably within vesicles) and in the nucleus of Caco-2, colon-derived 
epithelial cells. The cytoplasmic distribution of SSC5D in low-density Caco-2 cells is 
similar to that of hensin (rabbit homologue of DMBT1) in intestinal crypt cells (intestinal 
glands) (Vijayakumar et al., 1999). The intestinal epithelium is held together by tight 
junctions creating a barrier that difficult the entry of antigenic agents and is divided into 
two compartments the crypts, where stem cells proliferate and differentiate; and the 
villi, mainly composed of mature adsorptive cells (Van der Flier and Clevers, 2009). In 
one study, hensin was found inside vesicles in the crypts, and associated to the 
extracellular matrix in the villi (Vijayakumar et al., 1999). This study suggested that 
hensin was associated to the terminal differentiation of epithelia (Vijayakumar et al., 
1999). As SSC5D is highly expressed in the intestine and has cytoplasmic distribution 
similar to DMBT-1, it would be of interest to evaluate SSC5D role in epithelial 
differentiation. 
Images of confocal microscopy also showed SSC5D in the nucleus; however, the 
protein sequence of SSC5D does not carry a nuclear localization signal to direct it from 
the cytoplasm to the nucleus (Garcia-Bustos et al., 1991), so this observation was 
unexpected and we have not yet found a convincingly explanation for this effect.  
Adding to this first description of the expression of SSC5D in different organs and 
tissues, and because SSC5D seems to be expressed in many different body locations 
by diverse immune and non-immune cells, it was important to develop a mouse model 
deficient of the expression of Ssc5d. However, the strategy we first considered was not 
successful, as we could not obtain recombinant ES clones to generate chimeras. 
Nevertheless, using the new gene-editing technology CRISPR-Cas9 (Doudna and 
Charpentier, 2014), two independent mouse lines of Ssc5d KO have been very 
recently developed by our laboratory.  
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Despite no functional results being as yet available, we can observe that Ssc5d KO 
mice are viable. In light of what is now known about DMBT1, regarding functions in 
pathogenic recognition and mucosal homeostasis, it will be noteworthy to explore the 
function of SSC5D during pathogenic challenges and the susceptibility of Ssc5d-
defficient mice to different stimuli. 
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Discussion 
Functional and structural studies have shown that proteins of the SRCR superfamily 
are important in the host defence machinery. For example, they are implicated in the 
differentiation and activation of lymphocytes, in the protection against broad microbial 
agents, in the modulation of inflammation and in tissue repair mechanisms. Despite the 
common presence of the highly conserved SRCR domain, this large family constitutes 
a particularly heterogeneous group that includes transmembrane and soluble 
glycoproteins that are expressed in different cell types and body locations. Moreover, 
some functions of the SRCR proteins are not attributed to their SRCR domains but to 
other structures or regions within the protein (Martínez et al., 2011). On the other hand, 
very similar proteins, for example CD163L1 is not capable of bacteria recognition, while 
the highly similar protein CD163 binds bacteria through the second SRCR domain 
(Grønlund et al., 2000; Fabriek et al., 2009; Moeller et al., 2012). These findings 
suggest that the distinctive presence of the highly conserved SRCR domain might not 
be a requisite for the function of a SRCR member, and that we cannot predict the 
function of a singular SRCR member based only on its common structural features.  
Notwithstanding these arguments, there is some evidence to suggest that the SRCR 
domains are responsible for protein-protein interactions and that are correlated to 
protein function. For instance, the T cell transmembrane glycoprotein CD6 binds the 
surface cell ligand CD166 through its third SRCR member and this interaction is 
important to localize CD6 in the immunological synapse (Hassan et al., 2004; Castro et 
al., 2007). The structural interaction of these proteins was resolved recently and 
revealed that the SRCR domains 1 and 2 also indirectly favour this interaction  
(Chappell et al., 2015). The CD6-CD166 interaction induces a series of signal 
transduction cascades that endow CD6 with a role in T cell modulation during APC-
TCR contacts. Still, as it happens with other SRCR-related interactions, the extent and 
biological relevance of such interaction remains to be fully apprehended. 
The cloning and first analyses of SSC5D in our laboratory revealed the existence of a 
new soluble glycoprotein member of the SRCR-SF composed of 5 SRCR domains and 
a mucin-like domain (Gonçalves et al., 2009). Given that we are now working with a 
novel protein having no information whatsoever about its function, we proposed at the 
start of this study to cover the major steps in its characterization, namely its tissue 
distribution and its functional binding to other cells, self and/or non-self. Additionally, a 
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central aim was to develop a knockout mouse to infer the functional role of Ssc5d in 
models of infection and/or inflammation. 
For characterizing any functional effects, we were required to produce and purify the 
SSC5D protein. In chapter 1, we thus focused on the production of the moieties 
corresponding to the SRCR containing domains (N-SSC5D) and the mucin-like domain 
(C-SSC5D) to independently analyse their binding capacity to several cells surfaces. 
The rationale was to understand whether the SRCR domains were, like CD6, capable 
to bind cells surfaces and provide some evidence about the existence of a cognate 
ligand. However, some substantial differences exist between CD6 and SSC5D, namely 
the fact that CD6 is a transmembrane protein shown to be directly involved in cell-cell 
contact and in the activation of signalling pathways as discussed earlier, whereas 
SSC5D is a soluble/secreted protein expressed by a variety of cells, including epithelial 
and immune cells (chapter 3). We thus additionally produced the soluble recombinant 
Spα because it represented a more suitable comparable protein to SSC5D to analyse 
putative interactions.  
The proteins were assembled in a tetrameric form to increase the affinity for cell 
surface receptors (a previously strategy developed by our laboratory). Unfortunately, 
we did not detect significant N-SSC5D binding to any of the cells analysed. However, 
at this stage it is premature to discard a potential interaction of N-SSC5D with cell 
surface receptors as a wider analyse could deliver potential interactions. In addition, 
we did not explore other experimental conditions that could increase the sensitivity of 
this method. Regarding the mucin-like domain (C-SSC5D), the production of large 
quantities of soluble N-SSC5D was hampered by technical difficulties, namely the 
formation of massive aggregates during the purification steps, which we relate to the 
complexity of the O-glycosylation events of recombinant glycoproteins  (Dwek R., 
1996). Often the reduced availability of proteins (recombinant or native) poses an 
obstacle to complete experimental protocols. Hence, the development of more 
sensitive techniques are also hindered by this limitation.  
Not having obtained evidence for interactions of SSC5D with receptors in endogenous 
cells, we hypothesized that it might have a role in the identification of foreign cells, 
namely bacteria, as had been demonstrated for other SRCR proteins. In chapter 2, we 
thus explored this possibility and developed an SPR-based assay for the rapid and 
sensitive detection of bacterial binding to the SRCR domains of SSC5D. It must be 
noted that studies concerning the mouse homologue of SSC5D were published at the 
time of this work, so these and other reports, including those focusing on Spα and its 
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ability to bind bacteria, constitute an additional and more solid background from where 
to develop better suited experimental methods.  
The application of label-free detection mechanisms based on optical sensors has been 
gathering much attention and is now viewed as an alternative to conventional protocols 
used to study biomolecular interactions. Accordingly, SPR biosensors allow rapid, 
direct and real-time observation of the protein-bacteria interaction and usually require 
less protein and bacteria to perform multiple analyses. Moreover, since bacteria are not 
static and are usually carried by flowing fluids (water, urine, or blood), SPR-based 
analyses better represent the dynamics of pathogenic interaction, when compared with 
traditional methods (Zagorodko et al., 2015). Therefore, in this work we asked whether 
this tool was suitable to study the interaction of surface-immobilized N-SSC5D with 
different types of bacteria.  
As SSC5D is highly expressed in placenta, we selected types of bacteria, namely the 
Gram-negative E. coli O18:K1:H7 strains RS218 and IHE3034 as well as the Gram-
positive L. monocytogenes, which are able to cross the placental barrier and cause 
pregnancy and/or neonatal complications. The E. coli K1 strains are the main 
responsible for neonatal gram-negative bacillary meningitis and have several virulence 
factors including the outer membrane protein A and invasins (IbeA and IbeB) that 
promote the invasion of the blood-brain barrier (Yao et al., 2006). Nonetheless, the 
RS218 strain has additional virulence factors such as P fimbriaand the Hek outer 
membrane protein that mediate adherence to host cells (Yao et al., 2006). In the SPR 
assay we observed that N-SSC5D could bind both strains of bacteria, but it bound 
slightly better RS218, which hinted to a possible discrimination of bacteria surface 
molecules. Interestingly, N-SSC5D could not bind heat-killed IHE3034, which suggests 
that intact surface structures are needed for the interaction to occur. The binding 
affinity of N-SSC5D to L. monocytogenes was revealed by the SPR assay and was 
inferior to the binding to the E. coli strains, suggesting that N-SSC5D can differentiate 
between types of bacteria.  
As described in several studies, some SRCR-SF members bind to purified LPS, LTA 
and/or PGN; however, it is unclear whether these molecules are the ligands on the 
surface of intact bacteria (Areschoug and Gordon, 2009). It is possible that other 
microbial proteins are ligands for these PRR. For instance, the binding of the 
scavenger receptor-A (SR-A) to Neisseria meningitidis is independent of surface LPS, 
as shown by using a lipid A-deficient isogenic mutant of N. meningitidis (Peiser et al., 
2002). Later studies identified N. meningitidis outer membrane proteins as ligands for 
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SR-A (Areschoug and Gordon, 2009). In addition, as it happens with TLR, SRCR can 
have a wide range of ligands (Brubaker et al., 2015). This study emphasizes that 
differences in the ligands recognized by the SRCR receptors might exist. Therefore, 
sensitive studies using SPR multi-channel devices to detect the binding of SRCR 
receptors to whole bacteria may help in the search of the bacterial structures 
responsible for specific SRCR-bacteria interactions. 
The function of a protein depends on its location, so we devoted chapter 3 for a wide 
characterization of SSC5D expression. We observed that SSC5D is mainly expressed 
by the epithelial cells in several organs, especially at mucosal sites. Epithelial cells at 
the mucosal surfaces form a physical barrier that is protected by several immune 
effector systems that include the secretion of mucin glycoproteins, for example by 
intestinal goblet cells, that coat the intestinal epithelia to minimize bacterial-epithelial 
contact, and the production of antibacterial components such as α-defensins, collectins 
and soluble (s) IgA (McGuckin et al., 2011; Hooper et al., 2012). In addition, epithelial 
cells can directly respond to pathogenic and opportunistic agents via PRR, such as 
TLR and NLR, and trigger immune responses (Bulek et al., 2010; McGuckin et al., 
2011). DMBT1 at mucosal surfaces was shown to interact with pathogens, e.g., H. 
pylori, S. mutans and Influenza A virus, as well as antimicrobial components, including 
sIgA, MUC5 and lung surfactant proteins SP-D and SP-A (Kang and Reid, 2003). This 
capacity suggests that DMBT1 can directly bind pathogens or work in synergy with 
other host proteins to effectively clear microorganisms. In addition, DMBT1 also binds 
the host galectin-3 (Rossez et al., 2011), a glycoprotein involved in the regulation of 
cell proliferation, differentiation and apoptosis (Dumic et al., 2006). 
The expression profile of SSC5D (chapter 3), the ability to bind bacteria through the N-
SSC5D domain (chapter 2) which contains the scavenger domains, and the capacity of 
its mouse homologue to bind the endogenous extracellular proteins laminin, galectin-1 
and -3 (Miró-Julià et al., 2011; Miró-Julià et al., 2014) much resembles some of the 
DMBT1 features. However, unlike DMBT1 and a few other SRCR molecules, there 
were no knockout animals developed previously to allow us a better comparison with 
the function of the other SRCR proteins. We are about to fill that gap as we have just 
recently developed two independent lines of Ssc5d mice, and hopefully we will 
assemble important data regarding the function of Ssc5d in physiological conditions 
and in models of disease. The results obtained in this thesis predict a role for SSC5D 
in mucosal immunity and possibly in epithelial cell homeostasis. Therefore, future 
experiments, especially using our recently generated Ssc5d KO mice may open new 
avenues for studying the functional relevance of this intriguing immune receptor.   
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